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Staphylococcus	  aureus:	  background	  and	  impact	  
Staphylococcaceae	  are	  a	  family	  of	  Gram-­‐positive	  bacteria	  within	  the	  phylum	  Firmicutes.	  
Staphylococci	  are	  closely	  related	  to	  streptococci,	  as	  well	  as	  bacilli,	  lactococci,	  and	  clostridium,	  
many	  of	  which	  are	  opportunistic	  pathogens.	  The	  Staphylococcal	  genome	  is	  approximately	  2.8	  
Mb,	  with	  large	  variability	  within	  regions	  associated	  with	  human	  colonization	  and	  disease	  [1,2].	  
More	  than	  forty	  species	  of	  staphylococci	  have	  been	  described,	  several	  of	  which	  colonize	  
humans	  [1].	  Of	  these,	  two	  species	  particularly	  are	  relevant	  to	  human	  health:	  Staphylococcus	  
aureus,	  and	  to	  a	  lesser	  extent,	  Staphylococcus	  epidermidis.	  Staphylococcal	  colonization	  is	  
widespread.	  Nearly	  all	  humans	  are	  non-­‐infectiously	  colonized	  by	  S.	  epidermidis,	  an	  
opportunistic	  pathogen	  in	  immunocompromised	  individuals,	  and	  approximately	  ⅓	  of	  the	  
human	  population	  carries	  S.	  aureus	  in	  the	  anterior	  nares	  of	  the	  nose	  at	  any	  given	  time,	  with	  10-­‐
20%	  displaying	  persistent	  colonization	  [3,4].	  Noninfectious	  colonization	  can	  contribute	  to	  
Staphylococcal	  disease	  under	  certain	  conditions	  
	  
Staphylococcus	  aureus	  is	  a	  prominent	  pathogen	  based	  on	  its	  transmissibility,	  antibiotic	  
resistance,	  and	  potential	  to	  cause	  invasive	  disease	  [3,4].	  It	  is	  the	  primary	  source	  of	  hospital	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acquired	  “nosocomial”	  infections	  that	  cost	  loss	  of	  life	  and	  financial	  expenditures	  well	  over	  US	  
$1	  billion	  per	  year	  [4].	  Nosocomial	  infections	  may	  include	  devastating	  disorders	  like	  necrotizing	  
pneumonia	  and	  septic	  shock	  resulting	  from	  surgical	  site	  contamination	  [5].	  Toted	  as	  a	  
“superbug”,	  S.	  aureus	  is	  a	  titan	  of	  antibiotic	  resistance,	  causing	  devastating	  and	  difficult	  to	  treat	  
infections	  [6-­‐8].	  Methicillin	  and	  vancomycin	  antibiotic	  resistant	  strains	  are	  leading	  killers	  among	  
nosocomial	  infections	  [2,5,8-­‐10].	  Antibiotic	  resistant	  community-­‐acquired	  S.	  aureus	  strains	  
cause	  hard-­‐to-­‐treat	  diseases	  like	  osteomyelitis,	  septic	  arthritis,	  and	  skin	  infections	  [8].	  Certain	  
subgroups,	  including	  children,	  prison	  inmates,	  diabetics,	  AIDS	  patients	  and	  other	  
immunocompromised	  individuals,	  are	  more	  susceptible	  to	  infection	  [6-­‐8,	  11].	  S.	  aureus’	  
contribution	  to	  human	  disease	  is	  complicated	  by	  its	  non-­‐infectious	  colonization	  of	  a	  large	  
portion	  of	  the	  human	  population.	  Under	  certain	  conditions,	  acute	  and	  chronic	  infections	  result	  
from	  the	  invasion	  of	  specific	  tissues,	  resulting	  in	  pathogenicity	  [4].	  The	  mechanisms	  responsible	  
for	  S.	  aureus’	  transition	  from	  commensal	  to	  deadly	  pathogen	  are	  the	  subject	  of	  investigation.	  
S.	  aureus	  colonization	  correlates	  with	  infection	  
S.	  aureus	  has	  a	  complicated	  relationship	  with	  its	  human	  hosts:	  it	  persists	  in	  the	  anterior	  nares	  
as	  a	  commensal	  carried	  by	  20	  –	  50%	  of	  the	  general	  population	  where	  it	  may	  never	  cause	  
disease	  in	  the	  colonized	  individual	  [2].	  Other	  regions	  commonly	  colonized	  by	  S.	  aureus	  include	  
the	  nasopharynx,	  hands,	  skin,	  axilla,	  perineum,	  and	  vagina,	  where	  nasal-­‐colonized	  individuals	  
are	  more	  likely	  to	  carry	  at	  these	  other	  sites	  [3].	  Colonization	  may	  be	  persistent	  or	  transient,	  and	  
many	  individuals	  never	  host	  commensal	  S.	  aureus	  [3,	  10-­‐11].	  However,	  S.	  aureus	  is	  highly	  
transmissible,	  and	  inoculation	  occurs	  through	  contact	  with	  colonized	  individuals,	  and	  occurs	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both	  in	  hospital	  settings,	  and	  more	  recently,	  through	  community	  acquired	  sources.	  Disease	  is	  
often	  concurrent	  with	  colonization	  where	  invasive	  infection	  proceeds	  from	  damaged	  skin	  or	  
mucosal	  membranes	  [12].	  Staphylococcal	  nasal	  persistence	  correlates	  with	  an	  increased	  risk	  for	  
infection	  from	  disseminated	  bacteria	  entering	  the	  body	  from	  an	  epithelial	  breach	  that	  are	  
upregulating	  adherence	  factors	  [12-­‐14].	  Patients	  colonized	  with	  S.	  aureus	  are	  much	  more	  
susceptible	  to	  infection,	  but	  are	  less	  likely	  to	  die	  as	  a	  result	  of	  the	  infection	  than	  non-­‐colonized	  
individuals	  [12,13].	  The	  production	  of	  virulence	  factors	  is	  often	  very	  strain-­‐dependent	  and	  relies	  
on	  accessory	  gene	  regulatory	  systems	  that	  can	  be	  switched	  on	  and	  off	  rapidly	  to	  modulate	  
interactions	  with	  the	  host	  environment.	  
Quorum	  sensing	  coordinates	  S.	  aureus	  virulence	  
Highly	  virulent	  strains	  of	  S.	  aureus	  show	  marked	  upregulation	  of	  the	  accessory	  gene	  regulator	  
(agr)	  quorum	  sensing	  system,	  which	  is	  the	  major	  regulator	  of	  most	  staphylococcal	  virulence	  
factors	  (Fig.	  1.1).	  Quorum	  sensing	  is	  a	  form	  of	  social,	  growth-­‐phase	  dependent	  bacterial	  
communication	  that	  coordinates	  genetic	  expression	  and	  directs	  the	  construction	  and	  
maturation	  of	  the	  biofilm	  extracellular	  matrix	  [15].	  Like	  other	  Gram-­‐positive	  bacterial	  quorum	  
sensing	  systems,	  the	  agr	  system	  drives	  an	  autoinducing	  positive	  feedback	  loop	  using	  
extracellular	  peptide	  signals	  as	  a	  means	  of	  communication	  within	  the	  community	  [14].	  The	  agr	  
regulatory	  system	  is	  encoded	  in	  two	  divergently	  transcribed	  transcripts	  called	  RNAII	  and	  RNAIII.	  
RNAII	  encodes	  four	  genes,	  agrBDCA	  that	  produce	  the	  machinery	  of	  the	  quorum	  sensing	  system.	  
AgrA	  and	  AgrC	  form	  a	  two-­‐component	  system	  of	  a	  response	  regulator	  and	  receptor,	  
respectively.	  AgrD	  encodes	  the	  auto	  inducing	  peptide	  (AIP)	  signaling	  component,	  which	  is	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processed	  at	  the	  cell	  membrane	  by	  AgrB	  and	  signal	  peptidase	  SpsB	  	  [16-­‐18].	  The	  primary	  
effector	  molecule	  of	  agr	  is	  the	  regulatory	  RNA	  molecule,	  RNAIII.	  Within	  RNAIII	  is	  a	  gene	  (hld)	  
that	  codes	  for	  the	  peptide	  hemolysin	  delta-­‐toxin.	  Delta-­‐toxin	  expression	  does	  not	  affect	  the	  
quorum	  sensing	  system,	  but	  has	  downstream	  implications	  for	  virulence	  [19].	  Downstream	  
virulence	  results	  from	  upregulation	  of	  factors	  like	  proteases,	  lipases,	  and	  toxins	  that	  target	  host	  
tissues,	  as	  well	  as	  superantigens	  that	  cause	  widespread	  immunogenic	  shutdown	  [20].	  Highly	  
virulent	  strains	  of	  S.	  aureus	  can	  cause	  diseases	  ranging	  from	  relatively	  mild	  conditions,	  like	  skin	  
and	  soft	  tissue	  infections,	  to	  more	  serious	  diseases	  like	  toxic	  shock	  syndrome,	  which	  can	  be	  
complicated	  by	  septic	  shock	  [6].	  Under	  certain	  conditions,	  these	  infections	  can	  result	  in	  the	  
formation	  of	  biofilms.	  
S.	  aureus	  biofilm	  development	  
Invasive	  bacteria	  can	  attach	  to	  host	  extracellular	  matrix	  proteins	  or	  indwelling	  medical	  devices,	  
forming	  structures	  called	  biofilms.	  A	  biofilm	  is	  a	  surface-­‐associated	  community	  of	  microbes	  
encased	  in	  a	  self-­‐produced	  matrix	  of	  secreted	  biomolecules	  [21-­‐24].	  Biofilms	  range	  from	  thin,	  
unstructured	  monolayers	  to	  more	  complex	  and	  specialized	  microcolony	  structures	  (like	  
“mushrooms”	  or	  “pillars”),	  depending	  on	  the	  growth	  conditions	  and	  species	  [25-­‐27].	  The	  
transition	  from	  free-­‐living	  to	  surface-­‐attached	  bacterial	  communities	  is	  an	  important	  
component	  of	  microbial	  behavior.	  Biofilm	  related	  diseases	  that	  originate	  from	  non-­‐infective	  
colonization	  include	  osteomyelitis,	  vegetative	  growth	  on	  indwelling	  medical	  devices,	  
endocarditis,	  and	  other	  chronic	  wound	  infections	  [14,	  26].	  Once	  embedded	  in	  the	  polymeric	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biofilm	  matrix,	  bacterial	  cells	  are	  protected	  from	  antimicrobials	  and	  the	  host	  immune	  system	  
making	  biofilms	  difficult	  to	  clear.	  
S.	  aureus	  biofilm	  lifecycle	  
Biofilms	  usually	  form	  in	  four	  transitional	  steps:	  1)	  surface	  attachment	  by	  adherent	  cells,	  2)	  
microcolony	  assembly	  of	  attached	  cells,	  3)	  growth	  of	  the	  matrix	  to	  form	  mature	  biofilm	  
structures,	  and	  4)	  detachment	  and	  dispersal	  of	  individuals	  or	  small	  clusters	  of	  cells	  [25]	  (Fig.	  
1.2).	  Surface	  attachment	  is	  mediated	  by	  adhesion	  to	  virtually	  any	  biotic	  or	  abiotic	  surface	  
through	  electrostatic	  interactions	  and	  production	  of	  adhesion	  molecules.	  Proliferation	  along	  a	  
surface	  occurs	  concurrent	  with	  production	  of	  the	  polymeric	  extracellular	  matrix,	  promoting	  
intercellular	  aggregation	  and	  shaping	  of	  the	  biofilm.	  Shaping	  includes	  production	  of	  channels,	  
stratification	  of	  genetic	  expression,	  and	  physioheterogeneous	  partitioning	  that	  ultimately	  
produces	  the	  3D	  structure	  of	  mature	  biofilms.	  Detachment	  is	  mediated	  by	  the	  expression	  of	  
enzymes	  that	  degrade	  matrix	  materials,	  by	  the	  detergent-­‐like	  activity	  of	  surfactant	  molecules,	  
and	  by	  environmental	  stresses	  like	  mechanical	  shearing	  [6,23,-­‐24].	  Each	  step	  of	  the	  complex	  
biofilm	  lifecycle	  is	  controlled	  by	  a	  variety	  of	  transcriptional	  regulators,	  including	  agr	  [28].	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S.	  aureus	  biofilm	  lifecycle	  is	  influenced	  by	  agr	  
expression	  
Agr	  quorum	  sensing	  elicits	  a	  phenotypic	  change	  in	  population	  behavior	  that	  coordinates	  
growth-­‐phase	  dependent	  genetic	  expression	  of	  many	  important	  virulence	  factors,	  affecting	  
particular	  aspects	  of	  biofilm	  development	  [29,30].	  Many	  bacteria,	  like	  Pseudomonas	  aeruginosa	  
use	  quorum	  sensing	  signaling	  to	  build	  biofilms	  [31].	  The	  reverse	  is	  true	  in	  S.	  aureus.	  Activation	  
of	  quorum	  sensing	  negatively	  regulates	  biofilm	  formation	  by	  impeding	  attachment	  and	  
production	  of	  certain	  matrix	  components,	  and	  by	  promoting	  the	  dispersal	  of	  attached	  cells	  [16,	  
32].	  Other	  transcriptional	  regulators	  like	  SarA	  [33,48]	  alternate	  sigma	  factor	  SigB	  stress	  
response	  [35,36]	  and	  SaeRS	  work	  in	  tandem	  with	  the	  other	  regulators	  to	  counter	  agr	  and	  
promote	  biofilm	  formation	  [37].	  For	  example,	  SarA	  upregulates	  genes	  that	  are	  important	  for	  
biofilm	  formation	  while	  agr	  downregulates	  surface	  associated	  adherence	  factors	  and	  
upregulates	  secreted	  virulence	  factors	  [38].	  Many	  of	  the	  mechanisms	  S.	  aureus	  uses	  to	  disperse	  
biofilms	  are	  virulence	  factors	  that	  are	  antagonistic	  against	  the	  host.	  Associated	  with	  active	  
infection,	  agr	  disperses	  biofilms	  by	  upregulating	  the	  production	  of	  matrix	  degrading	  enzymes	  
like	  proteases	  and	  nucleases	  [39-­‐42].	  Although	  agr	  is	  considered	  a	  negative	  regulator	  of	  biofilm	  
formation,	  its	  contribution	  to	  the	  biofilm	  lifecycle	  is	  critical	  for	  its	  influence	  on	  the	  matrix	  
composition.	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Components	  of	  the	  S.	  aureus	  biofilm	  matrix	  	  
The	  biofilm	  matrix	  is	  defined	  by	  the	  production	  of	  secreted	  biomolecules	  that	  form	  the	  
structure	  of	  the	  biofilm	  over	  the	  course	  of	  its	  lifecycle.	  Like	  many	  bacteria,	  Staphylococcal	  
biofilms	  consist	  primarily	  of	  exopolysaccharides,	  eDNA,	  and	  proteins.	  	  
	  
S.	  aureus	  produces	  exopolysaccharides	  called	  polysaccharide	  intercellular	  adhesin	  (PIA)	  formed	  
primarily	  from	  beta-­‐1,6-­‐linked	  N-­‐acetylglucosamine	  residues	  [43].	  PIA	  is	  produced	  through	  the	  
icaABCDEFG	  operon	  and	  functions	  as	  a	  structural	  component	  that	  self-­‐associates	  and	  interacts	  
with	  matrix	  proteins	  to	  modulate	  the	  viscosity	  of	  the	  biofilm	  [44].	  Although	  exopolysaccharides	  
are	  important	  for	  biofilms	  in	  many	  species,	  PIA	  is	  only	  necessary	  for	  S.	  aureus	  biofilm	  formation	  
under	  certain	  growth	  conditions	  [45].	  	  
	  
Extracellular	  DNA	  (eDNA)	  contributes	  to	  biofilm	  formation	  in	  many	  important	  respects	  [46-­‐48].	  
eDNA	  release	  in	  S.	  aureus	  is	  mediated	  by	  the	  Cid/Lrg	  toxin/anti-­‐toxin	  system	  which	  responds	  to	  
extracellular	  cues	  like	  pH	  as	  a	  form	  of	  coordinated	  programmed	  cell	  death	  [49].	  Low	  levels	  of	  
beta-­‐lactam	  antibiotics	  can	  also	  cause	  eDNA	  release	  that	  promotes	  biofilm	  formation	  [50,51].	  
eDNA	  promotes	  bacterial	  attachment	  in	  early	  biofilm	  adherence.	  Exogenous	  addition	  of	  DNase	  
or	  induction	  of	  nuclease	  enzymes	  can	  cause	  dispersal	  [52-­‐54].	  	  However,	  mature	  biofilms	  
appear	  to	  be	  resistant	  to	  DNase	  dispersal,	  suggesting	  that	  eDNA	  is	  more	  important	  in	  early	  
biofilm	  persistence	  [52].	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A	  diversity	  of	  proteins	  also	  modulate	  biofilm	  development.	  Adhesins	  like	  the	  fibronectin	  binding	  
proteins	  (FnBPs),	  accumulation-­‐associated	  protein	  (Aap),	  and	  biofilm-­‐associated	  protein	  (Bap)	  
promote	  PIA-­‐independent	  biofilm	  formation	  [45,	  55].	  Enzymes	  like	  the	  major	  autolysin	  (AtlA)	  
also	  drive	  biofilm	  structuring.	  AtlA	  is	  important	  for	  cell	  wall	  metabolism	  and	  cell	  separation	  in	  S.	  
aureus,	  and	  can	  promote	  biofilm	  attachment	  or	  dispersal	  through	  coordinated	  autolysis	  within	  
biofilms	  [14,	  56-­‐-­‐71].	  Other	  proteins	  can	  form	  structural	  elements	  to	  stabilize	  biofilms,	  
preventing	  dispersal.	  Amyloids	  are	  a	  common	  form	  of	  structural	  protein	  found	  in	  bacterial	  
biofilms.	  Coordination	  of	  a	  novel	  protein	  interaction	  forming	  amyloids	  in	  the	  S.	  aureus	  biofilm	  
matrix	  has	  been	  the	  primary	  focus	  of	  my	  graduate	  studies.	  
Functional	  amyloids	  are	  important	  for	  biofilm	  
components	  
Amyloids	  are	  proteins	  that	  produce	  remarkably	  stable	  polymeric	  fibrils	  composed	  of	  folded	  β-­‐
sheets	  stacked	  perpendicular	  to	  the	  fibril	  access,	  forming	  structures	  with	  a	  central	  diameter	  of	  
3–12	  nm	  [58].	  Fibrillation	  is	  initiated	  by	  self-­‐aggregation	  of	  protein	  monomers	  into	  oligomers,	  
which	  accumulate	  over	  time.	  These	  oligomers	  nucleate	  the	  self-­‐assembly	  cascade	  of	  fibril	  
polymerization	  characterized	  by	  the	  stacking	  of	  parallel	  or	  anti-­‐parallel	  β-­‐sheet	  secondary	  
structure.	  Hydrogen	  bonding	  between	  adjacent	  β-­‐sheets	  provides	  additional	  fiber	  stability.	  
Once	  formed,	  amyloid	  fibers	  are	  robust	  and	  can	  resist	  disassembly	  by	  enzymatic	  or	  chemical	  
digestion	  [59].	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Amyloids’	  inherent	  resistance	  to	  protease	  digestion	  and	  denaturation	  helps	  them	  reinforce	  and	  
shield	  biofilms	  from	  harsh	  environmental	  stresses	  [60].	  Chapman	  et	  al.	  first	  recognized	  the	  
concept	  of	  functional	  bacterial	  amyloids	  in	  their	  groundbreaking	  2002	  Science	  article.	  Their	  
work	  characterized	  curli	  fimbriae	  produced	  in	  Escherichia	  coli	  biofilms	  as	  being	  biochemically	  
similar	  to	  disease-­‐associated	  amyloid	  structures	  [61].	  The	  production	  of	  curli	  greatly	  influences	  
E.	  coli	  biofilm	  formation	  [62,	  63].	  E.	  coli	  producing	  curli	  fibers	  are	  often	  coated	  in	  
exopolysaccharides	  and	  create	  flocculates	  that	  help	  to	  establish	  biofilms	  [64].	  Curli	  have	  also	  
been	  implicated	  in	  surface	  adhesion,	  immune	  evasion,	  and	  pathogenesis	  [65].	  Curli-­‐like	  systems	  
have	  been	  described	  in	  numerous	  enteric	  bacterial	  species,	  and	  recently	  interspecies	  
complementation	  between	  non-­‐homologous	  E.	  coli,	  Salmonella,	  Citrobacter,	  and	  Shewanella	  
curli	  subunits	  has	  been	  demonstrated	  [66].	  Beyond	  curli	  systems,	  bacterial	  amyloids	  produced	  
by	  gram-­‐negative	  organisms	  that	  contribute	  to	  biofilm	  formation,	  like	  FapC	  in	  Pseudomonas	  
fluorescens,	  continue	  to	  be	  elucidated	  (Table	  1)	  [67].	  The	  importance	  of	  amyloid	  formation	  in	  
biofilms	  is	  supported	  by	  the	  abundance	  of	  microbial	  systems	  that	  utilize	  them.	  
S.	  aureus	  phenol	  soluble	  modulins	  connect	  virulence	  to	  
biofilm	  persistence	  
Like	  many	  organisms,	  S.	  aureus	  produces	  proteins	  that	  aggregate	  to	  form	  robust	  fibril	  
structures	  called	  amyloids	  (Fig.	  1.3)	  [64].	  My	  work	  has	  revealed	  that	  S.	  aureus	  produces	  amyloid	  
structures	  composed	  of	  small	  peptides	  called	  phenol	  soluble	  modulins	  (PSMs)	  (Fig.	  1.4).	  PSMs	  
are	  most	  famously	  known	  as	  cytolytic	  toxins	  that	  are	  positively	  regulated	  by	  the	  agr	  virulence	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network	  [32,	  82-­‐69].	  PSMs	  are	  produced	  under	  direct	  control	  of	  the	  AgrA	  quorum	  sensing	  
response	  regulator	  [82,	  69).	  This	  discovery	  challenges	  the	  notion	  that	  agr	  is	  a	  purely	  negative	  
regulator	  of	  biofilm	  development	  in	  S.	  aureus.	  Agr	  is	  generally	  considered	  to	  be	  downregulated	  
in	  S.	  aureus	  biofilms	  under	  most	  conditions,	  although	  it	  can	  still	  remain	  active	  in	  certain	  areas	  of	  
the	  biofilm	  [40,42].	  Loss	  of	  agr	  function	  by	  repression	  or	  mutation	  produces	  strains	  with	  more	  
robust	  biofilm	  growth	  [8,	  16-­‐17,	  38-­‐39,	  70].	  However,	  PSMs	  are	  still	  produced	  during	  biofilm	  
growth,	  and	  their	  dispersal	  activity	  seems	  to	  vary	  depending	  on	  growth	  conditions	  [32,	  71-­‐72].	  
The	  co-­‐functioning	  of	  PSMs	  as	  both	  an	  instrument	  of	  infection	  and	  as	  a	  building	  block	  of	  the	  
biofilm	  matrix	  is	  particularly	  interesting	  as	  an	  intersection	  between	  the	  divergent	  bacterial	  
lifestyles	  of	  persistence	  and	  active	  infection.	  	  
PSMs	  are	  virulent	  small	  peptides	  produced	  by	  S.	  aureus	  
	  
The	  survival	  of	  S.	  aureus	  in	  the	  human	  body	  depends	  on	  the	  careful	  regulation	  of	  secreted	  
virulence	  factors	  by	  adaptive	  or	  accessory	  genetic	  regulatory	  networks	  [30,67].	  S.	  aureus'	  
capacity	  for	  virulence	  is	  largely	  determined	  by	  its	  ability	  to	  produce	  a	  wide	  range	  of	  toxins,	  
including	  factors	  that	  subvert	  the	  host	  immune	  system.	  Among	  these	  toxins	  are	  the	  phenol	  
soluble	  modulins,	  which	  are	  highly	  conserved	  and	  produced	  by	  nearly	  all	  strains	  of	  S.	  aureus	  
and	  S.	  epidermidis.	  PSMs	  are	  small	  amphipathic	  alpha	  helical	  peptides,	  none	  more	  than	  5	  kDa	  in	  
size	  that	  are	  expressed	  from	  several	  discrete	  loci	  in	  the	  S.	  aureus	  genome	  that	  are	  positively	  
regulated	  by	  agr	  quorum	  sensing	  [68-­‐69,73].	  Because	  the	  PSMs	  are	  so	  small,	  they	  fell	  beneath	  
the	  threshold	  for	  detection	  of	  annotation	  algorithms	  and	  assignment	  during	  genome	  
annotation	  and	  have	  only	  recently	  been	  characterized	  [73].	  PSMs	  are	  primarily	  grouped	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together	  by	  their	  biochemical	  properties	  and	  genomic	  location	  into	  the	  PSMα,	  PSMβ,	  and	  
staphylococcal	  delta	  hemolysin	  classes	  (Fig	  3).	  The	  smallest,	  PSMα	  1-­‐4	  are	  encoded	  in	  an	  
operon	  and	  are	  between	  20	  and	  22	  amino	  acids	  in	  length.	  The	  longer	  PSMs	  include	  PSMβ	  1	  -­‐2,	  
which	  are	  also	  encoded	  in	  an	  operon,	  and	  delta	  toxin,	  a	  26	  amino	  acid	  peptide	  divergently	  
transcribed	  from	  within	  the	  RNA	  III	  effector	  molecule	  of	  the	  agr	  quorum	  sensing	  system	  [74].	  
Outside	  of	  this	  core	  family	  of	  peptides,	  additional	  PSM-­‐like	  peptides	  have	  been	  described,	  
including	  PSM-­‐mec	  encoded	  in	  the	  mec	  pathogenicity	  island,	  and	  more	  recently,	  a	  cleavage	  
fragment	  of	  the	  agr	  quorum	  sensing	  molecule	  AgrD	  [75-­‐76].	  PSMs	  are	  of	  particular	  concern	  due	  
to	  the	  variety	  of	  functions	  they	  contribute	  to	  Staphylococcal	  infections.	  PSMs	  trigger	  
inflammatory	  responses	  by	  inducing	  cytokine	  production,	  recruiting	  neutrophils,	  triggering	  
cytolysis	  in	  host	  cells,	  and	  more	  recently	  they	  have	  been	  shown	  to	  play	  a	  role	  in	  the	  biofilm	  
lifecycle	  [68,74-­‐75,	  77].	  The	  discovery	  of	  PSMs	  as	  an	  amyloid	  protein	  opens	  many	  new	  and	  
exciting	  avenues	  for	  exploration	  based	  on	  previous	  data	  concerning	  disease-­‐associated	  amyloid	  
behavior.	  The	  unique	  biochemical	  properties	  of	  PSMs	  and	  other	  microbial	  amyloids	  make	  them	  
well	  suited	  to	  perform	  multiple	  roles	  in	  bacterial	  physiology	  [72].	  
Functional	  amyloids	  act	  as	  toxin	  repositories	  
Some	  amyloid	  proteins	  form	  into	  pre-­‐fibrillar	  toxic	  oligomers	  that	  cause	  damage	  to	  lipid	  
membranes	  [79].	  These	  toxic	  oligomers	  also	  promote	  amyloid	  fibril	  formation	  by	  acting	  as	  
nucleators	  for	  aggregation	  [78].	  Some	  bacteria	  can	  utilize	  the	  toxicity	  associated	  with	  amyloid	  
formation	  (Fig.	  1.5).	  Microcin	  E492	  (Mcc)	  is	  a	  small	  bactericidal	  peptide	  produced	  by	  Klebsiella	  
pneumoniae.	  Mcc	  monomers	  and	  oligomers	  create	  cytotoxic	  pores	  that	  induce	  cell	  lysis	  in	  
	   12	  
niche-­‐occupying	  enteric	  bacteria	  like	  Enterobacteriaceae	  [79].	  Mcc	  oligomers	  can	  aggregate	  
into	  amyloid	  fibers,	  effectively	  sequestering	  them	  as	  inert	  fibril	  structures	  [80].	  Recent	  studies	  
described	  environmental	  triggers,	  like	  pH	  and	  the	  ionic	  dissociation	  of	  salt,	  that	  induced	  fiber	  
formation	  accompanied	  by	  a	  loss	  of	  toxic	  oligomeric	  species.	  Changing	  environmental	  
conditions	  to	  favor	  fiber	  dissociation	  (high	  pH	  or	  low	  salt	  concentration)	  trigger	  Mcc	  amyloids	  to	  
disassociate	  back	  into	  cytotoxic	  oligmers	  [80].	  Similarly,	  S.	  aureus	  can	  use	  amyloid	  aggregation	  
to	  control	  PSM	  toxicity	  (Fig.	  1.5).	  
PSM	  toxicity	  is	  modulated	  by	  amyloid	  aggregation	  
PSMs	  contribute	  to	  staphylococcal	  pathogenesis	  in	  multiple	  ways.	  The	  innate	  immune	  system	  
detects	  foreign	  bodies	  through	  leukocytes,	  like	  macrophage	  and	  neutrophils,	  and	  initiates	  a	  
signaling	  cascade	  resulting	  in	  inflammation	  and	  recruitment	  of	  immune	  factors	  to	  clear	  bacteria	  
and	  debris	  from	  the	  site	  of	  infection	  [76].	  S.	  aureus	  is	  sensed	  by	  	  macrophages,	  triggering	  an	  
inflammatory	  immune	  response	  which	  recruits	  neutrophils	  [68].	  PSMs	  are	  described	  to	  be	  the	  
major	  neutrophils	  chemoattractants	  in	  S.	  aureus	  supernatants	  [68,	  81-­‐82].	  When	  S.	  aureus	  cells	  
are	  engulfed	  by	  neutrophils,	  a	  rapid	  increase	  in	  PSM	  expression	  contributes	  to	  neutrophil	  lysis,	  
effectively	  silencing	  the	  immune	  response	  [83].	  PSMs,	  like	  many	  small	  peptide	  toxins,	  interact	  
with	  cell	  membranes	  to	  create	  pores	  that	  induce	  cell	  lysis	  [84-­‐86].	  PSM-­‐mediated	  lysis	  has	  been	  
demonstrated	  for	  a	  wide	  range	  of	  cell	  types,	  including	  leukocytes	  and	  erythrocytes	  [68,	  87].	  In	  
my	  thesis	  work,	  I	  present	  evidence	  that	  pro-­‐inflammatory	  activity	  is	  silenced	  and	  cytotoxicity	  is	  
reduced	  when	  PSMs	  form	  amyloid	  fibrils	  [88].	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PSM	  amyloid	  fibrils	  promote	  biofilm	  stability	  
Our	  data	  provide	  new	  insight	  into	  biofilm	  structuring	  dynamics.	  It	  has	  been	  previously	  shown	  
that	  soluble	  PSM	  species	  can	  contribute	  to	  the	  dispersal	  of	  established	  biofilms.	  PSMs	  are	  
amphipathic	  molecules	  that	  have	  long	  been	  touted	  for	  their	  “surfactant-­‐like”	  properties	  [32,	  
73].	  	  Soluble	  PSM	  species	  have	  been	  shown	  to	  contribute	  to	  structuring	  and	  dispersal	  of	  
established	  biofilms	  In	  vitro	  and	  In	  vivo	  [72,	  64,	  59,89].	  Detachment	  and	  biofilm	  dispersal	  is	  an	  
efficacious	  way	  for	  S.	  aureus	  to	  travel	  without	  motility	  organelles	  [68,65].	  It	  was	  reported	  that	  
the	  PSMβs	  seemed	  to	  help	  structure	  the	  biofilm	  by	  facilitating	  movement	  and	  dispersal	  within	  
the	  matrix	  [72,	  75,64].	  Likewise,	  isogenic	  S.	  aureus	  Δagr	  and	  ΔPSM	  mutants	  formed	  biofilms	  
that	  were	  thinner	  and	  had	  fewer	  channels	  throughout	  the	  biofilm	  matrix	  as	  compared	  to	  the	  
wild	  type	  parent	  [65].	  Mutants	  that	  did	  not	  produce	  PSMs	  grew	  into	  robust	  biofilms	  with	  
reduced	  detachment	  of	  cell	  clusters	  from	  the	  matrix	  [89].	  In	  my	  work,	  I	  have	  demonstrated	  how	  
the	  assembly	  of	  PSMs	  into	  amyloid	  fibrils	  correlates	  to	  a	  robust	  biofilm	  phenotype	  that	  resists	  
dispersal	  by	  enzymes,	  surfactants	  and	  mechanical	  disruption	  [71].	  The	  addition	  of	  synthetic	  
soluble	  PSM	  peptide	  induced	  biofilm	  dispersal	  in	  a	  concentration	  dependent	  manner,	  while	  
pre-­‐aggregated	  fibrils	  did	  not,	  demonstrating	  the	  modulation	  of	  behavior	  before	  and	  after	  
amyloid	  aggregation	  [71].	  	  
The	  N-­‐terminal	  leader	  peptide	  of	  AgrD	  displays	  PSM-­‐like	  
amyloid	  formation	  and	  virulence	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In	  studying	  amyloid	  fibril	  formation	  in	  a	  highly	  virulent	  USA300	  S.	  aureus	  strain,	  I	  have	  also	  
discovered	  that	  a	  cleavage	  fragment,	  the	  N-­‐terminal	  leader	  sequence	  of	  AgrD	  (N-­‐AgrD),	  is	  also	  
capable	  of	  amyloid	  formation	  and	  PSM-­‐like	  activity	  [88].	  Our	  lab	  has	  characterized	  this	  peptide	  
as	  an	  additional	  member	  of	  the	  PSM	  family	  of	  toxins	  based	  on	  its	  sequential	  homology,	  
biophysical	  properties,	  and	  capacity	  for	  virulence.	  N-­‐AgrD	  is	  able	  to	  self-­‐seed	  its	  amyloid	  
formation,	  as	  well	  as	  that	  of	  known	  amyloid	  protein	  PSMα1.	  We	  provide	  evidence	  that	  N-­‐AgrD,	  
like	  PSMα1,	  induces	  pro-­‐inflammatory	  activity,	  neutrophil	  chemotaxis,	  and	  cytolysis.	  The	  
virulence	  associated	  with	  N-­‐AgrD	  and	  PSMα	  are	  inhibited	  when	  they	  are	  aggregated	  into	  
amyloid	  fibrils,	  suggesting	  that	  aggregation	  can	  sequester	  toxins	  and	  modulate	  their	  activity.	  
PSMs	  aggregate	  in	  the	  presence	  of	  DNA	  
One	  imminent	  question	  that	  proceeds	  from	  our	  characterizations	  of	  PSM	  amyloid	  formation	  is,	  
“what	  are	  the	  factors	  promoting	  PSM	  aggregation	  in	  biofilms”.	  This	  question	  led	  me	  to	  
investigate	  how	  other	  biofilm	  matrix	  components	  may	  influence	  aggregation	  in	  the	  biofilm.	  I	  
had	  previously	  observed	  that	  a	  mutant	  deficient	  in	  autolysis,	  the	  primary	  method	  of	  DNA	  
excretion	  in	  biofilms,	  did	  not	  produce	  extracellular	  fibrils	  (Fig.	  4.1).	  From	  this	  observation,	  I	  
proceeded	  and	  found	  that	  the	  absence	  of	  DNA	  in	  biofilms	  correlates	  with	  the	  absence	  of	  PSM	  
fibrils.	  Further	  characterization	  demonstrated	  that	  PSMα1	  can	  interact	  with	  DNA	  to	  form	  
amyloid	  fibrils	  (Fig.	  4.2-­‐4.4).	  Once	  aggregated,	  PSMα1	  showed	  reduced	  hemolysis,	  suggesting	  
that	  the	  presence	  of	  DNA	  can	  diminish	  toxicity	  (Fig.	  4.5).	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Conclusions	  
When	  I	  began	  my	  thesis	  work,	  I	  was	  interested	  in	  learning	  how	  biochemistry	  connected	  living	  
systems	  together	  from	  the	  microscopic	  to	  the	  macroscopic	  world.	  I	  chose	  to	  study	  microbial	  
biofilms	  as	  a	  model	  for	  biochemical	  interactions	  because	  it	  relates	  to	  so	  many	  disparate	  fields	  
of	  study	  –	  from	  organic	  chemistry	  to	  public	  health.	  Staphylococcus	  aureus	  is	  an	  important	  
opportunistic	  pathogen	  that	  spends	  the	  majority	  of	  its	  life	  cycle	  persisting	  in	  human	  hosts	  
undetected.	  S.	  aureus	  colonization	  is	  a	  fantastic	  example	  of	  how	  pathogenesis	  itself	  can	  be	  
considered	  a	  novel	  form	  of	  ecology.	  What	  processes	  are	  responsible	  for	  S.	  aureus’	  switch	  from	  
harmless	  commensal	  to	  deadly	  pathogen?	  In	  the	  Boles	  lab,	  we	  work	  through	  the	  paradigm	  of	  
microbial	  ecology	  to	  gain	  new	  insights	  into	  how	  the	  human	  body	  environment	  affects	  bacterial	  
physiology.	  
	  
In	  my	  graduate	  work,	  I	  have	  characterized	  a	  novel	  function	  for	  a	  well-­‐characterized	  class	  of	  
small	  peptide	  toxins,	  the	  phenol	  soluble	  modulins.	  I	  have	  discovered	  that	  PSMs	  can	  form	  
amyloid	  fibrils	  that	  stabilize	  biofilms	  (Fig.	  2.1-­‐2.8).	  Formation	  of	  amyloid	  fibrils	  modulates	  the	  
roles	  of	  these	  peptides	  by	  inhibiting	  their	  dispersal	  activity,	  or	  the	  injury	  of	  host	  cells.	  The	  
discovery	  of	  PSM-­‐like	  function	  in	  N-­‐AgrD	  suggests	  that	  S.	  aureus	  can	  utilize	  a	  wide	  arsenal	  of	  
small	  peptide	  toxins,	  many	  of	  which	  may	  still	  be	  unknown	  (Fig.3.1-­‐3.5).	  Finally,	  I	  have	  
determined	  that	  the	  presence	  of	  DNA	  can	  promote	  PSM	  amyloid	  formation	  and	  abrogate	  
toxicity,	  suggesting	  a	  link	  between	  matrix	  composition	  and	  impaired	  virulence	  (Fig.	  4.1-­‐4.5).	  
These	  findings	  shed	  new	  light	  on	  the	  complexities	  of	  agr	  and	  virulence	  as	  both	  a	  positive	  and	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negative	  regulator	  of	  biofilms.	  I	  also	  provide	  evidence	  that	  extracellular	  DNA	  can	  promote	  
amyloid	  formation	  and	  effectively	  detoxify	  PSM	  activity.	  This	  finding	  connects	  fibril	  formation	  
to	  the	  extracellular	  environment	  and	  illustrates	  a	  novel	  way	  in	  which	  the	  extracellular	  matrix	  
environment	  can	  alter	  bacterial	  behavior	  through	  direct	  biochemical	  interactions.	  
	  
Throughout	  my	  thesis,	  I	  have	  applied	  the	  notion	  that	  the	  physical	  environment	  can	  have	  a	  
profound	  biophysical	  effect	  on	  the	  phenotypic	  behavior	  we	  observe	  in	  bacterial	  communities.	  	  
	  
In	  my	  work,	  I	  have	  explored	  the	  following	  questions:	  
1.	  Are	  there	  novel	  conditions	  that	  promote	  biofilm	  resistance	  to	  dispersal?	  
2.	  How	  does	  amyloid	  formation	  contribute	  to	  S.	  aureus	  virulence?	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Figures	  and	  Tables	  
Table	  1.1,	  Characterized	  Bacterial	  Amyloid	  Systems.	  	  





















Figure	  1.1,	  Staphylococcus	  aureus	  accessory	  gene	  regulator	  (agr)	  quorum	  sensing	  system,	  
The	  agr	  quorum	  sensing	  locus	  is	  encoded	  on	  two	  divergently	  expressed	  transcripts	  in	  the	  core	  
region	  of	  the	  genome.	  Promoter	  P2	  regulates	  expression	  of	  the	  agrBDCA	  operon	  encoding	  the	  
quorum	  sensing	  machinery.	  The	  autoinducing	  peptide	  (AIP)	  signaling	  molecule	  AgrD	  is	  
translated	  as	  a	  propeptide	  composed	  of	  three	  parts:	  an	  N-­‐terminal	  leader	  peptide	  (N-­‐AgrD)	  to	  
direct	  the	  peptide	  to	  the	  membrane;	  a	  middle	  region	  that	  is	  modified	  to	  become	  AIP;	  and	  a	  
charged	  C-­‐terminal	  tail	  (C-­‐term).	  The	  AgrD	  propeptide	  is	  processed	  during	  transport	  by	  integral	  
membrane	  endopeptidase	  AgrB	  and	  SpsB	  type	  I	  signal	  peptidase.	  AgrC	  and	  AgrA	  form	  a	  two-­‐
component	  signaling	  system	  that	  senses	  AIP	  in	  the	  extracellular	  environment.	  AgrC	  is	  a	  
membrane	  histidine	  kinase	  with	  an	  extracellular	  receptor	  for	  AIP	  binding.,	  and	  AgrA	  is	  the	  
response	  regulator.	  Activated	  AgrA	  induces	  transcription	  at	  P2	  and	  P3	  promoters,	  and	  the	  P3	  
promoter	  drives	  expression	  of	  RNAIII,	  the	  primary	  effector	  of	  the	  agr	  system	  and	  virulence.	  
Delta	  hemolysin	  (hld)	  encoded	  within	  the	  RNAIII	  transcript	  does	  not	  affect	  agr,	  but	  has	  





















Figure	  1.2	  ,The	  S.	  aureus	  biofilm	  life	  cycle,	  	  
During	  the	  course	  of	  biofilm	  development,	  cells	  go	  through	  four	  main	  phases	  of	  growth.	  (1)	  
Attachment	  is	  characterized	  by	  surface	  attachment	  by	  cells	  producing	  adhesion	  molecules;	  (2)	  
Microcolony	  development	  involves	  repression	  of	  dispersal	  factors	  and	  initial	  production	  of	  
extracellular	  matrix	  holding	  the	  community	  in	  place;	  (3)	  Mature	  biofilms	  display	  spatio-­‐physical	  
heterogeneity	  among	  cell	  types	  and	  environmental	  states	  with	  regions	  of	  motile	  or	  detaching	  
cells	  that	  contribute	  to	  partial	  or	  total	  (4)	  Dispersal	  of	  the	  biofilm	  via	  enzymatic,	  chemical,	  or	  














1.	   2.	  
4.	  
3.	  





Figure	  1.3,	  TEM	  micrograph	  of	  a	  Staphylococcus	  aureus	  cell	  after	  five	  days	  of	  biofilm	  growth,	  	  
The	  extracellular	  fibers	  observed	  have	  amyloid	  properties	  and	  consist	  of	  small	  peptides	  called	  





















































Figure	  1.5,	  PSMs	  amyloids	  as	  toxin	  repositories	  
Staphylococcus	  aureus	  phenol	  soluble	  modulin	  amyloids	  act	  as	  toxic	  peptides	  forming	  amyloid	  
fibrils	  under	  certain	  environmental	  conditions.	  PSMs’	  cytotoxicity	  is	  attributed	  to	  pore	  
formation	  through	  aggregation	  on	  the	  outer	  membranes	  of	  mammalian	  cells	  and	  niche-­‐
occupying	  bacteria	  [68,71,	  88,	  93-­‐97].	  When	  PSMs	  autoaggregate	  into	  amyloid	  fibrils,	  they	  lose	  
the	  cytotoxic	  activity	  associated	  with	  smaller	  oligomeric	  and	  monomeric	  species	  [71,	  88].	  
Varying	  the	  growth	  conditions	  of	  S.	  aureus	  cultures	  can	  promote	  amyloid	  fibril	  aggregation	  in	  
biofilms	  [71].	  It	  is	  likely	  that	  this	  post-­‐translational	  control	  mechanism	  serves	  to	  regulate	  the	  
growth-­‐phase	  dependent	  level	  of	  toxic	  activity.	  Amyloid	  fibrils	  stabilize	  the	  biofilm	  and	  impede	  
dispersal,	  favoring	  a	  sessile	  lifestyle	  and	  reducing	  interactions	  with	  the	  host	  immune	  system	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Chapter	  2	  
Functional	  Amyloids	  Composed	  of	  Phenol	  




Staphylococcus	  aureus	  is	  an	  opportunistic	  pathogen	  that	  colonizes	  the	  skin	  and	  mucosal	  
surfaces	  of	  mammals.	  Persistent	  staphylococcal	  infections	  often	  involve	  surface-­‐associated	  
communities	  called	  biofilms.	  Here	  we	  report	  the	  discovery	  of	  a	  novel	  extracellular	  fibril	  
structure	  that	  promotes	  S.	  aureus	  biofilm	  integrity.	  Biochemical	  and	  genetic	  analysis	  has	  
revealed	  that	  these	  fibers	  have	  amyloid-­‐like	  properties	  and	  consist	  of	  small	  peptides	  called	  
phenol	  soluble	  modulins	  (PSMs).	  Mutants	  unable	  to	  produce	  PSMs	  were	  susceptible	  to	  biofilm	  
disassembly	  by	  matrix	  degrading	  enzymes	  and	  mechanical	  stress.	  Previous	  work	  has	  associated	  
PSMs	  with	  biofilm	  disassembly,	  and	  we	  present	  data	  showing	  that	  soluble	  PSM	  peptides	  
disperse	  biofilms	  while	  polymerized	  peptides	  do	  not.	  This	  work	  suggests	  the	  PSMs’	  aggregation	  
into	  amyloid	  fibers	  modulates	  their	  biological	  activity	  and	  role	  in	  biofilms.	  
	  
Introduction:	  
Staphylococcus	  aureus	  is	  the	  causative	  agent	  of	  numerous	  diseases	  ranging	  from	  relatively	  
benign	  skin	  conditions	  to	  fatal	  systemic	  infections.	  Formation	  of	  bacterial	  biofilms	  on	  host	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tissues	  and	  implanted	  materials	  contributes	  to	  chronic	  S.	  aureus	  infections,	  as	  biofilms	  are	  
exceptionally	  resistant	  to	  host	  immune	  response	  and	  chemotherapies	  [1].	  Biofilms	  are	  
multicellular	  structures	  encased	  in	  a	  matrix	  of	  proteins,	  polysaccharides,	  extracellular	  DNA,	  and	  
other	  environmental	  factors	  [1,2].	  Biomolecules	  that	  digest	  matrix	  components	  (e.g.,	  proteases,	  
DNases,	  and	  glycoside	  hydrolases)	  can	  disrupt	  established	  biofilms	  and	  render	  detached	  cells	  
susceptible	  to	  antimicrobials	  [3,4,5,6,7].	  
	  
The	  precise	  composition	  of	  the	  biofilm	  matrix	  varies	  greatly	  by	  strain,	  physiological	  state,	  and	  
nutrient	  availability	  [5,8,9,10,11,12].	  In	  this	  study,	  we	  examined	  how	  growth	  media	  affects	  the	  
composition	  of	  the	  biofilm	  matrix.	  This	  led	  to	  the	  discovery	  of	  an	  extracellular	  fibril	  structure	  in	  
S.	  aureus	  biofilms	  grown	  in	  a	  non-­‐standard	  rich	  media.	  These	  fibers	  share	  morphological	  and	  
biophysical	  characteristics	  with	  functional	  bacterial	  amyloids	  such	  as	  curli	  in	  Escherichia	  coli	  
biofilms,	  TasA	  of	  	  Bacillus	  subtilis,	  and	  the	  Fap	  fimbriae	  in	  Pseudomonas	  aeruginosa	  
[13,14,15,16].	  Biochemical	  and	  genetic	  analysis	  revealed	  that	  these	  fibril	  structures	  are	  
composed	  of	  small	  peptides	  called	  phenol	  soluble	  modulins	  (PSMs).	  Mutants	  incapable	  of	  
producing	  PSMs	  formed	  biofilms	  that	  were	  susceptible	  to	  disassembly	  by	  enzymatic	  
degradation	  and	  mechanical	  stress.	  
	  
Previous	  work	  has	  demonstrated	  that	  PSMs	  are	  surfactant-­‐like	  peptides	  that	  promote	  biofilm	  
disassembly	  [17,18,19,20,21];	  exhibit	  antimicrobial	  activity	  against	  niche	  bacteria	  [22,23,24];	  
hinder	  host	  immune	  response	  by	  recruiting	  and	  lysing	  neutrophils;	  and	  are	  abundant	  virulence	  
factors	  produced	  by	  community-­‐associated	  MRSA	  strains	  (CA-­‐MRSA)	  [18,25,26,27].	  The	  genes	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encoding	  the	  core	  family	  of	  PSM	  peptides	  are	  highly	  conserved	  across	  S.	  aureus	  strains:	  four	  are	  
expressed	  from	  the	  alpha	  (αpsm1-­‐4)	  operon,	  two	  are	  expressed	  from	  the	  beta	  (βpsm1&2)	  
operon,	  and	  the	  delta	  hemolysin	  (hld)	  is	  encoded	  within	  the	  regulatory	  RNA,	  RNAIII	  [28,29,30].	  
The	  significance	  of	  the	  PSMs	  has	  only	  recently	  been	  investigated	  because	  the	  coding	  sequences	  
of	  the	  αpsm	  &	  βpsm	  peptides	  are	  small	  enough	  to	  have	  eluded	  detection	  by	  conventional	  gene	  
annotation	  programs,	  and	  they	  are	  still	  poorly	  annotated	  in	  public	  databases	  [29,30].	  	  
	  
We	  have	  found	  that	  ordered	  aggregation	  of	  PSM	  peptides	  into	  amyloid-­‐like	  fibers	  can	  abrogate	  
the	  biofilm	  disassembly	  activity	  ascribed	  to	  monomeric	  PSM	  peptides	  [12,17,18,19,20,21].	  Our	  
findings	  suggest	  that	  PSMs	  can	  modulate	  biofilm	  disassembly	  using	  amyloid-­‐like	  aggregation	  as	  
a	  control	  point	  for	  their	  activity.	  This	  is	  the	  first	  report	  to	  identify	  and	  characterize	  extracellular	  
fimbriae	  in	  the	  S.	  aureus	  biofilm,	  and	  our	  research	  could	  lead	  to	  new	  approaches	  in	  treating	  
persistent	  biofilm	  associated	  infections.	  
Materials	  and	  Methods:	  
Bacterial	  strains	  and	  growth	  conditions,	  The	  bacterial	  strains	  and	  plasmids	  used	  in	  this	  study	  
are	  listed	  in	  Table	  1.	  All	  DNA	  manipulations	  were	  performed	  in	  Escherichia	  coli	  strain	  DH5α.	  
Oligonucleotides	  were	  synthesized	  by	  Integrated	  DNA	  Technologies	  (Coralville,	  IA).	  Plasmids	  
were	  transformed	  into	  Staphylococcus	  aureus	  RN4220	  by	  electroporation,	  purified,	  and	  moved	  
to	  indicated	  S.	  aureus	  strains	  by	  electroporation.	  Deletion	  mutants	  were	  generated	  via	  allelic	  
replacement	  using	  the	  vector	  pKFC	  as	  described	  previously	  [58].	  	  To	  create	  the	  αpsm	  mutation,	  
a	  region	  upstream	  of	  αpsm	  was	  amplified	  from	  SH1000	  genomic	  DNA	  using	  primers	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alphaPSM221	  (CGC	  GAG	  CTC	  GTT	  GAG	  GCA	  CGC	  GCC	  ACT	  CGC	  CAG)	  and	  alphaPSM162	  (GCT	  
AGC	  GGT	  ACC	  ACG	  CGT	  GAT	  GCC	  AGC	  GAT	  GAT	  ACC	  CAT	  TAA)	  and	  a	  downstream	  region	  was	  
amplified	  using	  alphaPSM163	  (ACG	  CGT	  GGT	  ACC	  GCT	  AGC	  TTA	  AAA	  TTC	  TCA	  GGC	  CAC	  TAT	  ACC)	  
and	  alphaPSM164	  (TAT	  CCC	  GGG	  GAT	  GGT	  GGG	  GGA	  CTA	  TCG	  CGC	  ACA	  G).	  	  The	  resulting	  PCR	  
products	  were	  gel	  purified,	  digested	  with	  KpnI,	  ligated	  with	  T4	  DNA	  ligase	  and	  the	  ligation	  was	  
used	  as	  a	  template	  in	  a	  subsequent	  PCR	  reaction	  with	  the	  primers	  alphaPSM221	  and	  
alphaPSM164.	  The	  resulting	  PCR	  product	  was	  gel	  purified	  and	  digested	  with	  SacI	  and	  XmaI	  and	  
ligated	  with	  pKFC	  plasmid	  digested	  with	  the	  same	  enzymes	  to	  create	  pKFC-­‐αpsm.	  The	  resulting	  
plasmid	  construct	  was	  used	  to	  create	  an	  allelic	  Δαpsm	  deletion	  in	  the	  SH1000	  background	  
following	  the	  protocol	  outline	  by	  Kato	  et	  al	  [58].	  
	  
To	  create	  the	  βpsm	  mutation,	  a	  region	  upstream	  of	  βpsm	  was	  amplified	  from	  SH1000	  genomic	  
DNA	  using	  primers	  BetaUpF	  (CCC	  GGA	  TCC	  GGT	  GTA	  GTG	  TTG	  GTG	  TAG	  TTC	  AGG)	  and	  BetaUpR	  
(ACG	  CGT	  GGT	  ACC	  GCT	  AGC	  GCG	  TTA	  AAT	  AAA	  CCT	  TCC	  ATT	  G)	  and	  a	  downstream	  region	  was	  
amplified	  using	  primers	  BetaDownF	  (5’GCT	  AGC	  GGT	  ACC	  ACG	  CGT	  GGC	  ACA	  AGT	  ATC	  GTA	  GAC	  
ATC	  G)	  and	  BetaDownR	  (5’GCG	  GTC	  GAC	  GGC	  GTC	  TGA	  TTT	  AAC	  CTT	  CTC).	  The	  resulting	  PCR	  
products	  were	  gel	  purified	  and	  used	  as	  a	  template	  in	  a	  subsequent	  PCR	  reaction	  with	  the	  
BetaUpF	  and	  BetaDownR	  primers.	  The	  resulting	  PCR	  product	  was	  gel	  purified	  and	  digested	  with	  
BamHI	  and	  SalI	  and	  ligated	  with	  pKFC	  plasmid	  digested	  with	  the	  same	  enzymes	  to	  create	  pKFC-­‐
βpsm.	  The	  resulting	  plasmid	  was	  used	  to	  create	  an	  allelic	  Δβpsm	  deletion	  in	  the	  SH1000	  Δαpsm	  
background	  following	  the	  protocol	  outline	  by	  Kato	  et	  al.	  to	  create	  the	  double	  knockout	  αβPSM	  
mutant	  [58].	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Complementation	  vectors	  were	  created	  as	  follows:	  the	  βpsm	  locus	  with	  its	  native	  promoter	  was	  
amplified	  from	  S.	  aureus	  SH1000	  genomic	  DNA	  using	  primers	  GAC	  GAA	  TTC	  AGG	  CAA	  CTT	  AAT	  
TGT	  G	  and	  GAC	  AAG	  CTT	  GCT	  TCC	  CAA	  TGT	  TGG	  TG.	  The	  resulting	  PCR	  product	  was	  digested	  
with	  HindIII	  and	  EcoRI	  and	  ligated	  with	  pAH8	  [4],	  that	  had	  been	  digested	  with	  the	  same	  
enzymes	  to	  create	  pRSβpsm.	  The	  αpsm	  locus	  was	  amplified	  from	  SH1000	  genomic	  DNA	  using	  
primers	  ACT	  GAG	  GTA	  CCA	  GAC	  TCA	  CCT	  CAC	  ATC	  AAT	  AA	  and	  ACT	  AGG	  AGC	  TCC	  AAA	  GGA	  GGT	  
AAT	  CTT	  AAT	  GGG	  T.	  	  The	  resulting	  PCR	  product	  was	  digested	  with	  KpnI	  and	  SacI	  and	  ligated	  
with	  pALC2073	  [59],	  then	  digested	  with	  the	  same	  enzymes	  to	  create	  pALC2073αPSM.	  
	  
Biofilm	  experiments,	  Flow	  cell	  and	  drip	  biofilms	  were	  grown	  as	  previously	  described	  [5,60].	  
Biofilm	  growth	  medium	  was	  either	  0.6	  g/L	  tryptic	  soy	  broth	  and	  1.5	  g/L	  	  glucose	  (TSBg)	  or	  3.3	  
g/L	  peptone,	  2.6	  g/L	  NaCl,	  3.3	  g/L	  glucose	  (PNG).	  	  
For	  biofilm	  disassembly	  experiments	  performed	  in	  flow	  cells,	  enzymes	  proteinase	  K,	  DNaseI	  and	  
dispersin	  B	  were	  suspended	  in	  water	  and	  added	  to	  the	  media	  reservoir	  at	  a	  final	  concentration	  
of	  0.2	  µg/mL.	  Confocal	  scanning	  laser	  microscopy	  and	  image	  analysis	  was	  performed	  as	  
described	  previously	  [5].	  Strains	  contained	  pAH9	  expressing	  mCherry	  or	  were	  stained	  with	  
propidium	  iodide	  as	  previously	  described	  [5].	  	  
	  
Test	  tube	  biofilms	  forming	  at	  the	  air-­‐liquid	  interface	  of	  glass	  culture	  tubes	  were	  grown	  in	  3	  mL	  
of	  TSBg	  or	  PNG	  for	  2	  days	  at	  37°C	  shaking	  at	  200	  rpm.	  Liquid	  media	  was	  removed	  and	  
exchanged	  with	  either	  10	  mL	  sterile	  ddH2O	  containing	  1%	  SDS	  or	  sterile	  ddH2O	  alone.	  Tubes	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were	  vortexed	  for	  5	  seconds	  and	  all	  liquid	  was	  removed.	  The	  remaining	  biofilm	  biomass	  was	  
visualized	  by	  staining	  with	  0.1%	  crystal	  violet	  and	  quantified	  by	  solublizing	  the	  stain	  in	  acidified	  
ethanol	  and	  measuring	  the	  optical	  density	  at	  A595.	  
	  
Transmission	  electron	  microscopy	  (TEM)	  was	  performed	  using	  a	  Philips	  CM12	  transmission	  
electron	  microscope.	  Samples	  prepared	  for	  TEM	  imaging	  were	  spotted	  onto	  formvar-­‐coated	  
copper	  grids,	  incubated	  for	  5	  minutes,	  washed	  with	  sterile	  ddH2O,	  and	  negatively	  stained	  with	  
2%	  uranyl	  acetate	  for	  60	  seconds.	  	  
	  
Isolation	  of	  fibers	  from	  biofilm	  cultures,	  Drip	  bioreactor	  biofilms	  were	  grown	  as	  previously	  
described	  [60].	  Fibers	  were	  collected	  after	  5	  days	  growth	  by	  scraping	  biofilms	  into	  3	  mL	  of	  
potassium	  phosphate	  buffer	  (50mM,	  pH	  7).	  	  The	  biofilm	  suspensions	  were	  homogenized	  using	  a	  
tissue	  homogenizer	  (TissueMiser,	  Fisher)	  to	  shear	  fibers	  free	  from	  the	  cell	  walls.	  Supernatants	  
were	  clarified	  by	  repeated	  centrifugation	  at	  13,000	  RPM	  for	  2	  minutes	  to	  remove	  cells.	  The	  cell-­‐
free	  supernatant	  was	  incubated	  in	  200mM	  NaCl	  and	  the	  fibers	  were	  isolated	  using	  Millipore	  
Amicon	  Ultra	  Centrifugal	  Filter	  Units	  with	  a	  pore	  size	  of	  100	  kDa.	  Presence	  of	  fibers	  was	  
confirmed	  via	  TEM	  imaging.	  
	  
Identification	  of	  aggregative	  peptides,	  Fibril	  subunits	  were	  identified	  by	  harvesting	  drip	  
biofilms	  after	  5	  days	  of	  growth	  in	  PNG	  and	  suspending	  them	  in	  15	  mL	  10	  mM	  Tris	  HCl,	  pH	  8.0	  
(Tris	  buffer),	  supplemented	  with	  0.1	  mg	  of	  RNase	  A	  (bovine	  pancreas;	  Sigma	  Chemical	  Co.,	  St.	  
Louis,	  Mo.)	  and	  0.1	  mg	  of	  DNaseI	  (bovine	  pancreas;	  Boehringer,	  Mannheim,	  Germany)	  per	  mL.	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Cells	  were	  lysed	  by	  repeated	  sonication	  and	  the	  addition	  of	  lysostaphin	  (1	  mg/mL,	  Sigma)	  and	  1	  
mM	  MgCl2	  prior	  to	  incubation	  at	  37°C	  for	  20	  min.	  Lysozyme	  (Sigma)	  was	  added	  to	  1	  mg/mL,	  and	  
the	  samples	  were	  incubated	  with	  shaking	  for	  40	  min	  at	  37°C,	  after	  which	  they	  were	  adjusted	  to	  
1%	  sodium	  dodecyl	  sulfate	  (SDS)	  and	  incubated	  further	  (30	  min,	  37°C).	  The	  remaining	  insoluble	  
material	  was	  collected	  by	  centrifugation	  (12,100	  x	  g,	  15	  min,	  25°C),	  washed	  and	  suspended	  in	  
10	  mL	  10mM	  Tris	  buffer.	  	  The	  pellet	  was	  digested	  again	  with	  RNase,	  DNaseI,	  and	  lysotaphin	  as	  
described	  above,	  washed	  twice	  with	  Tris	  buffer,	  and	  suspended	  in	  2	  mL	  SDS-­‐polyacrylamide	  gel	  
electrophoresis	  (PAGE)	  sample	  buffer	  (10%	  glycerol,	  5%-­‐mercaptoethanol,	  1%	  SDS,	  62.5	  mM	  
Tris	  HCl	  [pH	  6.8]).	  The	  sample	  was	  boiled	  for	  5	  min,	  loaded	  onto	  a	  12%	  polyacrylamide	  gel	  (3%	  
stacking	  gel),	  and	  subjected	  to	  electrophoresis	  at	  20	  mA	  for	  5	  h.	  The	  material	  retained	  in	  the	  
stacking	  gel	  was	  excised,	  washed	  three	  times	  in	  ddH20,	  extracted	  twice	  with	  95%	  ethanol,	  and	  
dried	  in	  a	  speedvac.	  The	  desiccated	  sample	  was	  resuspended	  in	  ddH20	  and	  sonicated	  to	  break	  
up	  any	  clumps.	  Half	  of	  this	  material	  was	  incubated	  with	  formic	  acid	  (90%)	  for	  20	  min	  then	  dried	  
in	  a	  speedvac.	  	  Both	  the	  formic	  acid	  treated	  and	  untreated	  samples	  were	  resuspended	  in	  SDS-­‐
PAGE	  sample	  buffer	  and	  run	  into	  a	  fresh	  12%	  PAGE	  gel.	  Bands	  that	  appeared	  in	  the	  formic	  acid	  
treated	  sample	  were	  excised	  and	  analyzed	  via	  LC-­‐MS/MS	  (MS	  Bioworks,	  Ann	  Arbor,	  MI).	  	  	  
	  
Fiber	  protein	  components	  were	  also	  identified	  by	  incubating	  fiber	  isolates	  in	  pepsin	  for	  24	  h	  
before	  subsequent	  LC-­‐MS/MS	  analysis	  (MS	  Bioworks,	  Ann	  Arbor,	  MI).	  The	  value	  for	  the	  
abundance	  measurement	  is	  the	  Normalized	  Spectral	  Abundance	  Factor	  (NSAF).	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PSM	  polymerization	  experiments,	  Non-­‐formylated	  PSM	  peptides	  were	  synthesized	  by	  Peptide	  
2.0	  and	  assayed	  to	  be	  >90%	  pure	  by	  HPLC.	  	  Synthetic	  peptides	  were	  prepared	  and	  assayed	  as	  
previously	  described	  [15,34]	  to	  eliminate	  large	  aggregates	  from	  lyophilization	  prior	  to	  assay.	  
Each	  dry	  peptide	  stock	  was	  dissolved	  to	  a	  concentration	  of	  0.5	  mg/mL	  in	  a	  1:1	  mixture	  of	  
trifluoroacetic	  acid	  (TFA)	  and	  hexafluoroisopropanol	  (HFIP).	  Peptides	  were	  then	  sonicated	  for	  
10	  minutes	  and	  incubated	  at	  room	  temperature	  for	  1	  h.	  Solvent	  TFA/HFIP	  was	  removed	  by	  
speedvac	  at	  room	  temperature.	  Dried	  peptide	  stocks	  were	  stored	  at	  -­‐80°C.	  All	  assays	  were	  
performed	  with	  equal	  stoichiometric	  ratios	  of	  0.1	  mg/mL	  peptide	  unless	  otherwise	  noted.	  
	  
All	  polymerization	  assays	  were	  performed	  in	  96-­‐well	  black	  opaque,	  polystyrene,	  TC-­‐treated	  
plates	  (Corning).	  Prior	  to	  assay,	  treated	  peptides	  were	  thawed	  and	  dissolved	  in	  dimethyl	  
sulfoxide	  (DMSO)	  to	  a	  concentration	  of	  10	  mg/mL	  immediately	  prior	  to	  assay.	  Freshly	  dissolved	  
peptides	  were	  diluted	  into	  sterile	  ddH2O	  containing	  0.2	  mM	  thioflavin	  T	  (ThT)	  and	  assayed	  at	  
room	  temperature.	  Fluorescence	  was	  measured	  every	  10	  minutes	  after	  shaking	  by	  a	  Tecan	  
Infinite	  M200	  plate	  reader	  at	  438	  nm	  excitation	  and	  495	  nm	  emission.	  ThT	  fluorescence	  during	  
polymerization	  was	  corrected	  by	  subtracting	  the	  background	  intensity	  of	  an	  identical	  sample	  
without	  ThT.	  	  
	  
Additionally,	  ThT	  fluorescence	  and	  Congo	  red	  (CR)	  absorbance	  scans	  were	  performed	  on	  
polymerized	  peptides	  that	  were	  allowed	  to	  polymerize	  for	  48	  h	  in	  ddH2O.	  Samples	  were	  
incubated	  in	  0.2	  mM	  ThT	  or	  0.001%	  (w/v)	  CR	  in	  ddH2O	  for	  15	  minutes	  prior	  to	  assay	  on	  the	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Tecan	  plate	  reader.	  CR	  and	  ThT	  scans	  were	  corrected	  by	  subtracting	  the	  background	  intensity	  of	  
an	  identical	  sample	  without	  dye.	  
	  
Circular	  dichroism	  spectroscopy,	  Treated	  peptide	  stocks	  were	  thawed	  and	  dissolved	  in	  
hexafluoroisopropanol	  (HFIP)	  to	  a	  concentration	  of	  10	  mg/mL	  immediately	  prior	  to	  assay.	  
Triplicate	  samples	  consisting	  of	  0.1	  mg/mL	  of	  each	  freshly	  dissolved	  peptide	  diluted	  together	  in	  
500μL	  sterile	  ddH2O	  were	  incubated	  with	  shaking	  at	  room	  temperature	  for	  48	  h.	  Samples	  were	  
then	  pelleted	  at	  15,000	  RPM	  for	  30	  minutes	  to	  isolate	  any	  aggregated	  species.	  The	  supernatant	  
was	  carefully	  removed	  from	  the	  pellet	  by	  aspiration	  and	  transferred	  to	  a	  clean,	  sterile	  
eppendorf	  tube.	  The	  remaining	  pellet	  was	  resuspended	  in	  200	  μL	  ddH2O	  by	  bath	  sonication	  for	  
10	  minutes.	  The	  supernatant	  and	  pellets	  of	  each	  sample	  were	  assayed	  separately.	  Far	  UV	  
circular	  dichroism	  (CD)	  measurements	  were	  performed	  with	  a	  Jasco-­‐J715	  spectropolarimeter	  
using	  quartz	  cells	  with	  0.1	  cm	  path	  length.	  CD	  spectra	  between	  190	  and	  250	  nm	  were	  recorded	  
in	  millidegrees	  and	  converted	  to	  molar	  ellipticity	  using	  an	  average	  MRW	  of	  113	  for	  αPSM1-­‐4,	  
βPSM1&2,	  and	  δ-­‐toxin.	  The	  average	  of	  five	  scans	  was	  recorded	  at	  25°C	  using	  a	  2	  nm	  bandwidth	  
with	  a	  20	  nm	  min-­‐1	  scanning	  speed.	  All	  triplicate	  samples	  showed	  similar	  ellipticity	  patterns.	  
	  
Biofilm	  dispersal	  assay,	  Synthetic	  PSM	  peptides	  were	  allowed	  to	  polymerize	  overnight,	  and	  
fibril	  formation	  was	  verified	  by	  TEM	  imaging.	  Equivalent	  concentrations	  of	  either	  polymerized	  
or	  freshly	  diluted	  peptides	  were	  added	  to	  24	  hours	  SH1000	  biofilms	  grown	  in	  66%	  TSB	  +	  0.2%	  
glucose	  and	  incubated	  at	  37˚C	  for	  6	  hours.	  Biofilms	  were	  washed	  to	  remove	  non-­‐adherent	  cells	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then	  stained	  with	  0.1%	  crystal	  violet,	  dried,	  and	  solublized	  with	  acidified	  ethanol	  and	  
spectroscopically	  quantitated	  at	  A595.	  
	  
Statistics	  were	  performed	  using	  a	  1-­‐way	  analysis	  of	  variance	  (ANOVA).	  Results	  are	  expressed	  as	  
mean	  ±	  standard	  deviation.	  
Results	  
Biofilms	  grown	  in	  PNG	  media	  resist	  biofilm	  disassembly	  
Biofilms	  that	  persist	  in	  the	  human	  body	  are	  often	  resistant	  to	  conventional	  antimicrobial	  
treatment	  prior	  to	  dispersal.	  To	  gain	  insight	  into	  how	  the	  S.	  aureus	  biofilm	  matrix	  affects	  
disassembly	  under	  different	  growth	  conditions,	  we	  grew	  S.	  aureus	  flow	  cell	  biofilms	  with	  
various	  lab	  media.	  Next	  we	  used	  enzymes	  known	  to	  target	  primary	  matrix	  components	  in	  order	  
to	  test	  biofilm	  resistance	  (Fig.	  1A	  &	  1B).	  These	  enzymes	  include	  proteinase	  K	  (protein),	  DNaseI	  
(DNA),	  and	  dispersin	  B	  (polysaccharide).	  By	  using	  a	  variety	  of	  degradative	  enzymes,	  we	  
expected	  to	  observe	  complete	  biofilm	  eradication.	  Biofilms	  grown	  in	  tryptic	  soy	  broth	  
supplemented	  with	  glucose	  (TSBg)	  rapidly	  disassembled	  after	  enzymatic	  treatment	  (Fig.	  1A).	  
However,	  biofilms	  grown	  in	  peptone-­‐NaCl-­‐glucose	  (PNG)	  media	  did	  not	  disassemble	  after	  the	  
same	  enzymatic	  treatment	  (Fig.	  1B).	  
	  
We	  also	  assessed	  the	  ability	  of	  biofilms	  attatched	  at	  the	  air-­‐liquid	  interface	  of	  glass	  culture	  
tubes	  to	  withstand	  exposure	  to	  an	  anionic	  surfactant,	  sodium	  dodecyl	  sulfate	  (SDS).	  Again,	  
biofilms	  grown	  in	  TSBg	  were	  more	  sensitive	  to	  surfactant-­‐mediated	  disassembly	  than	  those	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grown	  in	  PNG	  (Fig.	  1C).	  We	  interpreted	  these	  results	  to	  be	  an	  indication	  that	  growth	  in	  PNG	  
alters	  the	  matrix	  composition,	  increasing	  the	  biofilm’s	  resistance	  to	  enzymatic	  degradation	  and	  
surfactant	  dispersal.	  We	  hypothesized	  that	  a	  new,	  previously	  unaccounted	  for	  matrix	  
component	  was	  influencing	  S.	  aureus	  biofilm	  integrity	  under	  these	  growth	  conditions.	  	  	  
	  
Biofilms	  resistant	  to	  dispersal	  contain	  extracellular	  fibers	  
To	  investigate	  how	  biofilms	  grown	  in	  PNG	  media	  are	  able	  to	  resist	  disassembly,	  we	  grew	  
biofilms	  in	  drip	  bioreactors	  under	  sensitive	  (TSBg)	  or	  resistant	  (PNG)	  conditions	  for	  five	  days.	  	  
Biofilms	  were	  harvested	  and	  disrupted	  by	  vortexing	  and	  sonication.	  Transmission	  electron	  
microscope	  (TEM)	  imaging	  of	  cells	  revealed	  the	  presence	  of	  extracellular	  fibers	  in	  enzyme-­‐
resistant	  biofilms	  (Fig.	  2B),	  but	  not	  in	  enzyme-­‐sensitive	  biofilms	  (Fig.	  2A).	  The	  fibers	  had	  a	  
central	  diameter	  of	  ~12	  nm	  and	  were	  closely	  associated	  with	  bacterial	  cells	  (Fig.	  2C).	  S.	  aureus	  
has	  never	  before	  been	  shown	  to	  produce	  large,	  extracellular	  structures.	  Additionally,	  we	  
observed	  identical	  fibers	  associated	  with	  biofilm	  cells	  in	  several	  lab	  strains	  (LAC,	  UAMS,	  MN8)	  
and	  six	  clinical	  isolates	  (three	  nasal	  isolates	  and	  three	  blood	  isolates)	  by	  TEM,	  demonstrating	  
that	  fiber	  formation	  is	  not	  specific	  to	  strain	  SH1000.	  Of	  note,	  we	  found	  that	  an	  agr	  quorum	  
sensing	  mutant	  (SH1001)	  was	  unable	  to	  produce	  fibers	  (Fig.	  2D).	  	  
	  
Staphylococcus	  aureus	  fibers	  are	  composed	  of	  phenol	  soluble	  modulins	  (PSMs)	  
The	  novel	  extracellular	  fibers	  isolated	  from	  robust	  biofilm	  matrices	  share	  morphological	  
similarities	  with	  the	  bacterial	  functional	  amyloids	  curli	  in	  E.	  coli	  and	  TasA	  in	  B.	  subtilis	  [15,16].	  
Amyloid	  proteins	  form	  highly	  stable	  polymerized	  aggregates	  that	  exhibit	  well-­‐defined	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biochemical	  and	  biophysical	  characteristics	  [14,31,32].	  We	  hypothesized	  that	  our	  fibers	  were	  
also	  functional	  bacterial	  amyloids.	  To	  identify	  the	  protein	  composing	  these	  fibers,	  we	  used	  two	  
approaches	  to	  take	  advantage	  of	  the	  biophysical	  characteristics	  of	  functional	  bacterial	  
amyloids.	  	  
	  
Amyloid	  fibrils	  from	  bacterial	  biofilms	  were	  previously	  shown	  to	  be	  poorly	  soluble	  in	  sodium	  
dodecyl	  sulfate	  (SDS)	  and	  do	  not	  migrate	  through	  polyacrylamide	  gels	  [33].	  We	  therefore	  
employed	  SDS-­‐PAGE	  to	  isolate	  large	  insoluble	  structures.	  	  S.	  aureus	  biofilm	  samples	  were	  grown	  
in	  drip	  bioreactors	  for	  five	  days	  with	  PNG	  media	  or	  TSBg.	  These	  biofilms	  were	  harvested,	  
homogenized,	  and	  lysed,	  and	  the	  lysates	  were	  run	  into	  a	  12%	  SDS-­‐polyacrylamide	  gel.	  Lysates	  
from	  biofilms	  grown	  in	  PNG	  media	  retained	  insoluble	  material	  in	  the	  wells	  of	  the	  stacking	  gel	  
while	  TSBg-­‐grown	  lysates	  did	  not	  (Fig.	  3A).	  The	  insoluble	  material	  retained	  within	  the	  wells	  of	  
the	  stacking	  gel	  was	  recovered,	  treated	  with	  100%	  formic	  acid	  (FA),	  then	  separated	  once	  more	  
by	  SDS-­‐PAGE	  alongside	  an	  untreated	  control	  (Fig.	  3B).	  We	  observed	  protein	  enrichment	  in	  the	  
FA-­‐treated	  sample,	  and	  the	  four	  dominant	  bands	  were	  excised	  and	  analyzed	  via	  mass	  
spectrometry	  (MS).	  Surprisingly,	  MS	  analysis	  identified	  the	  same	  peptides	  as	  being	  abundant	  in	  
each	  sample,	  regardless	  of	  the	  band’s	  migration	  through	  the	  gel	  matrix	  (Fig.	  3B	  &	  3D).	  These	  
proteins	  were	  the	  alpha	  (αPSM)	  phenol	  soluble	  modulins	  and	  the	  S.	  aureus	  delta	  hemolysin	  (δ-­‐
toxin)	  (Fig.	  4A	  &	  4B).	  	  
	  
An	  additional	  approach	  to	  identify	  the	  fiber	  subunit	  was	  to	  isolate	  fibers	  from	  biofilm	  cells	  using	  
a	  tissue	  homogenizer	  (Fig.	  3C),	  incubate	  fiber	  isolates	  for	  48	  hours	  at	  pH	  2	  with	  pepsin,	  and	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analyze	  the	  sample	  with	  MS.	  Again,	  we	  detected	  the	  same	  αPSM	  peptides	  present	  in	  the	  SDS-­‐
PAGE	  isolation	  plus	  two	  beta	  PSMs	  (βPSM)	  (Fig.	  3D).	  αPSM3	  was	  not	  identified	  in	  either	  
preparation,	  but	  it	  should	  be	  noted	  that	  αPSM3's	  sequence	  contains	  several	  trypsin	  cleavage	  
sites,	  so	  it	  is	  likely	  that	  it	  would	  not	  be	  detected	  after	  extensive	  digestion.	  The	  same	  fiber	  
isolation	  procedure	  revealed	  no	  visible	  fibers	  by	  TEM	  when	  biofilms	  were	  grown	  in	  TSBg.	  
	  
We	  generated	  an	  ΔαβPSM	  double-­‐knockout	  mutant	  and	  assessed	  fiber	  production.	  	  TEM	  
analysis	  of	  biofilm	  cells	  revealed	  that	  this	  mutant	  did	  not	  produce	  fibers	  after	  five	  days	  of	  
growth	  in	  PNG	  media	  (Fig.	  5B)	  compared	  to	  the	  wildtype	  parent	  strain	  grown	  under	  the	  same	  
conditions	  (Fig.	  5A).	  In	  addition,	  fibers	  could	  be	  isolated	  from	  wildtype	  (Fig.	  5D)	  but	  not	  mutant	  
biofilms	  (Fig.	  5E).	  Fiber	  production	  was	  complemented	  by	  expression	  of	  the	  αpsm	  and	  βpsm	  
operons	  in	  trans	  (Fig.	  5C	  &	  5F).	  
	  
PSM	  peptides	  form	  fibers	  similar	  to	  bacterial	  functional	  amyloids	  
We	  assayed	  synthetic	  PSMs	  peptides	  for	  their	  capacity	  to	  form	  fibers	  in	  vitro.	  To	  minimize	  the	  
prevalence	  of	  polymeric	  “seed”	  complexes,	  all	  synthetic	  peptides	  were	  treated	  with	  HFIP/TFA	  
and	  dried	  in	  vacuo	  prior	  to	  assay	  [34].	  Incubation	  of	  the	  seven	  previously	  identified	  PSM	  
peptides	  (αPSMs1-­‐4,	  βPSMs1-­‐2,	  and	  δ-­‐toxin)	  demonstrated	  their	  capacity	  to	  self-­‐assemble	  into	  
fibers	  (Fig.	  6B).	  We	  used	  the	  amyloid-­‐specific	  dye	  thioflavin	  T	  (ThT)	  to	  observe	  amyloid	  
formation	  over	  time	  [34,35].	  When	  we	  assayed	  the	  PSMs	  for	  polymerization	  in	  the	  presence	  of	  
ThT	  at	  room	  temperature,	  we	  observed	  a	  robust	  increase	  in	  normalized	  fluorescence	  (Fig.	  6A).	  
Greater	  peptide	  concentration	  increased	  ThT	  fluorescence	  and	  showed	  rapid	  binding	  kinetics	  
	   45	  
similar	  to	  an	  amyloid-­‐nucleator	  system	  (Fig.	  6A)	  [35,36,37].	  PSM	  fibers	  exposed	  to	  ThT	  
exhibited	  an	  emission	  spike	  near	  490	  nm	  that	  is	  also	  observed	  in	  other	  amyloid	  fibrils	  (Fig.	  6C)	  
[36,38,39].	  Incubation	  of	  PSM	  fibers	  with	  the	  dye	  Congo	  red	  (CR)	  resulted	  in	  a	  characteristic	  
absorbance	  “red	  shift”,	  indicative	  of	  cross	  β	  structure	  conserved	  in	  all	  amyloid	  fibers	  (Fig.	  6D)	  
[40].	  Furthermore,	  PSM	  fibers	  isolated	  from	  solution	  through	  centrifugation	  displayed	  
increased	  β-­‐sheet	  content	  (Fig.	  6E),	  which	  is	  consistent	  with	  data	  published	  from	  other	  bacterial	  
amyloids	  [13,16].	  These	  in	  vitro	  observations	  compliment	  our	  genetic	  and	  physiological	  data,	  
further	  supporting	  the	  notion	  that	  PSMs	  can	  form	  amyloid	  fibrils.	  	  
	  
Mutants	  unable	  to	  synthesize	  PSMs	  produce	  biofilms	  susceptible	  to	  matrix-­‐degrading	  
enzymes	  and	  mechanical	  stress	  
Because	  biofilms	  grown	  in	  PNG	  media	  resist	  disassembly	  by	  matrix-­‐degrading	  enzymes	  and	  
surfactants	  (Fig.	  1),	  we	  challenged	  Δαβpsm	  mutant	  biofilms	  grown	  under	  the	  same	  conditions.	  
In	  contrast	  to	  its	  isogenic	  parent	  strain,	  an	  Δαβpsm	  mutant	  biofilm	  readily	  disassembled	  after	  
exposure	  to	  proteinase	  K,	  DNaseI,	  and	  dispersin	  B	  (Fig.	  7A).	  Complementation	  of	  the	  αβPSM	  
mutant	  in	  trans	  restored	  the	  resistant	  biofilm	  phenotype	  (Fig.	  7B).	  We	  also	  examined	  the	  
effects	  of	  mechanical	  stress	  (vortexing)	  on	  biofilms	  attatched	  at	  the	  air-­‐liquid	  interface	  of	  glass	  
culture	  tubes.	  An	  Δαβpsm	  mutant	  biofilm	  readily	  disassembled	  with	  exposure	  to	  mechanical	  
stress,	  while	  biofilms	  of	  the	  isogenic	  parent	  and	  complemented	  strains	  both	  remained	  intact	  
(Fig.	  7C).	  	  Taken	  together	  these	  data	  do	  suggest	  that	  PSM	  fibers	  enhance	  biofilm	  integrity.	  	  
	  
Fibrilation	  modulates	  PSM	  activity	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Previous	  work	  has	  demonstrated	  that	  soluble	  PSMs	  assist	  biofilm	  disassembly	  [19,21,27].	  Based	  
on	  our	  findings	  that	  PSM	  fibers	  improve	  biofilm	  integrity	  (Fig.	  1	  &	  Fig.	  7),	  we	  hypothesized	  that	  
sequestration	  of	  PSMs	  into	  extracellular	  fibers	  could	  alter	  their	  activity.	  Synthetic	  αPSM1	  
peptides	  readily	  formed	  fibers	  that	  bind	  CR	  and	  ThT	  after	  24	  hours	  of	  incubation	  in	  solution	  
(Fig.	  8C,	  8D,	  8E).	  To	  test	  whether	  or	  not	  fibrillation	  alters	  peptide	  activity,	  we	  exposed	  24-­‐hour	  
S.	  aureus	  biofilms	  to	  either	  freshly	  solublized	  αPSM1	  peptides	  (Fig.	  8B)	  or	  αPSM1	  that	  had	  been	  
allowed	  to	  polymerize	  overnight	  (Fig.	  8C).	  Exposure	  to	  soluble	  αPSM1	  significantly	  reduced	  the	  
amount	  of	  adherent	  biofilm;	  however,	  exposure	  to	  αPSM1	  fibers	  had	  no	  discernable	  effect	  on	  
the	  biofilms	  (Fig.	  8A).	  This	  finding	  suggests	  that	  the	  aggregation	  of	  PSMs	  into	  amyloid-­‐like	  fibers	  
can	  modulate	  their	  ability	  to	  disassemble	  biofilms.	  	  	  
Discussion	  
Biofilm	  formation	  and	  disassembly	  are	  carefully	  coordinated	  with	  the	  production	  and	  
breakdown	  of	  matrix	  components.	  The	  biofilm	  lifecycle	  of	  attachment,	  maturation,	  and	  
disassembly	  participates	  as	  a	  mechanism	  of	  virulence	  in	  many	  persistent	  S.	  aureus	  infections	  
[1,2,4,5,11,12,19].	  A	  better	  understanding	  of	  the	  dynamic	  S.	  aureus	  matrix	  environment	  may	  
inspire	  new,	  innovative	  techniques	  for	  controlling	  biofilm	  infections.	  	  
	  
Previous	  studies	  have	  shown	  that	  the	  S.	  aureus	  biofilm	  matrix	  contains	  polysaccharides	  and	  
DNA	  that	  interact	  with	  structural	  and	  enzymatic	  proteins	  [3,4,5,7,41].	  In	  this	  work	  we	  
demonstrate	  that	  under	  certain	  growth	  conditions,	  S.	  aureus	  produces	  amyloid-­‐like	  fibers	  that	  
contribute	  to	  biofilm	  integrity	  (Fig.	  1,	  2,	  7).	  Purification	  and	  analysis	  of	  fibers	  revealed	  that	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several	  small	  peptides	  of	  the	  phenol	  soluble	  modulin	  family	  were	  present	  (Fig.	  3	  &	  Fig.	  4).	  Fibers	  
were	  not	  detected	  in	  biofilms	  of	  an	  Δαβpsm	  deletion	  mutant	  under	  the	  same	  conditions	  that	  
favor	  their	  production	  in	  wildtype	  strains	  (Fig.	  5).	  Δαβpsm	  mutant	  biofilms	  were	  further	  
demonstrated	  to	  be	  significantly	  more	  susceptible	  to	  disassembly	  with	  matrix	  degrading	  
enzymes	  and	  mechanical	  stress	  than	  their	  isogenic	  parent	  (Fig.	  7).	  	  
	  
To	  the	  best	  of	  our	  knowledge,	  this	  is	  the	  first	  report	  describing	  an	  extracellular	  fibril	  structure	  in	  
S.	  aureus	  biofilms.	  We	  refer	  to	  these	  matrix	  components	  as	  being	  amyloid-­‐like	  because	  they	  
possess	  some	  of	  the	  characteristics	  often	  attributed	  to	  amyloid	  proteins:	  fibril	  morphology	  (Fig.	  
2,	  5,	  6,	  8),	  relative	  SDS	  insolubility	  (Fig.	  1	  &	  Fig.	  3),	  	  binding	  to	  the	  amyloid-­‐specific	  dyes	  
thioflavin	  T	  and	  Congo	  red	  (Fig.	  6	  &	  Fig.	  8	  ),	  and	  they	  display	  β-­‐sheet	  structure	  	  [14,31].	  The	  
observation	  that	  PSM	  peptides	  not	  only	  self-­‐assemble,	  but	  contribute	  to	  the	  biofilm’s	  structural	  
integrity	  is	  intriguing	  in	  light	  of	  recent	  work	  describing	  the	  PSMs’	  involvement	  in	  biofilm	  
disassembly	  [11,20,27].	  	  
	  
It	  is	  well-­‐documented	  that	  the	  PSMs	  are	  regulated	  by	  the	  agr	  quorum-­‐sensing	  network	  
[11,12,28,42],	  and	  we	  similarly	  have	  found	  that	  an	  agr	  deficient	  strain	  did	  not	  produce	  fibers	  
(Fig.	  2D).	  This	  contributes	  to	  a	  growing	  body	  of	  evidence	  which	  implicates	  the	  agr	  system	  to	  
have	  wide-­‐ranging	  effects	  beyond	  heightened	  pathogenicity	  and	  biofilm	  dispersal	  [4,20,21,43].	  
It	  is	  tempting	  to	  speculate	  that	  the	  media-­‐dependant	  fiber	  production	  is	  somehow	  influencing	  
agr	  regulation,	  perhaps	  through	  metabolism	  or	  through	  other	  signaling	  cues.	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PSMs	  were	  first	  isolated	  from	  Staphylococcus	  epidermidis	  cultures	  as	  a	  polypeptide	  complex,	  
and	  have	  since	  been	  shown	  to	  interact	  biochemically	  [22,29].	  We	  have	  demonstrated	  that	  
synthetic	  S.	  aureus	  PSM	  peptides	  are	  capable	  of	  self-­‐assembling	  into	  amyloid-­‐like	  fibers	  in	  vitro	  
(Fig.	  6A	  &	  Fig.	  6B).	  These	  fibers	  demonstrate	  CR	  and	  ThT	  binding	  capacities	  similar	  to	  known	  
amyloid	  proteins.	  PSMs,	  including	  δ-­‐toxin	  have	  been	  previously	  characterized	  as	  amphipathic	  α	  
helices	  [22,30,44,45].	  Our	  data	  indicate	  that	  soluble	  PSMs	  have	  a	  helical	  structure	  in	  solution,	  
but	  transition	  to	  adopt	  a	  more	  β-­‐rich	  structure	  after	  aggregation	  (Fig.	  6E).	  The	  assembly	  of	  
αPSM1	  into	  fibers	  prevents	  the	  biofilm	  disassembly	  activity	  attributed	  to	  soluble	  peptides	  
species	  (Fig.	  7).	  We	  interpret	  these	  results	  as	  evidence	  that	  aggregation	  into	  amyloid	  fibers	  can	  
regulate	  PSM	  activity	  in	  the	  microenvironment	  of	  the	  biofilm.	  
	  
Our	  findings	  demonstrate	  that	  S.	  aureus	  PSMs	  can	  be	  found	  in	  biofilms	  as	  fibrils,	  and	  may	  
implicate	  fibril	  formation	  as	  a	  means	  of	  altering	  their	  activity	  and	  function.	  It	  is	  not	  known	  at	  
this	  time	  what	  mechanisms	  influence	  the	  PSMs’	  ability	  to	  switch	  from	  a	  monomeric	  to	  fibril	  
state,	  nor	  is	  it	  clear	  how	  this	  affects	  the	  formation	  and	  disassembly	  of	  biofilms.	  It	  is	  possible	  
that	  PSM	  fibrillation	  is	  synchronized	  in	  vivo	  by	  a	  nucleator	  protein,	  similar	  to	  CsgB	  in	  E.	  coli	  [34].	  
Formylation	  may	  also	  play	  a	  role;	  the	  PSMs	  and	  δ-­‐toxin	  are	  detected	  at	  the	  protein	  level	  both	  
with	  and	  without	  with	  a	  formylated	  methionine	  modification	  [29,30,46,47],	  and	  the	  PSMs	  
identified	  in	  our	  MS	  analysis	  contained	  primarily	  deformylated	  N-­‐methionines.	  Recent	  work	  
demonstrates	  that	  non-­‐N-­‐formylated	  PSMs	  are	  strong	  activators	  of	  FPR2	  receptors,	  which	  also	  
respond	  to	  amyloidogenic	  peptides	  like	  Aβ1-­‐42	  and	  serum	  amyloid	  A	  [48,49,50],	  and	  may	  
implicate	  a	  role	  for	  deformylation	  in	  fibril	  construction.	  We	  speculate	  that	  there	  are	  numerous	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other	  environmental	  cues	  (such	  as	  pH	  and	  osmolarity)	  driving	  the	  PSMs	  commitment	  to	  the	  
fibrillation	  pathway,	  and	  this	  is	  currently	  under	  investigation.	  
	  
This	  study	  builds	  upon	  an	  emerging	  paradigm	  emphasizing	  that	  amyloid	  fibers	  are	  common	  in	  
the	  biofilm	  matrices	  of	  many	  bacterial	  species.	  Curli	  fibers	  produced	  by	  pathogenic	  E.	  coli	  and	  
other	  enterics	  were	  the	  first	  functional	  amyoloids	  to	  be	  characterized	  [15,32,33].	  The	  gram-­‐
positive	  bacteria	  Streptomyces	  coelicolor	  produces	  several	  small	  peptide	  species,	  which	  have	  
been	  shown	  to	  polymerize	  in	  vitro	  and	  in	  vivo	  to	  facilitate	  sporulation	  at	  the	  air-­‐liquid	  interface	  
[51,52,53,54].	  Recent	  work	  in	  B.	  subtilis	  has	  shown	  that	  the	  antimicrobial	  and	  spore	  coat	  
protein	  TasA	  can	  assemble	  into	  amyloid-­‐like	  fibrils	  during	  biofilm	  growth	  [16].	  Even	  natural	  
biofilms	  collected	  from	  a	  variety	  of	  environmental	  niches	  appear	  to	  contain	  amyloid-­‐like	  fibers	  
[55],	  indicating	  that	  the	  production	  of	  bacterial	  amyloids	  may	  be	  a	  shared	  feature	  of	  biofilm	  
matrices	  from	  many	  different	  bacterial	  communities.	  	  	  	  	  	  	  	  
	  
We	  propose	  that	  amyloid-­‐like	  aggregation	  of	  toxic	  proteins	  is	  an	  under	  appreciated	  form	  of	  
posttranslational	  regulation	  utilized	  throughout	  nature,	  and	  even	  more	  examples	  continue	  to	  
emerge.	  The	  antimicrobial	  activity	  of	  the	  Klebsiella	  pneumonia	  bacteriocin	  microcin	  E492	  can	  be	  
turned	  off	  through	  their	  assembly	  into	  amyloid-­‐like	  fibers	  [56].	  Recent	  work	  by	  Maji	  et	  al.	  has	  
demonstrated	  that	  even	  human	  peptide	  hormones	  can	  form	  amyloid-­‐like	  structures	  for	  storage	  
[57].	  Likewise,	  PSMs	  may	  be	  stored	  as	  inert	  fibrils	  in	  a	  sessile	  biofilm	  until	  conditions	  arise	  that	  
favor	  their	  dissociation	  to	  promote	  biofilm	  disassembly,	  antimicrobial	  activity,	  or	  virulence.	  This	  
work	  presents	  evidence	  that	  S.	  aureus	  PSMs	  can	  be	  found	  in	  biofilms	  as	  large	  fibril	  structures	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providing	  new	  insight	  into	  how	  quorum	  sensing	  and	  virulence	  play	  into	  the	  complexity	  of	  the	  
biofilm	  lifecycle.	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Figures	  and	  Tables:	  
Table	  2.1,	  Strains	  and	  plasmids	  used	  in	  the	  present	  study.	  
	  
Strain	  or	  plasmid	   Relevant	  Genotype	   Resistance	   Source	  or	  reference	  
Escherichia	  coli	   	   	   	  
DH5α-­‐E	   Cloning	  strain	   	   Invitrogen	  
	   	   	   	  
Staphylococcus	  aureus	   	   	   	  
RN4220	   Restriction	  modification	  deficient	   	   [61]	  
SH1000	   Lab	  strain-­‐	  σB+	  derivative	  of	  
NCTC8325-­‐4	  
	   [62]	  
SH1001	   SH1000	  agr::tet	  	   	   [62]	  
UAMS-­‐1	   Osteomylitus	  isolate	   	   [63]	  
MN8	   Toxic	  shock	  isolate	   	   [64]	  	  
LAC	   CA-­‐MRSA	  USA300-­‐0114	   	   [4]	  
AH500	   SH1000	  /	  pAH9	   Erm	   [4]	  
BB606	   Blood	  isolate	   	   This	  work	  
BB607	   Blood	  isolate	   	   This	  work	  
BB608	   Blood	  isolate	   	   This	  work	  
BB862	   Nasal	  isolate	   	   This	  work	  
BB863	   Nasal	  isolate	   	   This	  work	  
BB864	   Nasal	  isolate	   	   This	  work	  
BB2388	   SH1000	  ΔαβPSM	  	   	   This	  work	  	  
BB2407	   ΔαβPSM	  +	  pALC2073	  &	  pAH8	  	   Erm,	  Cm	   This	  work	  	  
BB2408	   ΔαβPSM	  +	  pALC2073-­‐	  αPSM	  	  &	  
pRSβPSM	  	  
Erm,	  Cm	   This	  work	  	  
Plasmids	   	   	   	  
pAH8	   agr	  promoter	  P3-­‐RFP	   Amp,	  Erm	   [4]	  
pALC2073	   agr	  promoter	  P3-­‐RFP	   Cm	   [4]	  
pALC2073	  -­‐	  αPSM	   αPSM	  locus	  under	  control	  of	  tet	  
promoter	  
Cm	   This	  work	  
pRS	  -­‐	  βPSM	   βPSM	  locus	  under	  control	  of	  
native	  promoter	  in	  pRS10	  
Amp,	  Erm	   This	  work	  
pKFC	   Gene	  replacement	  vector	   Amp,	  Tet	   [58]	  
pKFC-­‐	  αPSM	   αPSM	  knockout	  vector	   Amp,	  Tet	   This	  work	  
pKFC-­‐	  βPSM	  	   βPSM	  knockout	  vector	  	   Amp,	  Tet	   This	  work	  
	  




Figure	  2.1,	  Growth	  media	  influences	  biofilm	  disassembly	  	  
Confocal	  micrographs	  of	  S.	  aureus	  SH1000	  biofilms	  grown	  in	  TSBg	  media	  (A)	  for	  30	  hours	  readily	  
disassemble	  upon	  exposure	  to	  biofilm	  matrix	  degrading	  enzymes	  proteinase	  K,	  dispersin	  B,	  and	  
DNaseI	  at	  0.2	  µg/mL	  each.	  S.	  aureus	  biofilms	  grown	  in	  PNG	  media	  (B)	  for	  30	  hours	  fail	  to	  
disassemble	  upon	  exposure	  to	  matrix-­‐degrading	  enzymes.	  Images	  are	  representative	  of	  three	  
separate	  experiments	  and	  each	  side	  of	  a	  grid	  square	  represents	  20	  µm.	  (C)	  Biofilms	  at	  the	  air-­‐
liquid	  interface	  of	  test	  tube	  cultures	  withstand	  1%	  SDS	  exposure	  when	  grown	  in	  PNG	  media	  but	  
disassemble	  when	  grown	  in	  TSBg.	  Top	  images	  show	  stained	  test	  tube	  biofilms;	  graph	  below	  is	  
quantification	  of	  biofilm	  biomass.	  *	  P<0.002	  compared	  to	  no	  SDS	  treatment.	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Figure	  2.2	  ,	  S.	  aureus	  produces	  extracellular	  fibers	  during	  biofilm	  growth	  in	  PNG	  media.	  	  
TEM	  micrographs	  of	  cells	  from	  S.	  aureus	  SH1000	  biofilms	  grown	  in	  TSBg	  medium	  (A)	  versus	  cells	  
from	  biofilms	  grown	  in	  PNG	  media	  (B).	  High	  magnification	  reveals	  fibers	  are	  associated	  with	  the	  
cell	  wall	  and	  approximately	  12	  nm	  in	  width	  (C).	  An	  agr	  mutant	  does	  not	  produce	  extracellular	  
fibers	  (D).	  Bar	  length	  indicates	  1	  μm	  in	  A,	  B,	  and	  D,	  and	  250	  nm	  in	  C.	  
	  




Figure	  2.3,	  Fibers	  are	  composed	  of	  phenol	  soluble	  modulins.	  	  
(A)	  S.	  aureus	  biofilm	  cells	  were	  lysed	  and	  run	  into	  a	  12%	  SDS-­‐PAGE	  gel	  (TSBg	  first	  lane	  or	  PNG	  
second	  lane);	  protein	  that	  did	  not	  migrate	  through	  the	  gel	  (indicated	  by	  arrow)	  was	  extracted	  
from	  the	  staking	  gel,	  treated	  with	  formic	  acid	  to	  break	  up	  aggregated	  proteins,	  and	  finally	  run	  
on	  a	  new	  12%	  SDS-­‐PAGE	  gel	  (B).	  Bands	  that	  appeared	  after	  formic	  acid	  treatment	  (1-­‐4)	  were	  
excised	  and	  analyzed	  via	  LC-­‐MS/MS.	  (C)	  TEM	  micrograph	  of	  purified	  fiber	  sample	  that	  was	  then	  
exposed	  to	  extensive	  pepsin	  digestion	  and	  analyzed	  via	  LC-­‐MS/MS.	  Bar	  indicates	  250	  nm.	  (D)	  





















































Figure	  2.5,	  Mutants	  unable	  to	  produce	  α	  and	  βPSMs	  fail	  to	  form	  fibers	  during	  biofilm	  growth.	  
TEM	  micrographs	  of	  S.	  aureus	  biofilm	  cells	  grown	  for	  five	  days	  in	  PNG	  media.	  (A)	  wildtype	  
(strain	  SH1000),	  (B)	  Δαβpsm	  (strain	  BB2388),	  (C)	  Δαβpsm	  complemented	  (strain	  BB2408).	  (D-­‐F)	  
TEM	  micrographs	  of	  fiber	  preparations	  from	  wildtype	  (D),	  Δαβpsm	  	  (E),	  and	  Δαβpsm	  
complemented	  (F).	  Bars	  indicate	  500	  nm.	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Figure	  2.6,	  Synthetic	  phenol	  soluble	  modulin	  peptides	  bind	  ThT	  and	  polymerize	  into	  amyloid-­‐
like	  fibers.	  	  
(A)	  Normalized	  fluorescence	  intensity	  of	  [white	  circle]	  0.1	  mg/mL	  of	  each	  PSM	  peptide	  or	  [black	  
circle]	  0.05	  mg/mL	  of	  each	  PSM	  peptide	  in	  2	  mM	  ThT.	  Fluorescence	  emission	  was	  measured	  at	  
495	  nm	  after	  excitation	  at	  438	  nm.	  Assays	  were	  repeated	  in	  triplicate	  and	  all	  demonstrated	  a	  
similar	  trend.	  (B)	  48	  hours	  after	  mixing	  100	  µg/mL	  each	  of	  the	  seven	  PSM	  peptides	  (α1-­‐4,	  β1-­‐2,	  
and	  δ-­‐toxin),	  fibril	  structures	  are	  readily	  observed	  by	  TEM.	  (C)	  PSM	  fibers	  	  [black	  circle]	  display	  a	  
ThT	  fluorescence	  peak	  around	  482nm	  compared	  to	  a	  ThT-­‐only	  blank	  [grey	  circle].	  (D)	  PSM	  fibers	  
[black	  circle]	  produce	  a	  characteristic	  Congo	  red	  (CR)	  absorbance	  “red-­‐shift”	  associated	  with	  
amyloid	  binding	  compared	  to	  a	  CR-­‐only	  blank	  [grey	  circle].	  (E)	  Pelleted	  PSM	  fibers	  [grey	  circle]	  
display	  a	  greater	  β-­‐sheet	  content	  than	  the	  remaining	  supernatant	  [black	  circle].	  Assays	  were	  
repeated	  in	  triplicate	  and	  displayed	  similar	  trends.	  Bar	  indicates	  500	  nm.	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Figure	  2.7,	  An	  αβPSM	  mutant	  forms	  biofilms	  susceptible	  to	  disassembly	  by	  matrix	  degrading	  
enzymes	  and	  mechanical	  stress.	  	  
Confocal	  micrographs	  of	  Δαβpsm	  mutant	  (A)	  (strain	  BB2388)	  versus	  complemented	  mutant	  
expressing	  α	  and	  βpsm	  operons	  in	  trans	  (B)	  (strain	  BB2408)	  flow	  cell	  biofilms	  grown	  for	  30	  
hours	  prior	  to	  proteinase	  K,	  dispersin	  B,	  and	  DNaseI	  exposure	  (at	  0.2	  µg/mL	  each).	  Images	  are	  
representative	  of	  three	  separate	  experiments	  and	  each	  side	  of	  a	  grid	  square	  represents	  20	  µm.	  
(C)	  Analysis	  of	  biofilm	  development	  at	  the	  air-­‐liquid	  interface	  of	  test	  tube	  cultures	  in	  PNG	  media	  
after	  vortexing.	  Graph	  shows	  quantification	  of	  biofilm	  biomass	  (OD	  A595)	  and	  images	  below	  
show	  stained	  test	  tube	  biofilms.	  *	  P<	  0.005	  compared	  to	  wildtype.	  
	  





Figure	  2.8	  ,	  Amyloid	  fiber	  formation	  modulates	  PSM	  activity.	  	  
(A)	  S.	  aureus	  wildtype	  biofilms	  were	  grown	  in	  microtiter	  plates	  for	  24	  hours	  then	  washed	  and	  
exposed	  to	  increasing	  concentrations	  of	  soluble	  αPSM1	  or	  αPSM1	  fibers	  at	  concentrations	  of	  
10,	  50	  or	  100	  µg/mL	  for	  six	  hours.	  Biofilms	  were	  then	  washed,	  stained	  and	  remaining	  biofilm	  
biomass	  was	  visualized	  (images	  of	  wells	  below	  graph)	  and	  quantitated	  (OD	  at	  A595).	  (B	  &	  C)	  TEM	  
micrographs	  of	  αPSM1	  samples	  used	  in	  the	  experiment	  demonstrate	  the	  absence	  (B)	  and	  
presence	  (C)	  of	  fibers.	  *	  P<0.002	  compared	  to	  control	  no	  αPSM1	  treatment.	  We	  verified	  that	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Chapter	  3	  
The	  AgrD	  N-­‐terminal	  leader	  peptide	  of	  
Staphylococcus	  aureus	  has	  cytolytic	  and	  




Staphylococcus	  aureus	  virulence	  is	  coordinated	  through	  the	  Agr	  quorum	  sensing	  system	  to	  
produce	  an	  array	  of	  secreted	  molecules.	  One	  important	  class	  of	  secreted	  virulence	  factors	  is	  the	  
phenol	  soluble	  modulins	  (PSMs).	  PSMs	  are	  small	  peptide	  toxins	  that	  have	  been	  recently	  
characterized	  for	  their	  roles	  in	  infection,	  biofilm	  development,	  and	  subversion	  the	  host	  immune	  
system.	  	  In	  this	  work,	  we	  illustrate	  that	  the	  signal	  peptide	  of	  the	  S.	  aureus	  quorum-­‐sensing	  
signal,	  AgrD,	  shares	  structural	  and	  functional	  similarities	  with	  the	  PSM	  family	  of	  toxins.	  Efficacy	  
of	  this	  peptide	  (termed	  “N-­‐AgrD”)	  outside	  of	  AgrD	  propeptide	  trafficking	  has	  never	  before	  been	  
described.	  We	  observe	  that	  N-­‐AgrD,	  like	  the	  PSMs,	  is	  found	  in	  amyloid	  fibrils	  of	  S.	  aureus	  
biofilms,	  and	  is	  capable	  of	  forming	  and	  seeding	  amyloid	  fibrils	  in	  vitro.	  N-­‐AgrD	  displays	  cytolytic	  
and	  pro-­‐inflammatory	  properties	  that	  are	  abrogated	  after	  fibril	  formation.	  These	  data	  suggest	  
that	  the	  N-­‐AgrD	  leader	  peptide	  affects	  S.	  aureus	  biology	  in	  a	  manner	  similar	  to	  that	  previously	  
described	  for	  the	  PSM	  peptide	  toxins.	  Taken	  together,	  our	  findings	  suggest	  that	  peptide	  
cleavage	  products	  can	  affect	  cellular	  function	  beyond	  their	  canonical	  roles,	  and	  may	  represent	  a	  
class	  of	  virulence	  factors	  warranting	  further	  exploration.	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Introduction	  
Staphylococcus	  aureus	  is	  a	  common	  constituent	  of	  the	  human	  microflora,	  living	  commensally	  
on	  the	  skin	  or	  in	  the	  anterior	  nares	  of	  approximately	  one	  third	  of	  the	  population	  (1,	  2).	  Despite	  
this	  typically	  innocuous	  relationship,	  S.	  aureus	  can	  cause	  diseases	  ranging	  from	  benign	  skin	  
conditions	  to	  fatal	  systemic	  infections	  (3-­‐6).	  The	  severity	  of	  a	  S.	  aureus	  infection	  is	  partially	  
attributed	  to	  toxins	  produced	  by	  the	  infecting	  strain,	  which	  include	  superantigens,	  α-­‐toxin,	  
leukocidins	  and	  other	  small	  peptide	  toxins	  like	  phenol-­‐soluble	  modulins	  (PSMs)	  (7-­‐12).	  PSMs	  
are	  of	  particular	  interest	  because	  they	  perform	  multiple	  roles	  in	  pathogenesis.	  These	  short	  
peptides	  compound	  pathogenicity	  by	  activating	  host	  receptor-­‐mediated	  inflammatory	  
responses	  (12-­‐17),	  lysing	  red	  and	  white	  blood	  cells	  (16,	  18,	  19),	  altering	  biofilm	  development	  
(20-­‐23),	  and	  also	  by	  acting	  as	  antimicrobial	  agents	  against	  niche-­‐occupying	  organisms	  in	  the	  
host	  (24-­‐27).	  
	  
Our	  group	  has	  described	  previously	  that	  PSMs	  enhance	  S.	  aureus	  biofilm	  structures,	  likely	  
through	  coordinated	  aggregation	  into	  amyloid	  structures	  (22).	  Amyloid	  aggregates	  are	  robust	  
fibril	  structures	  produced	  through	  the	  self-­‐seeded	  auto-­‐aggregation	  of	  monomeric	  units.	  
Mature	  amyloid	  fibrils	  display	  a	  characteristic	  cross	  β-­‐sheet	  structure	  and	  are	  strongly	  resistant	  
to	  chemical	  and	  enzymatic	  degradation	  (28,	  29).	  Biofilms	  that	  produced	  PSM	  fibrils	  were	  
resistant	  to	  dispersal	  by	  matrix	  degrading	  enzymes,	  surfactants,	  and	  mechanical	  disruption.	  
Soluble	  PSMs	  dispersed	  biofilms,	  while	  pre-­‐aggregation	  of	  PSMs	  into	  amyloid	  fibrils	  abolished	  
this	  dispersal	  activity	  (22).	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The	  S.	  aureus	  accessory	  gene	  regulatory	  (Agr)	  quorum	  sensing	  system	  is	  associated	  with	  toxin	  
production	  during	  aggressive	  acute	  infections,	  while	  in	  several	  animal	  models	  agr	  mutants	  are	  
less	  virulent	  (3,	  5,	  10,	  30-­‐32).	  Agr	  directly	  regulates	  the	  expression	  of	  all	  three	  characterized	  
PSM	  types	  (PSMα1–4,	  PSMβ1–2, and δ-­‐toxin)	  (13,	  33).	  The	  agrBDCA	  operon	  encodes	  the	  core	  
components	  of	  the	  quorum-­‐sensing	  system,	  while	  the	  divergently	  transcribed	  RNAIII	  is	  a	  
regulatory	  RNA	  and	  the	  primary	  effector	  of	  the	  Agr	  regulon.	  Briefly,	  the	  Agr	  quorum	  sensing	  
circuit	  functions	  through	  the	  AgrCA	  two-­‐component	  sensory	  complex,	  which	  detects	  and	  
responds	  to	  the	  autoinducing	  peptide	  (AIP)	  signal	  derived	  from	  AgrD	  (30,	  31,	  34).	  AgrA	  binds	  to	  
promoters	  P2	  and	  P3	  to	  upregulate	  production	  of	  Agr	  machinery	  and	  the	  RNA	  III	  response	  
element.	  It	  was	  thought	  that	  P2	  and	  P3	  were	  AgrA’s	  exclusive	  targets	  until	  it	  was	  demonstrated	  
that	  AgrA	  binds	  to	  promoters	  upstream	  from	  the	  PSMα	  and	  PSMβ	  operons	  (33).	  Thus,	  Agr	  and	  
the	  PSMs	  are	  linked	  through	  their	  shared	  transcriptional	  regulation.	  	  
 
AgrD	  is	  translated	  as	  a	  propeptide	  composed	  of	  three	  parts:	  an	  N-­‐terminal	  amphipathic	  leader,	  
a	  middle	  region	  of	  eight	  residues	  that	  is	  processed	  into	  the	  final	  AIP	  structure,	  and	  a	  charged	  C-­‐
terminal	  tail	  (Fig.	  1F)	  (31).	  The	  N-­‐terminal	  region	  of	  AgrD	  is	  essential	  for	  directing	  the	  
propeptide	  to	  the	  cell	  membrane	  (35)	  ,	  where	  the	  integral	  membrane	  endopeptidase	  AgrB	  
removes	  the	  C-­‐terminal	  tail,	  catalyzes	  thiolactone	  ring	  formation,	  and	  transports	  the	  AgrD-­‐AIP	  
intermediate	  across	  the	  cell	  membrane	  (34,	  36).	  Once	  this	  intermediate	  peptide	  is	  secreted	  
from	  the	  cell,	  the	  SpsB	  signal	  peptidase	  cleaves	  the	  N-­‐terminal	  peptide	  to	  release	  the	  active	  
form	  of	  AIP,	  leaving	  the	  leader	  peptide	  associated	  with	  the	  cytoplasmic	  membrane	  (37,	  38).	  
Thus,	  the	  current	  model	  of	  AIP	  processing	  suggests	  that	  the	  N-­‐terminal	  leader	  fragment	  is	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essential	  for	  targeting	  the	  propeptide	  to	  the	  cell	  membrane,	  but	  the	  fate	  of	  the	  peptide	  after	  
AIP	  processing	  is	  unknown.	  	  
	  
Here	  we	  provide	  evidence	  for	  the	  first	  time	  that	  the	  N-­‐terminal	  amphipathic	  leader	  of	  the	  AgrD	  
propeptide	  (termed	  N-­‐AgrD)	  has	  multiple	  properties	  that	  are	  similar	  to	  the	  PSM	  peptides.	  N-­‐
AgrD	  is	  present	  in	  S.	  aureus	  amyloid	  fibrils	  during	  biofilm	  growth,	  and	  is	  capable	  of	  
autoaggregation	  and	  of	  seeding	  amyloid	  polymerization	  of	  PSM	  peptides	  in	  vitro.	  Soluble	  N-­‐
AgrD	  is	  cytolytic	  against	  human	  cells	  and	  displays	  pro-­‐inflammatory	  activity.	  These	  findings	  
demonstrate	  a	  novel	  biological	  role	  for	  a	  leader	  peptide	  beyond	  trafficking,	  and	  may	  provide	  
additional	  context	  into	  staphylococcal	  PSM	  biological	  function. 
Materials	  and	  Methods	  
	  
Bacterial	  Strains	  and	  Growth	  Conditions.	  S.	  aureus	  strain,	  LAC	  (MRSA	  USA300-­‐0114)	  was	  the	  
wildtype	  strain	  used	  in	  this	  study	  (39).	  Construction	  of	  the	  pAgrBD	  plasmid	  was	  described	  
previously	  (40).	  Plasmids	  pAgrBD	  and	  empty	  vector	  pEPSA5	  were	  transformed	  into	  a	  S.	  aureus	  
LAC	  agr-­‐	  mutant	  by	  electroporation	  to	  create	  strains	  BB2933	  (LAC	  agr-­‐	  +	  pAGRBD)	  and	  BB2945	  
(LAC	  agr-­‐	  +	  pEPSA5).	  
	  
Strains	  were	  routinely	  grown	  in	  trypic	  soy	  broth	  (TSB)	  incubated	  at	  37	  °C	  with	  200	  rpm	  shaking	  
unless	  otherwise	  noted.	  Carbon	  limited	  growth	  media	  (CLM)	  for	  detection	  of	  N-­‐AgrD	  in	  culture	  
supernatants	  consisted	  of:	  glucose	  (75	  mM),	  ammonium	  sulfate	  (7.5	  mM),	  potassium	  
phosphate	  (33	  mM),	  di-­‐potassium	  phosphate	  (60	  mM)	  supplemented	  with	  NaCl	  (11	  mM),	  KCl	  (2	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mM),	  Casamino	  Acids	  (BD	  Biosciences)	  (0.5%),	  MgSO4	  (0.1	  mM),	  and	  the	  vitamins	  nicotinamide	  
(500	  μg/liter),	  thiamine	  (500	  μg/liter),	  pantothenate	  (500	  μg/liter),	  and	  biotin	  (0.3	  μg/liter)	  (40).	  
	  
Biofilm	  Experiments,	  amyloid	  fibril	  isolation,	  mass	  spectrometry	  and	  microscopy.	  Drip-­‐flow	  
biofilms	  were	  grown	  in	  3.3	  g/L	  peptone,	  2.6	  g/L	  NaCl,	  3.3	  g/L	  glucose	  (PNG	  media)	  as	  previously	  
described	  (22,	  41).	  Amyloid	  fibrils	  were	  collected	  after	  5	  days	  of	  growth.	  Briefly,	  biofilms	  were	  
scraped	  into	  3	  mL	  of	  potassium	  phosphate	  buffer	  (50	  mM,	  pH	  7)	  and	  homogenized	  
(TissueMiser,	  Fisher)	  to	  shear	  fibrils	  from	  the	  cell	  walls.	  Supernatants	  were	  clarified	  by	  repeated	  
centrifugation	  at	  13,000	  RPM	  for	  2	  minutes	  to	  remove	  cells.	  The	  cell-­‐free	  supernatant	  was	  
incubated	  in	  200	  mM	  NaCl	  and	  the	  fibrils	  were	  isolated	  using	  Millipore	  Amicon	  Ultra	  Centrifugal	  
Filter	  Units	  with	  a	  pore	  size	  of	  100	  kDa.	  	  
	  
Fibril	  protein	  components	  were	  identified	  by	  LC-­‐MS/MS	  after	  digestion	  with	  pepsin	  (MS	  
Bioworks,	  Ann	  Arbor,	  MI)	  as	  previously	  described	  (22).	  The	  value	  for	  the	  abundance	  
measurement	  is	  the	  Normalized	  Spectral	  Abundance	  Factor	  (NSAF).	  	  
Transmission	  electron	  microscopy	  (TEM)	  was	  performed	  using	  a	  Philips	  CM12	  transmission	  
electron	  microscope.	  Samples	  prepared	  for	  TEM	  imaging	  were	  spotted	  onto	  formvar-­‐coated	  
copper	  grids,	  incubated	  for	  5	  minutes,	  washed	  with	  sterile	  ddH2O,	  and	  negatively	  stained	  with	  
2%	  uranyl	  acetate	  for	  60	  seconds.	  
	  
To	  detect	  the	  presence	  of	  N-­‐AgrD	  in	  culture	  supernatants,	  cultures	  were	  grown	  in	  100	  ml	  CLM	  
for	  24	  hours	  at	  37°C	  and	  cells	  were	  removed	  by	  centrifugation	  and	  passage	  of	  supernatant	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through	  a	  0.22	  micron	  filter.	  The	  supernatant	  was	  then	  concentrated	  1000	  fold	  by	  TCA	  
precipitation	  and	  resuspended	  in	  water.	  	  Following	  trypsin	  digestion	  samples	  were	  analyzed	  by	  
nano-­‐LC-­‐MS/MS	  (MS	  Bioworks,	  Ann	  Arbor,	  MI).	  	  
	  
PSM	  Polymerization	  Experiments.	  N-­‐AgrD	  and	  PSMα1	  peptides	  were	  synthesized	  by	  Lifetein	  
(South	  Plainfield,	  NJ)	  and	  assayed	  to	  be	  >90%	  pure	  by	  HPLC.	  Synthetic	  peptides	  were	  prepared	  
and	  assayed	  as	  previously	  described	  to	  eliminate	  large	  aggregates	  from	  lyophilization	  prior	  to	  
assay	  (22,	  42).	  The	  amino	  acid	  sequence	  of	  the	  N-­‐AgrD	  peptide	  was	  
MNTLFNLFFDFITGILKNIGNIAA	  ;	  the	  scrambled	  N-­‐AgrD	  peptide	  was	  
LGAAFNMNLINFDFTGIFNKLTII,	  and	  the	  sequence	  of	  the	  PSMα1	  peptide	  was	  
MGIIAGIIKVIKSLIEQFTGK.	  Each	  lyophilized	  peptide	  stock	  was	  dissolved	  directly	  into	  
hexafluoroisopropanol	  (HFIP)	  to	  a	  concentration	  of	  0.5	  mg/mL	  and	  briefly	  vortexed.	  Peptide	  
stocks	  were	  aliquoted	  into	  microcentrifuge	  tubes	  and	  the	  HFIP	  solvent	  was	  removed	  by	  
speedvac	  at	  room	  temperature.	  Dried	  peptide	  stocks	  were	  stored	  at	  −80°C.	  
	  
All	  amyloid	  dye-­‐binding	  assays	  were	  performed	  in	  96-­‐well	  black	  opaque,	  polystyrene,	  TC-­‐
treated	  plates	  (Costar	  3603,	  Corning).	  Immediately	  prior	  to	  assay,	  dried	  peptide	  stocks	  were	  
thawed	  and	  dissolved	  in	  dimethyl	  sulfoxide	  (DMSO)	  to	  a	  concentration	  of	  10	  mg/mL.	  Freshly	  
dissolved	  peptides	  were	  diluted	  into	  sterile	  ddH2O	  containing	  0.2	  mM	  Thioflavin	  T	  (ThT)	  and	  
assayed	  at	  room	  temperature.	  Fluorescence	  was	  measured	  every	  10	  minutes	  after	  shaking	  by	  a	  
Tecan	  Infinite	  M200	  plate	  reader	  at	  438	  nm	  excitation	  and	  495	  nm	  emission.	  ThT	  fluorescence	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during	  polymerization	  was	  corrected	  by	  subtracting	  the	  background	  intensity	  of	  an	  identical	  
sample	  without	  ThT.	  Assays	  were	  repeated	  at	  least	  twice.	  
	  
Congo	  red	  (CR)	  absorbance	  scans	  were	  performed	  on	  polymerized	  peptides	  that	  were	  allowed	  
to	  polymerize	  for	  24	  h	  in	  ddH2O.	  Samples	  were	  incubated	  in	  0.001%	  (w/v)	  CR	  in	  ddH2O	  for	  30	  
minutes	  prior	  to	  assay	  on	  a	  Tecan	  Infinite	  M200	  plate	  reader.	  CR	  scans	  were	  corrected	  by	  
subtracting	  the	  background	  intensity	  the	  identical	  sample	  before	  addition	  of	  dye.	  Assays	  were	  
repeated	  at	  least	  twice.	  
	  
Circular	  dichroism	  spectroscopy.	  Treated	  peptide	  stocks	  were	  thawed	  and	  dissolved	  in	  
hexafluoroisopropanol	  (HFIP)	  to	  a	  concentration	  of	  10	  mg/mL	  and	  incubated	  on	  ice	  for	  20	  
minutes.	  Samples	  15	  μM	  peptide	  were	  made	  by	  diluting	  dissolved	  peptide	  into	  500	  µL	  sterile	  
ddH2O	  immediately	  prior	  to	  assay.	  Far	  UV	  circular	  dichroism	  (CD)	  measurements	  were	  
performed	  with	  a	  Jasco-­‐J810	  spectropolarimeter	  using	  quartz	  cells	  with	  0.1	  cm	  path	  length.	  CD	  
spectra	  between	  190	  and	  260	  nm	  were	  recorded	  in	  millidegrees	  and	  converted	  to	  molar	  
ellipticity.	  	  The	  average	  of	  five	  scans	  was	  recorded	  at	  25°C	  using	  a	  2	  nm	  bandwidth	  with	  a	  20	  nm	  
min−1	  scanning	  speed.	  CD	  scans	  were	  performed	  over	  the	  course	  of	  20	  hours.	  Triplicate	  samples	  
showed	  similar	  ellipticity	  patterns.	  	  
	  
Hemolysis	  Assays.	  The	  collection	  of	  blood	  from	  human	  subjects	  was	  approved	  by	  the	  University	  
of	  Michigan	  Institutional	  Review	  Board,	  approval	  number	  IRB00001995.	  Human	  whole	  blood	  
was	  washed	  in	  PBS	  and	  diluted	  to	  a	  final	  concentration	  of	  1:25	  (v/v)	  in	  PBS.	  100	  μL	  of	  blood	  was	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then	  placed	  into	  individual	  wells	  of	  a	  flat-­‐bottom	  96-­‐well	  microtiter	  plate	  (Costar	  3596,	  
Corning).	  	  
PSMα1	  and	  N-­‐AgrD	  synthetic	  peptides	  resuspended	  in	  DMSO	  were	  added	  directly	  to	  the	  wells	  
at	  indicated	  concentrations,	  and	  the	  mixture	  was	  incubated	  for	  60	  min	  at	  37°C.	  After	  
incubation,	  plates	  were	  centrifuged	  at	  500	  ×	  g	  for	  10	  min,	  and	  an	  aliquot	  of	  supernatant	  (100	  
µL)	  was	  transferred	  to	  a	  separate	  microtiter	  plate	  to	  measure	  hemoglobin	  absorbance	  at	  450	  
nm	  on	  a	  Tecan	  Infinite	  M200	  plate	  reader.	  Assays	  were	  repeated	  in	  triplicate	  
	  
Overnight	  cultures	  of	  S.	  aureus	  containing	  plasmids	  encoding	  pAgrBD	  	  or	  pESPA5	  were	  diluted	  
1:100	  in	  5	  ml	  of	  TSB	  containing	  indicated	  levels	  of	  xylose.	  Cells	  were	  grown	  by	  shaking	  at	  37°C	  
to	  an	  optical	  density	  of	  2.00	  at	  600	  nm.	  Supernatants	  were	  then	  prepared	  by	  passing	  through	  
0.22-­‐µm	  filters.	  	  10	  µL	  of	  supernatant	  was	  then	  added	  to	  100	  µL	  of	  blood	  and	  incubated	  for	  60	  
min	  at	  37°C.	  After	  incubation,	  plates	  were	  centrifuged	  at	  500	  ×	  C	  for	  10	  min,	  and	  an	  aliquot	  of	  
supernatant	  (100	  ical	  density	  of	  2.00	  at	  	  separate	  microtiter	  plate	  to	  measure	  hemoglobin	  
absorbance	  at	  450	  nm	  on	  a	  Tecan	  Infinite	  M200	  plate	  reader.	  	  	  
	  
Lysis	  of	  human	  neutrophils.	  Venous	  blood	  was	  collected	  from	  healthy	  human	  volunteers	  
(approved	  by	  the	  University	  of	  Michigan	  Institutional	  Review	  Board,	  approval	  number	  
IRB00001995)	  using	  0.2%	  EDTA	  as	  an	  anticoagulant.	  Neutrophils	  were	  isolated	  by	  sequential	  
centrifugation	  in	  Ficoll	  Paque	  Plus	  (GE	  Healthcare),	  and	  hypotonic	  lysis	  of	  erythrocytes,	  as	  
previously	  described	  (12,	  18).	  Briefly,	  3.7	  μM	  of	  either	  PSMα1	  or	  N-­‐AgrD	  synthetic	  peptide	  was	  
added	  to	  wells	  of	  a	  96-­‐well	  microtiter	  plate	  containing	  106	  neutrophils,	  and	  plates	  were	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incubated	  at	  37°C	  for	  2	  h.	  Neutrophil	  lysis	  was	  determined	  by	  quantitating	  the	  release	  of	  lactate	  
dehydrogenase	  (LDH)	  (Cytotoxicity	  Detection	  Kit,	  Roche	  Applied	  Sciences).	  	  Assays	  were	  
repeated	  in	  triplicate.	  
	  
Measurement	  of	  IL-­‐8	  production	  and	  neutrophil	  chemotaxis.	  Neutrophil	  chemotaxis	  in	  the	  
presence	  of	  2	  μM	  N-­‐AgrD	  or	  PSMα1	  synthetic	  peptide	  was	  analyzed	  using	  a	  QCM	  3	  µm	  
chemotaxis	  assay	  kit	  (Millipore	  #ECM504).	  Briefly	  isolated	  human	  neutrophils	  were	  subjected	  to	  
a	  brief	  hypotonic	  shock	  with	  pyrogen-­‐free	  water	  (Sigma),	  washed,	  and	  suspended	  at	  5×106	  
cells/ml	  in	  HBSS	  containing	  0.05%	  human	  serum	  albumin.	  Chemotaxis	  of	  neutrophils	  was	  
determined	  by	  using	  fluorescently-­‐labeled	  neutrophils	  that	  migrated	  through	  a	  membrane	  
fitted	  into	  an	  insert	  of	  a	  24-­‐well	  microtiter	  plate	  transwell	  system	  containing	  a	  prewetted	  3-­‐µm-­‐
pore-­‐size	  polycarbonate	  filter.	  Measurement	  of	  IL-­‐8	  production	  in	  human	  neutrophils	  after	  
exposure	  to	  6	  μM	  N-­‐AgrD	  or	  PSMα1	  synthetic	  peptide	  was	  performed	  as	  described	  using	  a	  
commercial	  ELISA	  assay	  kit	  (R&D	  systems)	  according	  to	  the	  manufacturer's	  instructions.	  
Statistics	  were	  performed	  using	  a	  1-­‐way	  analysis	  of	  variance	  (ANOVA).	  
RESULTS	  
N-­‐AgrD	  peptide	  is	  present	  in	  purified	  amyloid	  fibrils	  
Our	  previous	  work	  demonstrated	  that	  S.	  aureus	  laboratory	  strain	  SH1000	  produced	  amyloid	  
fibrils	  composed	  primarily	  of	  PSMs	  (22).	  In	  the	  current	  study,	  we	  sought	  to	  investigate	  whether	  
a	  clinical	  isolate	  produced	  amyloid	  fibrils	  of	  a	  different	  composition	  than	  our	  common	  lab	  
strain.	  For	  this	  work	  we	  utilized	  CA-­‐MRSA	  USA300	  strain	  LAC,	  which	  exhibits	  robust	  Agr	  activity	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producing	  high	  levels	  of	  PSMs	  (12,	  43).	  When	  viewed	  by	  transmission	  electron	  microscopy	  
(TEM),	  LAC	  biofilms	  also	  produced	  substantial	  quantities	  of	  extracellular	  fibrils	  that	  were	  readily	  
isolated	  from	  cells	  (Figs.	  1A	  &	  1B).	  LC-­‐MS/MS	  analysis	  of	  LAC	  biofilm	  fibrils	  confirmed	  that	  PSM	  
species	  were	  associated	  with	  the	  amyloid	  fibrils	  but	  we	  also	  detected	  substantial	  quantities	  of	  
the	  AgrD	  N-­‐terminal	  leader	  peptide	  in	  our	  fibrils	  isolations	  (Figs.	  1C	  &	  1F)(22).	  This	  finding	  
prompted	  our	  investigation	  to	  determine	  the	  relevance	  of	  the	  N-­‐terminal	  AgrD	  peptide	  in	  S.	  
aureus	  biofilms.	  
	  
N-­‐AgrD	  displays	  amyloid-­‐like	  characteristics	  
An	  alignment	  of	  the	  N-­‐AgrD	  amino	  acid	  sequence	  to	  PSMα1	  showed	  distinct	  similarity	  to	  
PSMα1	  (Fig.	  1D).	  N-­‐AgrD	  has	  also	  been	  predicted	  to	  adopt	  an	  amphipathic	  α-­‐helical	  structure	  
that	  is	  similar	  to	  the	  PSMs	  (12,	  38)	  (Fig.	  1E).	  These	  striking	  primary	  and	  secondary	  structural	  
similarities,	  combined	  with	  the	  observation	  that	  N-­‐AgrD	  is	  associated	  with	  fibrils	  in	  biofilms,	  led	  
us	  to	  speculate	  that	  N-­‐AgrD	  may	  contribute	  to	  amyloid	  formation.	  
	  
The	  cross	  β-­‐sheet	  architecture	  of	  mature	  amyloid	  fibrils	  can	  be	  detected	  using	  several	  
biochemical	  assays,	  including	  amyloid	  specific	  dyes	  and	  circular	  dichroism	  (28,	  29,	  44,	  45).	  To	  
test	  whether	  N-­‐AgrD	  could	  form	  amyloids,	  we	  assayed	  synthetic	  N-­‐AgrD	  peptide	  for	  its	  capacity	  
to	  autoaggregate	  using	  an	  in	  vitro	  Thioflavin	  T	  (ThT)	  fluorescence	  assay	  (46).	  Amyloid	  
aggregation	  generally	  occurs	  in	  two	  phases	  —	  1)	  a	  lag	  phase,	  during	  which	  monomers	  associate	  
into	  oligomeric	  nuclei,	  and	  2)	  an	  exponential	  polymerization	  phase,	  during	  which	  mature	  
amyloid	  fibrils	  are	  formed	  (a	  shift	  in	  ThT	  fluorescence	  occurs	  as	  it	  binds	  to	  amyloid	  fibrils,	  and	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fluorescence	  levels	  will	  increase	  over	  time	  as	  more	  monomers	  adopt	  the	  amyloid	  fold	  in	  
solution)	  (46,	  47).	  Over	  a	  12	  hour	  time	  course,	  synthetic	  N-­‐AgrD	  displayed	  an	  initial	  lag	  phase	  
followed	  by	  a	  concentration-­‐dependent	  increase	  in	  ThT	  fluorescence	  indicative	  of	  amyloid	  
assembly	  (Fig.	  2A)(46).	  We	  verified	  the	  presence	  of	  amyloid	  aggregates	  at	  the	  end	  of	  the	  time	  
course	  by	  taking	  transmission	  electron	  microscopy	  (TEM)	  images	  of	  N-­‐AgrD	  24	  hours	  post-­‐
inoculation.	  We	  observed	  fibrils	  with	  a	  diameter	  of	  ~12	  microns,	  consistent	  with	  amyloid	  fibril	  
morphology	  (Fig.	  2B).	  A	  scrambled	  peptide	  control	  (sN-­‐AgrD)	  did	  not	  display	  ThT	  fluorescence,	  
and	  did	  not	  form	  fibrils,	  indicating	  that	  amyloid	  aggregation	  is	  sequence-­‐dependent	  (Figs.	  2C	  &	  
2D).	  
	  
To	  further	  demonstrate	  that	  the	  observed	  fibrils	  were	  amyloids,	  we	  incubated	  N-­‐AgrD	  fibrils	  
with	  another	  amyloid-­‐binding	  dye,	  Congo	  Red	  (CR).	  A	  characteristic	  absorbance	  “red	  shift”	  at	  ~	  
515	  nm	  was	  observed	  relative	  to	  a	  buffer	  control,	  which	  is	  indicative	  of	  the	  cross-­‐β	  structure	  of	  
amyloid	  fibrils	  (Fig.	  2E)(48).	  To	  confirm	  that	  N-­‐AgrD	  was	  adopting	  a	  β-­‐sheet	  conformation	  after	  
aggregation,	  we	  used	  circular	  dichroism	  (CD)	  to	  assay	  the	  secondary	  structural	  changes	  of	  
synthetic	  N-­‐AgrD	  over	  time.	  As	  predicted,	  freshly	  dissolved	  peptide	  displayed	  a	  change	  in	  peak	  
absorbances	  consistent	  with	  a	  transition	  to	  increased	  in	  β-­‐sheet	  content	  over	  time	  (Fig.	  2F).	  	  
	  
Considering	  the	  sequence	  similarity	  shared	  between	  N-­‐AgrD	  and	  PSMα1	  (Fig.	  1),	  these	  
observations	  suggest	  a	  potential	  role	  for	  both	  peptides	  in	  biofilms.	  These	  biochemical	  and	  
biophysical	  data	  were	  consistent	  with	  our	  hypothesis	  that	  N-­‐AgrD	  is	  capable	  of	  forming	  amyloid	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fibrils	  (Fig.	  2).	  We	  next	  aimed	  to	  investigate	  the	  biological	  relationship	  between	  N-­‐AgrD	  and	  the	  
PSM	  amyloids.	  	  
	  
N-­‐AgrD	  is	  capable	  of	  seeding	  PSM	  amyloid	  polymerization	  	  
Autoaggregation	  of	  amyloid	  proteins	  is	  rate-­‐limiting,	  but	  aggregation	  is	  accelerated	  with	  the	  
addition	  of	  oligomers	  or	  preformed	  fibrils	  called	  “seeds”	  (49,	  50).	  We	  asked	  whether	  
polymerized	  N-­‐AgrD	  could	  seed	  its	  own	  amyloid	  formation	  or	  seed	  the	  aggregation	  of	  PSM	  
peptides	  (Fig.	  3).	  	  Addition	  of	  5%	  (w/v)	  N-­‐AgrD	  fibrils	  (seeds)	  to	  freshly	  resuspended	  soluble	  N-­‐
AgrD	  reduced	  the	  lag	  phase	  and	  increased	  the	  relative	  ThT	  fluorescence	  intensity	  (Fig.	  3A).	  5%	  
N-­‐AgrD	  seeds	  alone	  displayed	  negligible	  fluorescence	  throughout	  the	  duration	  of	  the	  
experiment.	  A	  similar	  lag-­‐reduction	  was	  observed	  when	  5%	  N-­‐AgrD	  seeds	  were	  added	  to	  freshly	  
resuspended	  PSMα1	  (Fig.	  3B).	  These	  findings	  demonstrate	  that	  N-­‐AgrD	  can	  seed	  in	  vitro	  
amyloid	  formation	  of	  both	  itself	  and	  PSMα1.	  	  
	  
Soluble	  N-­‐AgrD	  has	  cytolytic	  activity	  against	  human	  cells	  
PSMs	  are	  cytolytic	  against	  several	  host	  cell	  types	  –	  a	  quality	  contributing	  to	  S.	  aureus	  infection	  
(12,	  18).	  Cytotoxicity	  is	  attributed	  to	  PSM	  peptides	  found	  as	  soluble	  species	  found	  in	  the	  
supernatants	  of	  liquid	  cultures	  (51,	  52).	  Thus,	  and	  we	  used	  LC-­‐MS/MS	  to	  verify	  that	  N-­‐AgrD	  is	  
also	  found	  in	  culture	  supernatants.	  Indeed,	  we	  detected	  N-­‐AgrD	  (full	  length:	  
MNTLFNLFFDFITGILKNIGNIAA,	  and	  two	  fragments:	  FITGILKNIGNIAA	  and	  ILKNIGNIAA)	  in	  cell-­‐free	  
supernatants	  from	  S.	  aureus	  LAC	  grown	  in	  a	  minimal	  media	  to	  late	  stationary	  phase	  (data	  not	  
shown).	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We	  next	  tested	  synthetic	  N-­‐AgrD	  peptide	  for	  cytolytic	  activity	  (Fig.	  4).	  Using	  an	  LDH	  assay	  as	  an	  
indicator	  of	  cell	  lysis,	  we	  found	  that	  exposure	  of	  neutrophils	  to	  3.7	  μM	  of	  N-­‐AgrD	  or	  PSMα1	  
induced	  neutrophils	  lysis	  after	  a	  90	  minute	  incubation	  (Fig.	  4A).	  N-­‐AgrD,	  also	  lysed	  human	  red	  
blood	  cells,	  resulting	  in	  64%	  hemoglobin	  release	  (Fig.	  4B).	  To	  determine	  whether	  amyloid	  
formation	  abrogated	  this	  effect,	  we	  compared	  N-­‐AgrD	  and	  PSMα1	  fibrils	  lytic	  activity.	  
Interestingly,	  we	  observed	  these	  fibrils	  displayed	  a	  pronounced	  reduction	  in	  cytolysis	  against	  
neutrophils	  and	  red	  blood	  cells	  relative	  to	  freely	  soluble	  peptides	  (Figs.	  4A	  &	  4B).	  Taken	  
together,	  these	  findings	  suggest	  that	  N-­‐AgrD	  may	  act	  as	  a	  virulence	  factor	  by	  lysing	  human	  cells,	  
and	  that	  this	  activity	  can	  be	  modulated	  by	  the	  ordered	  aggregation	  of	  N-­‐AgrD	  and	  PSMs	  into	  
amyloid	  fibrils.	  
	  
To	  test	  N-­‐AgrD’s	  cytotoxicity	  in	  a	  biological	  context,	  we	  overexpressed	  AgrD	  from	  a	  plasmid	  
containing	  an	  agrBD	  construct	  on	  a	  xylose-­‐inducible	  promoter	  in	  an	  agr	  mutant	  background	  
(strain	  BB2933).	  agrB	  was	  included	  in	  this	  construct	  because	  it	  is	  necessary	  for	  proper	  
processing	  and	  secretion	  of	  the	  AgrD	  propeptide	  to	  release	  the	  N-­‐terminal	  leader	  peptide	  (34,	  
53).	  Compared	  to	  the	  empty	  vector	  control,	  expression	  of	  agrBD	  resulted	  in	  increased	  lysis	  of	  
red	  blood	  cells	  (Fig.	  4C).	  	  
	  
N-­‐AgrD	  displays	  pro-­‐inflammatory	  properties	  
PSMs	  can	  induce	  neutrophil	  pro-­‐inflammatory	  responses	  like	  neutrophil	  chemotaxis	  and	  IL-­‐8	  
cytokine	  release	  (12-­‐14).	  Since	  N-­‐AgrD	  displayed	  cytolytic	  activity	  against	  host	  cells	  (Fig.	  4),	  we	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examined	  the	  pro-­‐inflammatory	  response	  to	  N-­‐AgrD	  peptides.	  Human	  neutrophils	  displayed	  a	  
similar	  chemotactic	  response	  upon	  exposure	  to	  soluble	  N-­‐AgrD	  and	  PSM	  peptides,	  including	  
both	  PSMα1	  and	  δ-­‐toxin	  (Fig.	  5A).	  However,	  polymerization	  of	  N-­‐AgrD	  and	  PSMα1	  peptides	  
prior	  to	  assay	  abrogated	  this	  neutrophil	  chemotactic	  activity	  (Fig.	  5A).	  	  
	  
Next,	  we	  assayed	  the	  production	  of	  cytokine	  IL-­‐8	  in	  human	  neutrophils	  after	  exposure	  to	  N-­‐
AgrD	  and	  PSM	  peptides.	  We	  observed	  a	  robust	  induction	  of	  IL-­‐8	  production	  in	  response	  to	  
soluble	  N-­‐AgrD	  and	  PSMα1	  that	  was	  significantly	  reduced	  in	  polymerized	  peptide	  samples	  (Fig.	  
5B).	  These	  findings	  suggest	  that	  N-­‐AgrD	  promotes	  a	  pro-­‐inflammatory	  response	  similar	  to	  that	  
induced	  by	  known	  PSMs,	  and	  further	  promotes	  the	  idea	  that	  N-­‐AgrD	  should	  be	  considered	  a	  
PSM-­‐like	  peptide	  in	  structure	  and	  activity.	  	  
Discussion	  
PSM	  peptides	  are	  major	  determinants	  of	  S.	  aureus	  virulence	  that	  possess	  cytolytic	  and	  immune	  
modulating	  activities	  (12,	  14,	  15,	  52).	  The	  high	  levels	  of	  PSMs	  produced	  by	  CA-­‐MRSA	  strains	  like	  
USA300	  is	  thought	  to	  contribute	  to	  the	  increased	  virulence	  of	  these	  strains	  (43).	  We	  previously	  
demonstrated	  that,	  under	  certain	  growth	  conditions,	  PSMs	  are	  capable	  of	  forming	  amyloid	  
fibrils	  that	  protect	  S.	  aureus	  biofilms	  from	  disassembly	  (22).	  In	  the	  present	  study,	  we	  identify	  
the	  N-­‐terminal	  secretion	  signal	  peptide	  of	  AgrD	  as	  a	  PSM-­‐like	  peptide	  and	  a	  supplementary	  
component	  of	  the	  amyloid	  fibrils	  produced	  in	  clinically	  relevant	  CA-­‐MRSA	  biofilms.	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The	  N-­‐AgrD	  peptide	  displays	  structural	  and	  functional	  similarity	  to	  the	  canonical	  PSM	  family	  of	  
peptides	  (Figs.	  1	  &	  2).	  We	  have	  found	  that	  N-­‐AgrD	  can	  autoaggregate	  to	  form	  fibrils,	  and	  that	  
pre-­‐aggregated	  N-­‐AgrD	  can	  seed	  amyloid	  formation	  of	  both	  soluble	  PSMα1	  and	  N-­‐AgrD	  (Figs.	  2	  
&	  3).	  N-­‐AgrD	  is	  present	  in	  both	  biofilms	  and	  the	  planktonic	  supernatants	  of	  S.	  aureus	  LAC	  
bacterial	  cultures,	  and	  also	  shares	  many	  biophysical	  characteristics	  with	  the	  PSMs	  and	  other	  
amyloid	  proteins	  (Figs.	  1-­‐3)	  (22,	  28).	  Amyloid	  toxicity	  is	  often	  attributed	  to	  the	  presence	  of	  
reactive	  intermediate	  species	  (54,	  55)	  and	  here	  we	  present	  evidence	  that	  the	  cytotoxic	  activity	  
of	  N-­‐AgrD	  and	  PSMα1	  can	  also	  be	  modulated	  through	  amyloid	  aggregation	  (Fig.	  4).	  We	  
observed	  high	  levels	  of	  cytolytic	  and	  pro-­‐inflammatory	  activity	  from	  soluble	  forms	  of	  N-­‐AgrD	  
and	  PSMα1	  peptides	  that	  was	  inhibited	  after	  aggregation	  (Figs.	  4	  &	  5).	  Because	  of	  the	  striking	  
similarities	  between	  PSMα1	  and	  N-­‐AgrD	  in	  form	  and	  function,	  we	  propose	  that	  N-­‐AgrD	  should	  
be	  considered	  a	  new	  member	  of	  the	  PSM	  family.	  
	  
Aside	  from	  its	  role	  in	  cellular	  trafficking,	  no	  other	  activity	  has	  been	  associated	  with	  N-­‐AgrD.	  Like	  
many	  signal	  peptides,	  it	  was	  considered	  a	  waste	  product	  that	  is	  simply	  discarded	  into	  the	  
extracellular	  milieu,	  or	  associated	  with	  the	  cellular	  membrane	  (38,	  56,	  57).	  We	  provide	  
evidence	  that	  the	  N-­‐terminal	  signal	  peptide	  is	  not	  a	  waste	  product	  derived	  from	  AIP	  processing,	  
but	  instead	  appears	  to	  possess	  qualities	  similar	  to	  other	  peptide	  virulence	  factors	  known	  to	  be	  
beneficial	  for	  the	  S.	  aureus	  lifecycle.	  	  
	  
Functions	  of	  other	  N-­‐terminal	  leader	  peptides	  have	  been	  described	  in	  the	  literature.	  The	  N-­‐
terminal	  region	  of	  the	  Pantone	  Valentine	  Leukocidin	  (PVL)	  was	  found	  to	  promote	  S.	  aureus	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cellular	  adhesion	  to	  extracellular	  matrix	  components	  like	  heparan	  (58).	  Enterococcus	  spp.	  utilize	  
a	  distinctive	  set	  of	  sex	  signaling	  pheromones	  that	  are	  derived	  from	  the	  signal	  peptides	  of	  
lipoproteins	  (59,	  60).	  In	  eukaryotic	  systems,	  signal	  peptides	  processed	  at	  the	  endoplasmic	  
reticulum	  promote	  calmodulin	  signaling	  (61)	  and	  promote	  the	  inflammatory	  response	  (62).	  
Many	  viruses,	  including	  the	  Hepatitis	  C	  virus,	  cytomegalovirus,	  and	  foamy	  virus,	  utilize	  cleaved	  
signal	  peptides	  to	  assist	  in	  cellular	  targeting	  and	  virus	  maturation	  (63-­‐65).	  Signal	  peptides	  are	  
being	  considered	  as	  novel	  targets	  for	  vaccine	  development,	  owing	  to	  their	  unique	  biology	  (66).	  
There	  is	  even	  evidence	  that	  signal	  peptides	  can	  sequester	  misfolded	  proteins	  at	  the	  ER	  
membrane	  to	  prevent	  toxicity	  (67),	  suggesting	  a	  potential	  role	  for	  N-­‐AgrD	  in	  seeding	  amyloid	  
fibril	  aggregation	  at	  the	  S.	  aureus	  cellular	  membrane.	  
	  
Based	  on	  these	  published	  accounts,	  we	  speculate	  that	  N-­‐AgrD,	  like	  other	  leader	  peptides	  
previously	  thought	  only	  to	  direct	  protein	  trafficking,	  may	  also	  serve	  additional	  roles	  outside	  of	  
the	  organism	  after	  processing	  at	  the	  cellular	  membrane.	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Figure	  3.1	  ,	  S.	  aureus	  USA300	  strain	  LAC	  displays	  robust	  amyloid	  fibril	  formation.	  	  
Fibrils	  extracted	  from	  biofilms	  contained	  high	  levels	  of	  phenol	  soluble	  modulins	  the	  N-­‐terminus	  
region	  of	  AgrD	  (N-­‐AgrD).	  (A)	  Transmission	  electron	  micrograph	  (TEM)	  illustrating	  fibril	  
formation	  (indicated	  by	  arrow)	  of	  S.	  aureus	  strain	  LAC	  after	  5	  days	  of	  biofilm	  growth.	  Bar	  
indicates	  500	  nm.	  (B)	  TEM	  of	  purified	  fibrils	  that	  were	  next	  subjected	  to	  mass	  spectrometry	  
(MS)	  analysis.	  Bar	  indicates	  500	  nm.	  (C)	  Peptide	  species	  identified	  from	  duplicate	  fibril	  isolations	  
via	  MS	  analysis	  and	  their	  relative	  abundance	  factors	  within	  the	  sample	  (NSAF).	  (D)	  ClustalW	  
sequence	  alignment	  illustrating	  the	  similarity	  of	  primary	  structure	  shared	  between	  the	  N-­‐
terminal	  region	  of	  AgrD	  and	  PSMα1	  (E)	  Predicted	  arrangement	  of	  N-­‐AgrD	  in	  an	  α-­‐helical	  wheel	  
showing	  amphipathy	  that	  is	  typical	  of	  PSMs	  (http://heliquest.ipmc.cnrs.fr/cgi-­‐
bin/ComputParamsV2.py)	  (F)	  Graphic	  illustration	  of	  AgrD	  propeptide	  domains,	  including	  the	  
amphipathic	  leader	  sequence,	  the	  autoinducing	  peptide	  (AIP),	  and	  the	  C-­‐terminal	  charged	  tail	  
(figure	  illustrates	  Agr	  Type	  I	  with	  residues	  conserved	  amongst	  Agr	  types	  lightened).	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Figure	  3.2,	  N-­‐AgrD	  possesses	  amyloid-­‐like	  characteristics.	  	  
A)	  Thioflavin	  T	  (ThT)	  assay	  which	  monitors	  amyloid	  polymerization	  kinetics	  with	  synthetic	  N-­‐
AgrD	  peptide.	  	  Normalized	  fluorescence	  intensity	  is	  shown	  for	  N-­‐AgrD	  at	  indicated	  
concentrations	  incubated	  with	  2	  mM	  ThT	  ()	  37.3	  μM;	  ()	  7.46	  μM;	  ()	  3.73	  μM	  ;	  ()	  no	  
peptide	  control.	  B)	  TEM	  of	  	  37.3	  μM	  N-­‐AgrD	  after	  24	  hours	  in	  solution.	  Bar	  indicates	  500	  nm.	  (C)	  
A	  scrambled	  version	  of	  the	  N-­‐AgrD	  peptide	  (labeled	  “sN-­‐AgrD”)	  ()	  does	  not	  display	  amyloid	  
ThT	  fluorescence	  relative	  to	  intact	  N-­‐AgrD	  ().	  Peptides	  were	  assayed	  at	  a	  concentration	  of	  37.3	  
μM.	  (D)	  TEM	  of	  	  37.3	  μM	  scrambled	  N-­‐AgrD	  after	  24	  hours	  in	  solution.	  Bar	  indicates	  500	  nm.	  (E)	  
Congo	  Red	  (CR)	  absorbance	  of	  N-­‐AgrD	  peptide	  displays	  a	  concentration-­‐dependant	  
characteristic	  absorbance	  increase	  515	  nm	  at	  ()	  370	  μM	  and	  ()	  185	  μM	  relative	  to	  ()	  a	  CR	  











Figure	  3.3,	  N-­‐AgrD	  amyloid	  fibrils	  are	  capable	  of	  seeding	  amyloid	  formation.	  
	  
(A)	  ThT	  polymerization	  assay	  of	  15	  μM	  N-­‐AgrD	  synthetic	  peptide	  in	  the	  presence	  ( )	  or	  absence	  
( )	  of	  5%	  (w/w)	  sonicated	  N-­‐AgrD	  seeds	  ( )	  (B)	  ThT	  polymerization	  assay	  of	  PSMα1	  peptide	  at	  
4.5	  μM	  in	  the	  presence	  ( )	  or	  absence	  ( )	  of	  5%	  (w/w)	  sonicated	  N-­‐AgrD	  seeds	  ( ).	  
	  




Figure	  3.4,	  Soluble	  N-­‐AgrD	  possesses	  cytolytic	  activity	  against	  human	  cells.	  	  	  
(A)	  Neutrophil	  lysis	  by	  3.7	  μM	  N-­‐AgrD	  or	  PSMα1	  after	  90	  minutes	  exposure.	  (B)	  Red	  blood	  cell	  
lysis	  by	  3.7	  μM	  N-­‐AgrD	  or	  PSMα1	  for	  90	  minutes.	  For	  both	  assays	  N-­‐AgrD	  and	  PSMα1	  were	  
analyzed	  in	  both	  their	  soluble	  versus	  polymerized	  states.	  (C)	  Lysis	  of	  red	  blood	  cells	  after	  
exposure	  to	  cell	  free	  S.	  aureus	  supernatants	  from	  strains	  BB2933	  (agr-­‐	  +	  pAgrBD)	  and	  BB2945	  
(agr-­‐	  +	  pEPSA5	  (empty	  vector)).	  
	  






Figure	  3.5.	  N-­‐AgrD	  and	  PSMα1	  display	  pro-­‐inflammatory	  activity.	  	  	  
(A)	  Chemotaxis	  of	  human	  neutrophils.	  Peptides	  were	  applied	  at	  a	  concentration	  of	  2	  μM;	  sN-­‐
AgrD	  refers	  to	  the	  scrambled	  peptide	  LGAAFNMNLINFDFTGIFNKLTII.	  Error	  bars	  show	  standard	  
error	  of	  the	  mean;	  *	  P<0.01	  comparing	  samples	  to	  RPMI	  media	  control	  (B)	  Neutrophil	  secretion	  
of	  IL-­‐8	  after	  treatment	  with	  N-­‐AgrD	  or	  PSMα1	  at	  a	  concentration	  of	  6	  μM.	  LPS	  was	  used	  at	  10	  
ng/ml.	  For	  both	  assays	  N-­‐AgrD	  and	  PSMα1	  were	  analyzed	  in	  both	  soluble	  versus	  polymerized	  
states.	  Error	  bars	  show	  standard	  error	  of	  the	  mean;	  *	  P<0.01	  comparing	  samples	  to	  DMSO	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Chapter	  4	  





Invasive	  Staphylococcus	  aureus	  strains	  produce	  large	  concentrations	  of	  phenol	  soluble	  modulin	  
(PSM)	  toxic	  peptides.	  PSMs	  serve	  to	  recruit,	  activate	  and	  subsequently	  lyse	  human	  neutrophils.	  
Amyloid	  fibril	  formation	  inhibits	  PSM	  toxicity,	  demonstrating	  that	  autoaggregation	  of	  small	  
peptide	  species	  can	  switch	  off	  virulence	  associated	  with	  freely	  diffusible	  peptides.	  The	  
mechanisms	  that	  regulate	  PSM	  amyloid	  aggregation	  in	  vivo	  are	  not	  known.	  Autoaggregation	  of	  
PSMs	  into	  amyloid	  fibers	  was	  previously	  shown	  to	  abrogate	  biofilm	  dispersal	  activity	  caused	  by	  
soluble	  peptides.	  We	  speculated	  that	  extracellular	  DNA	  produced	  during	  biofilm	  formation	  may	  
promote	  amyloid	  assembly.	  Using	  a	  combination	  of	  techniques,	  we	  demonstrate	  that	  PSMα1,	  a	  
main	  component	  of	  S.	  aureus	  biofilm	  fibrils,	  interacts	  with	  DNA	  to	  form	  large	  aggregates.	  These	  
aggregates	  were	  confirmed	  to	  be	  amyloids,	  and	  have	  fibril	  morphology.	  Finally,	  we	  
demonstrate	  that	  PSMα1	  displays	  reduced	  toxicity	  when	  incubated	  with	  DNA,	  which	  supports	  
prior	  evidence	  suggesting	  amyloid	  aggregation	  is	  control	  point	  for	  virulence	  in	  S.	  aureus	  
biofilms.	  These	  findings	  demonstrate	  that	  amyloid	  formation	  modulates	  PSM	  activity	  in	  the	  
microenvironment	  of	  the	  biofilm	  and	  beyond.	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Introduction	  
Microorganisms	  can	  survive	  in	  dynamic	  environments	  as	  multicellular	  communities,	  altering	  
their	  environment	  through	  the	  coordinated	  secretion	  of	  biomolecules	  to	  resist	  environmental	  
stressors.	  Multicellular	  communities	  encased	  in	  a	  self-­‐produced	  matrix	  are	  called	  biofilms	  [1].	  
Biofilm	  structure	  and	  composition	  varies	  greatly.	  The	  progression	  of	  biofilm	  development	  and	  
the	  components	  used	  to	  construct	  these	  structures	  also	  change	  over	  time,	  and	  are	  largely	  
dependent	  on	  cues	  received	  from	  the	  external	  environment.	  We	  observe	  this	  phenomenon	  in	  
the	  diversity	  of	  macrostructures	  associated	  with	  variable	  biofilm	  phenotypes	  [1].	  The	  variability	  
observed	  in	  biofilm	  construction	  and	  composition	  highlights	  the	  fact	  that	  biofilms	  can	  form	  
through	  numerous	  mechanisms.	  The	  biophysical	  interactions	  that	  occur	  within	  the	  biofilm	  
matrix	  help	  to	  create	  an	  adaptable	  structure	  during	  adherence,	  maturation,	  and	  dispersal	  [2].	  	  
	  
The	  Gram-­‐positive	  opportunistic	  pathogen	  Staphylococcus	  aureus	  has	  been	  studied	  in	  biofilm	  
communities	  that	  contribute	  to	  colonization	  and	  disease	  in	  humans	  [1,3].	  To	  survive	  in	  biofilms,	  
S.	  aureus	  produces	  a	  variety	  of	  secreted	  virulence	  factors.	  Prominent	  among	  these	  secreted	  
factors	  are	  the	  phenol	  soluble	  modulins,	  or	  PSMs	  [4].	  PSMs	  are	  small,	  amphipathic	  peptides	  
characterized	  to	  have	  profound	  impacts	  in	  S.	  aureus	  persistence	  and	  disease	  	  [4].	  PSMs	  can	  
attract	  neutrophils,	  lyse	  host	  cells,	  induce	  inflammation,	  and	  promote	  colony	  spreading	  through	  
surfactant-­‐like	  activity	  [4-­‐9].	  Strains	  capable	  of	  producing	  PSMs	  demonstrate	  an	  increased	  
ability	  to	  cause	  disease	  in	  mouse	  bacteremia,	  skin	  abscess	  and	  peritonitis	  models	  of	  infection	  
[4].	  Beyond	  the	  PSMs	  role	  in	  virulence,	  our	  lab	  previously	  demonstrated	  that	  the	  assembly	  of	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extracellular	  amyloid	  fibers	  composed	  of	  PSMs	  correlates	  with	  resistance	  to	  biofilm	  dispersal	  
[10].	  
	  
Staphylococcal	  biofilms	  form	  in	  a	  variety	  of	  ways,	  but	  most	  often	  contain	  polysaccharides	  called	  
PIA	  (polysaccharide	  intracellular	  adhesions)	  extracellular	  DNA	  (eDNA),	  and	  a	  variety	  of	  proteins	  
including	  enzymes,	  adhesions,	  and	  structural	  amyloids	  fibers.	  These	  components	  work	  together	  
synergistically	  to	  shape	  the	  biofilm	  matrix.	  Selective	  degradation	  or	  modulation	  of	  key	  
components	  can	  have	  profound	  effects	  on	  biofilm	  lifecycle	  [11].	  	  
	  
The	  methods	  by	  which	  PSM	  amyloid	  fibers	  assemble	  in	  situ	  are	  not	  known.	  When	  PSMs	  are	  
produced	  during	  biofilm	  growth	  and	  take	  on	  a	  soluble	  form,	  they	  can	  induce	  dispersal	  through	  
surfactant-­‐like	  activity	  [9,12].	  However,	  PSM	  amyloid	  assembly	  inhibits	  this	  PSM-­‐mediated	  
dispersal	  and	  furthermore	  stabilizes	  the	  biofilm	  against	  enzymatic	  and	  mechanical	  dispersal	  
[10].	  When	  PSMs	  form	  amyloid	  fibrils	  they	  not	  only	  resist	  dispersal,	  but	  are	  less	  toxic	  to	  red	  
blood	  cells	  and	  neutrophils,	  suggesting	  that	  biofilms	  producing	  amyloid	  fibers	  are	  less	  
deleterious	  than	  those	  that	  do	  not	  [10,	  13].	  Factors	  that	  dictate	  if	  PSMs	  take	  on	  a	  soluble	  or	  
amyloid	  form	  are	  unknown.	  We	  hypothesized	  that	  other	  biofilm	  matrix	  components	  could	  play	  
a	  role	  in	  PSM	  aggregation.	  	  
	  
One	  of	  the	  primary	  candidates	  for	  a	  potential	  amyloid	  interacting	  partner	  is	  extracellular	  DNA,	  
(eDNA),	  an	  important	  component	  of	  many	  biofilms	  [14].	  In	  other	  systems,	  it	  has	  been	  noted	  
that	  nucleic	  acids	  modulate	  amyloid	  assembly.	  Amyloidogenic	  proteins	  including	  alpha	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synuclein,	  prions,	  and	  amyloid-­‐beta	  are	  all	  known	  to	  interact	  with	  nucleic	  acids	  to	  regulate	  
amyloid	  assembly	  in	  vitro,	  [15-­‐17].	  DNA-­‐amyloid	  hybrids	  have	  long	  been	  implicated	  in	  the	  
pathology	  promoting	  neurodegenerative	  amyloidosis,	  and	  DNA	  has	  even	  been	  found	  inside	  
plaques	  isolated	  from	  brains	  of	  Alzheimer's	  patients	  [18-­‐21].	  	  
	  
Here,	  we	  provide	  evidence	  that	  phenol	  soluble	  modulin	  aggregation	  is	  enhanced	  in	  the	  
presence	  of	  DNA.	  Biofilms	  lacking	  eDNA	  do	  not	  produce	  extracellular	  fibers,	  and	  in	  vitro	  assays	  
demonstrate	  the	  interaction	  between	  DNA	  and	  PSMs	  and	  that	  DNA	  can	  promote	  amyloid	  
formation	  of	  PSMs.	  PSMs	  mixed	  with	  DNA	  are	  less	  cytotoxic	  solule	  peptides,	  indicating	  DNA	  
may	  act	  as	  a	  “chelating”	  agent	  against	  toxicity.	  These	  findings	  reveal	  a	  previously	  unappreciated	  
interaction	  between	  biofilm	  matrix	  components	  that	  furthers	  our	  understanding	  of	  S.	  aureus	  
biofilm	  biology.	  
Materials	  and	  Methods	  
Bacterial	  Strains	  and	  Growth	  Conditions,	  S.	  aureus	  strain,	  SH1000	  was	  the	  wildtype	  strain	  used	  
in	  this	  study.	  Construction	  of	  mutant	  strains	  is	  described	  elsewhere	  for	  the	  ΔPSM	  [10]	  and	  ΔatlA	  
[22].	  Liquid	  cultures	  were	  routinely	  grown	  in	  trypic	  soy	  broth	  (TSB)	  incubated	  at	  37	  °C	  with	  200	  
rpm	  shaking	  unless	  otherwise	  noted.	  	  
	  
Biofilm	  Experiments	  and	  amyloid	  fibril	  isolation,	  Drip-­‐flow	  biofilms	  were	  grown	  in	  3.3	  g/L	  
peptone,	  2.6	  g/L	  NaCl,	  3.3	  g/L	  glucose	  (PNG	  media)	  as	  previously	  described	  [10,	  23].	  After	  5	  
days	  of	  growth,	  biofilms	  were	  scraped	  into	  3	  mL	  of	  potassium	  phosphate	  buffer	  (50	  mM,	  pH	  7)	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and	  homogenized	  (TissueMiser,	  Fisher).	  Cell	  densities	  were	  measured	  and	  samples	  were	  
normalized	  to	  OD600	  of	  0.1.	  
	  
Amyloid	  fibrils	  were	  collected	  by	  shearing	  fibrils	  from	  the	  cell	  walls	  by	  tip	  sonication	  of	  cells	  on	  
ice.	  Supernatants	  were	  clarified	  by	  repeated	  centrifugation	  at	  13,000	  RPM	  for	  2	  minutes	  to	  
remove	  cells.	  The	  cell-­‐free	  supernatant	  was	  incubated	  in	  200	  mM	  NaCl	  and	  the	  fibrils	  were	  
isolated	  using	  Millipore	  Amicon	  Ultra	  Centrifugal	  Filter	  Units	  with	  a	  pore	  size	  of	  100	  kDa.	  The	  
retentate	  fractions	  (fiber	  isolates)	  were	  collected	  and	  used	  for	  further	  experimentation.	  	  
	  
Extracellular	  DNA	  was	  quantitated	  using	  a	  protocol	  used	  by	  Jones	  et	  al.	  [24]	  and	  adapted	  for	  
Qubit	  using	  a	  kit	  and	  fluorometer	  (Invitrogen)	  according	  to	  the	  manufacturer’s	  protocol.	  The	  
supernatants	  of	  homogenized	  biofilms	  scraped	  into	  TE	  buffer	  (10	  mM	  Tris-­‐Cl	  (pH	  8.0),	  0.1	  mM	  
NaCl)	  or	  high	  salt	  TE	  buffer	  (TE	  buffer	  +	  1	  M	  NaCl)	  with	  the	  cellular	  fraction	  spun	  out	  at	  5000K	  
RPM.	  	  
	  
Transmission	  Electron	  Microscopy	  (TEM),	  Biofilm	  cells,	  fibril	  isolates,	  and	  synthetic	  peptide	  
fibrils	  were	  prepared	  and	  imaged	  via	  TEM	  as	  described	  previously	  [10].	  Transmission	  electron	  
microscopy	  (TEM)	  was	  performed	  using	  a	  Philips	  CM12	  transmission	  electron	  microscope.	  
Samples	  prepared	  for	  TEM	  imaging	  were	  spotted	  onto	  formvar-­‐coated	  copper	  grids,	  incubated	  
for	  10	  minutes,	  washed	  with	  sterile	  ddH2O,	  and	  negatively	  stained	  with	  2%	  uranyl	  acetate	  for	  
60	  seconds.	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Production	  of	  PSMα1	  antibody,	  Rabbit	  polyclonal	  antibodies	  against	  PSMα1	  were	  generated	  by	  
Abgent	  	  (San	  Diego,	  CA)	  against	  a	  PSMα1	  epitope	  peptide	  sequence	  aa	  7-­‐21(NH2-­‐
IKVIKSLIEQFTGKC-­‐CONH2,	  wherein	  a	  cysteine	  was	  added	  to	  C-­‐terminus	  of	  peptide	  sequence	  to	  
provide	  for	  conjugation	  to	  KLH	  carrier)	  generated	  by	  Abgent	  (San	  Diego,	  CA)	  making	  the	  antigen	  
more	  readily	  soluble	  in	  aqueous	  environments	  than	  the	  full	  length	  PSMα1	  peptide.	  Rabbits	  
were	  immunized	  with	  purified	  peptide	  epitopes	  (Abgent)	  and	  the	  resulting	  sera	  were	  tested	  by	  
enzyme-­‐linked	  immunosorbent	  assay	  (ELISA)	  before	  Protein	  A	  affinity	  purification	  (Abgent).	  
	  
Western	  Blot	  Protocol,	  Cell	  Fractions	  were	  prepared	  as	  follows:	  Biofilms	  cells	  from	  drip	  
bioreactor	  cultures	  were	  harvested,	  washed	  in	  once	  with	  filter	  sterile	  HPLC	  grade	  water,	  and	  
normalized	  by	  cell	  density	  to	  an	  OD600	  of	  0.1	  in	  a	  total	  of	  200	  μL	  filter	  sterile	  HPLC	  grade	  water.	  	  
	  
Fibril	  isolates	  were	  prepared	  as	  previously	  described	  (Schwartz	  et	  al.).	  Proteins	  from	  1	  mL	  of	  
pooled	  fibril	  isolates	  isolated	  with	  250	  μL	  100%	  TCA	  and	  incubated	  at	  4°	  for	  2	  hours.	  
Precipitated	  protein	  samples	  were	  resuspended	  in	  40	  μL	  SDS	  loading	  buffer	  was	  added.	  
Samples	  were	  bath	  sonicated	  for	  20	  min,	  vortexed,	  and	  boiled	  for	  10	  min.	  
	  
For	  cell	  lysate	  fractions,	  1	  mg/mL	  lysostaphin	  was	  added	  to	  each	  culture	  and	  samples	  were	  
incubated	  for	  1	  hour	  at	  37°C	  with	  shaking.	  These	  samples	  were	  then	  pelleted	  and	  the	  
supernatant	  transferred	  to	  a	  fresh	  tube.	  40	  µL	  SDS	  loading	  dye	  was	  added,	  and	  samples	  were	  
boiled	  for	  10	  min,	  bath	  sonicated	  for	  20	  min,	  vortexed,	  and	  finally	  boiled	  10	  min.	  
	  
	  100	  
20	  μL	  of	  each	  cell	  fraction	  was	  loaded	  into	  a	  16.5%	  SDS	  PAGE	  gel.	  Gels	  were	  run	  in	  duplicate	  
and	  in	  the	  same	  electrophoresis	  tank	  (BioRad	  Mini-­‐Protean	  Tetra)	  for	  wet-­‐transfer.	  After	  
denaturation	  in	  sample	  buffer	  (BioRad	  –	  1x	  Biorad	  Tris-­‐Tricine	  SDS	  PAGE	  loading	  dye	  plus	  200	  
mM	  BME),	  20	  μL	  of	  each	  sample	  was	  loaded	  into	  pre-­‐cast	  16.5%	  Biorad	  Tris-­‐Tricine	  acrylimde	  
gels	  and	  run	  100V/65mA	  for	  100	  min	  at	  room	  temperature.	  These	  gels	  were	  transferred	  onto	  
0.22	  μM	  polyvinylidene	  fluoride	  (PVDF)	  membrane	  run	  at	  70V/250mA	  for	  80	  min	  at	  4°C.	  	  
	  
Western	  blotting	  procedure	  was	  performed	  for	  use	  with	  the	  LiCor	  Odyssey	  imaging	  system	  
according	  to	  LiCor	  protocols.	  10X	  TBS	  (25mM	  Tris-­‐Base,	  150mM	  NaCl,	  2mM	  KCl,	  pH	  7.40)	  was	  
stored	  at	  4°C	  and	  diluted	  just	  prior	  to	  use	  for	  1X	  TBS	  and	  1X	  TBST.	  1X	  TBST	  (100	  mL	  10x	  TBS	  +	  
900	  mL	  MQ	  H2O	  +	  1	  mL	  Tween-­‐20)	  was	  stored	  at	  4°C	  between	  washes.	  Blocking	  Buffer	  was	  
made	  fresh	  using	  200	  mL	  1X	  TBS	  	  8.5	  g	  powdered	  skim	  milk	  and	  used	  to	  dilute	  antibodies.	  
Membranes	  were	  incubated	  with	  5%	  milk	  blocking	  buffer	  (Li-­‐Cor)	  prior	  to	  incubation	  with	  rabbit	  
anti-­‐PSMα1	  (1:1000,	  Abgene)	  and	  goat	  anti-­‐rabbit	  IRDye	  800	  (1:15000,	  Li-­‐Cor)	  secondary	  
antibody	  rocking	  at	  RT	  for	  1	  hr,	  washed	  between	  antibodies	  with	  1X	  TBST.	  Imaging	  was	  carried	  
out	  using	  the	  LI-­‐COR	  Odyssey®	  scanner	  and	  software	  (LI-­‐COR	  Biosciences).	  Experiments	  
performed	  at	  least	  two	  times	  showed	  similar	  results.	  
	  
Peptide	  Preparations,	  Lyophilized	  peptide	  stocks	  (10	  mg,	  LifeTein)	  were	  mixed	  with	  ice	  cold	  
HFIP	  and	  transferred	  to	  sterile	  silicone	  coated	  tubes	  (Fisherbrand™	  Siliconized	  Low-­‐Retention	  
Microcentrifuge	  Tubes)	  at	  0.5	  mg	  per	  tube,	  and	  dried	  via	  speed	  vac	  (2	  hrs)	  and	  further	  dried	  to	  
completion	  under	  N2	  stream	  (2	  hr).	  Immediately	  prior	  to	  assay,	  dried	  peptide	  stocks	  were	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thawed	  and	  dissolved	  into	  filtered	  HPLC-­‐grade	  dimethyl	  sulfoxide,	  and	  allowed	  to	  solubilize	  for	  
at	  least	  30	  min	  rocking	  at	  room	  temperature.	  
	  
Gel	  Shift	  Assay,	  PSMα1	  peptide	  stock	  was	  resuspended	  in	  50	  μL	  filtered	  HPLC-­‐grade	  DMSO,	  
vortexed	  well	  to	  solubilize,	  and	  incubated	  with	  shaking	  at	  room	  temperature	  for	  20	  minutes	  
prior	  to	  assay.	  Care	  was	  taken	  to	  ensure	  that	  no	  protein	  was	  stuck	  to	  the	  sides	  of	  the	  wells.	  
	  
Staphylococcus	  aureus	  and	  Escherichia	  coli	  genomic	  DNA	  were	  isolated	  using	  Gentra	  Puregene	  
Yeast/Bact.	  Kit	  (Quigen).	  S.	  aureus	  or	  E.	  coli	  gDNA	  (100	  ng/μL),	  1000	  μg/mL	  PSMα1	  stock,	  
preformed	  fibrils,	  or	  1000	  μg/mL	  BSA	  (Invitrogen,	  1:10	  dilution)	  were	  dissolved	  into	  a	  total	  
volume	  of	  20	  uL	  in	  sterile	  HPlC-­‐grade	  H2O	  and	  incubated	  rocking	  at	  room	  temperature.	  Samples	  
were	  separated	  by	  electrophoresis	  at	  1h	  30min	  at	  150V/400mA	  on	  a	  1%	  agarose	  gel.	  Fresh	  
ethidium	  bromide	  was	  mixed	  into	  ddH2O	  and	  the	  gel	  was	  stained	  for	  30	  min,	  and	  soaked	  in	  
ddH2O	  for	  30	  min	  before	  visualization.	  	  
	  
For	  time	  course	  assays,	  samples	  were	  prepared	  and	  incubated	  for	  the	  stated	  duration	  of	  time	  
rocking	  at	  room	  temperature.	  PSMα1	  stock	  was	  diluted	  into	  equal	  volumes	  of	  filter	  sterile	  
HPLC-­‐grade	  DMSO	  when	  stated.	  TEM	  imaging	  was	  performed	  on	  samples	  containing	  DNA	  




Dynamic	  light	  scattering	  (DLS),	  DLS	  was	  performed	  on	  a	  compact	  goniometer	  system	  (ALV	  CGS-­‐
3,	  ALV,	  Langen	  Germany)	  equipped	  with	  a	  multi-­‐tau	  digital	  correlator	  (ALV	  7004,	  Langen,	  
Germany)	  and	  a	  laser	  light	  source	  of	  wavelength	  λ=	  632.8	  nm	  (He-­‐Ne,	  JDS	  Uniphase	  Corp,	  USA).	  
All	  measurements	  were	  done	  at	  T	  =	  298	  ±	  0.5	  K.	  The	  solvents	  and	  buffers	  used	  to	  make	  the	  DNA	  
and	  protein	  solutions	  were	  first	  sterilized,	  filtered	  through	  0.2	   µm	  Whatman	  Anotop	  syringe	  
filters	  (Whatman,	  USA).	  The	  samples	  were	  prepared	  in	  siliconized	  microcentrifuge	  tubes	  
(Fisherbrand™	  Siliconized	  Low-­‐Retention	  Microcentrifuge	  Tubes)	  to	  prevent	  sample	  from	  
binding	  to	  the	  walls	  of	  the	  tube.	  The	  hydrodynamic	  radii,	  RH	  (nm),	  of	  the	  samples	  were	  obtained	  
using	  relaxation	  times,	  τ	  (ms),	  measured	  at	  a	  fixed	  scattering	  angle	  of	  θ	  =	  90°	  and	  the	  Stokes	  –	  
Einstein	  relation.	  Peptides	  were	  prepared	  as	  described	  above	  for	  gel	  shift	  assay.	  Salmon	  Sperm	  
DNA	  (sDNA)	  was	  purchased	  from	  Invitrogen	  (Carlsbad,	  Ca).	  
	  
Thioflavin	  T	  Assays,	  All	  amyloid	  dye-­‐binding	  assays	  were	  performed	  in	  96-­‐well	  black	  opaque,	  
polystyrene,	  TC-­‐treated	  plates	  (Costar	  3603,	  Corning).	  Freshly	  dissolved	  peptide	  stocks	  in	  DMSO	  
were	  inoculated	  with	  or	  without	  DNA	  as	  stated,	  and	  diluted	  into	  sterile	  HPLC-­‐grade	  H2O	  
containing	  0.2	  mM	  Thioflavin	  T	  (ThT)	  prior	  to	  assay.	  Fluorescence	  was	  measured	  every	  10	  
minutes	  after	  shaking	  by	  a	  Tecan	  Infinite	  M200	  plate	  reader	  at	  438	  nm	  excitation	  and	  495	  nm	  
emission.	  ThT	  fluorescence	  during	  polymerization	  was	  corrected	  by	  subtracting	  the	  background	  
intensity	  of	  an	  identical	  sample	  without	  ThT.	  Samples	  were	  imaged	  via	  TEM	  upon	  completion	  of	  
timecourse.	  Assays	  were	  repeated	  at	  least	  twice	  and	  showed	  similar	  trends.	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Preparation	  of	  RBC	  stock	  solutions,	  5	  mL	  of	  mechanically	  defibrinated	  rabbit	  blood	  (Hemostat	  
Laboratories,	  Dixon	  CA)	  were	  pelleted	  to	  isolate	  red	  blood	  cells	  (RBCs)	  and	  washed	  twice	  with	  9	  
mL	  PBS	  by	  centrifuging	  at	  2000	  rpm	  for	  5	  min.	  The	  RBCs	  were	  diluted	  into	  a	  total	  of	  10	  mL	  of	  
PBS	  and	  gently	  resuspended	  by	  inversion.	  Cells	  were	  diluted	  1:1000	  and	  visually	  inspected	  in	  a	  
hemacytometer	  (0.1	  mm3	  volume)	  under	  a	  microscope	  for	  counting.	  Based	  on	  cell	  counts,	  a	  
working	  stock	  was	  diluted	  such	  that	  a	  100	  μL	  reaction	  volume	  contained	  3.0	  ×	  108	  cells/mL	  in	  
each	  microplate	  well.	  	  
	  
Hemolysis	  of	  Red	  Blood	  Cells,	  Red	  blood	  cell	  preparation	  and	  heme	  absorbance	  assay	  
performed	  according	  to	  Kuroda	  Lab	  protocol	  [25].	  Summarily,	  PSMα1	  synthetic	  peptide	  was	  
resuspended	  in	  25	  μL	  filtered	  HPLC	  grade	  DMSO	  	  (20	  mg/mL).	  Invitrogen	  salmon	  sperm	  DNA	  (10	  
mg/mL)	  was	  mixed	  100	  μL	  into	  900	  μL	  filtered	  HPLC	  water,	  and	  this	  working	  stock	  (1	  mg/mL)	  
was	  aliquoted	  for	  all	  DNA	  samples	  in	  fresh,	  sterile	  microcentrifuge	  tubes.	  	  
	  
Either	  1	  μL	  or	  2	  μL	  of	  a	  10	  mg/mL	  PSMα1	  stock	  was	  added	  to	  filter	  sterile	  HPLC	  water	  or	  DNA	  
working	  stock	  to	  make	  a	  100	  μL	  volume	  and	  flicked	  to	  mix.	  10	  μL	  sample	  was	  added	  to	  90	  μL	  of	  
3.0	  x	  108	  rabbit	  red	  blood	  cells	  (RBCs).	  Positive	  control	  was	  1%	  Triton	  X	  in	  PBS,	  negative	  was	  PBS	  
only.	  DNA	  only	  has	  no	  DMSO,	  and	  DMSO	  has	  2	  μL	  of	  filtered	  DMSO.	  Samples	  were	  set	  to	  rock	  
on	  a	  shaker	  at	  RT	  until	  assay	  (24	  hrs).	  Sample	  averages	  are	  background	  subtracted	  of	  PBS	  alone.	  
After	  addition	  of	  freshly	  inoculated	  PSMα1	  samples	  or	  incubated	  samples	  were	  added	  to	  RBCs	  
and	  were	  incubated	  1	  hour	  shaking	  at	  180	  rpm	  at	  37°C.	  Plates	  were	  spun	  down	  to	  pellet	  RBCs	  
and	  6	  μL	  supernatant	  was	  added	  to	  94	  μ
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heme	  release.	  Triplicates	  were	  averaged	  and	  experiments	  performed	  a	  minimum	  of	  3	  times	  
showed	  identical	  trends.	  
	  
Peptide	  stock	  solutions	  or	  control	  solutions	  were	  added	  as	  annotated	  to	  a	  96	  well	  microplate	  
(PP,	  round	  bottom,	  not	  treated	  for	  cell	  culture)	  containing	  90	  μL	  RBC	  working	  stock.	  Plates	  were	  
parafilmed	  with	  their	  lids	  and	  incubated	  for	  1	  hr	  at	  37°C	  at	  180	  rpm	  in	  an	  orbital	  shaker.	  After	  
incubation,	  the	  microplate	  was	  centrifuged	  for	  5	  minutes	  at	  1000	  rpm	  at	  4°C.	  The	  supernatant	  
(6	  µL)	  was	  diluted	  into	  96	  μL	  PBS	  buffer	  and	  the	  absorbance	  measured	  at	  415	  nm	  was	  read	  as	  
the	  hemoglobin	  concentration.	  1%	  (v/v)	  Triton	  X-­‐100	  and	  PBS	  buffer	  were	  used	  as	  positive	  
(100%)	  and	  negative	  (0%)	  control	  samples	  in	  every	  experiment.	  
	  
Percentage	  of	  hemolysis	  (H)	  was	  calculated	  from	  the	  equation:	  
	  
RESULTS	  
S.	  aureus	  biofilms	  are	  encased	  in	  a	  self-­‐produced	  matrix	  composed	  primarily	  of	  polysaccharides,	  
proteins,	  and	  eDNA.	  The	  overall	  composition	  can	  vary	  depending	  on	  growth	  conditions,	  leading	  
to	  a	  highly	  variable	  biofilm	  architecture.	  Unlike	  many	  bacterial	  species,	  including	  
Staphylococcus	  epidermidis,	  S.	  aureus	  does	  not	  depend	  on	  the	  production	  of	  polysaccharides	  to	  
maintain	  biofilm	  structural	  integrity	  [26].	  Previous	  research	  suggests	  that	  in	  the	  absence	  of	  
polysaccharide	  production,	  S.	  aureus	  relies	  on	  alternative	  components	  to	  maintain	  biofilm	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structure	  [22,	  26].	  Among	  these	  "protein-­‐dependent"	  biofilm	  phenotypes	  described	  for	  strain	  
SH1000,	  it	  was	  noted	  that	  an	  ΔatlA	  mutant	  was	  deficient	  in	  autolysis	  and	  displayed	  a	  reduced	  
ability	  to	  form	  biofilms	  [22,27].	  	  
	  
To	  determine	  whether	  the	  presence	  of	  eDNA	  would	  influence	  PSM	  amyloid	  formation	  in	  
biofilms,	  we	  grew	  the	  autolysis	  deficient	  mutant	  ΔatlA	  in	  biofilm	  drip	  bioreactors	  under	  fiber	  
producing	  conditions	  (Fig.	  1).	  We	  observed	  that	  these	  biofilms	  did	  not	  produce	  extracellular	  
fibril	  structures	  (Fig.	  1A).	  Western	  blots	  verified	  the	  presence	  of	  PSMα1	  in	  fibril	  isolates	  of	  a	  
wildtype	  parent	  strain,	  but	  not	  in	  ΔPSM	  or	  ΔatlA	  strains	  lacking	  the	  fibril	  structures	  detected	  via	  
TEM.	  (Fig.	  1B).	  We	  also	  confirmed	  that	  PSMα1	  was	  produced	  in	  whole	  cell	  lysates	  of	  the	  ΔatlA	  
mutant,	  demonstrating	  that	  PSMα1	  was	  produced	  by	  these	  biofilms,	  but	  not	  assembled	  into	  
fibrils	  (Fig.	  1C).	  We	  quantitated	  the	  eDNA	  levels	  in	  the	  matrices	  of	  these	  biofilms,	  and	  
confirmed	  that	  ΔatlA	  mutant	  biofilms	  did	  not	  produce	  detectable	  amounts	  of	  eDNA	  as	  
compared	  to	  a	  wild	  type	  and	  a	  ΔPSM	  mutant,	  in	  both	  high	  and	  low	  salt	  TE	  buffers	  (Fig.	  1D).	  
Taken	  together,	  these	  findings	  led	  us	  to	  speculate	  that	  PSMs	  and	  eDNA	  may	  both	  be	  necessary	  
for	  fibril	  formation	  in	  biofilms.	  To	  test	  this	  hypothesis,	  we	  grew	  co-­‐cultured	  biofilms	  of	  ΔPSM	  
and	  ΔatlA	  mutant	  strains,	  and	  found	  that	  this	  was	  sufficient	  to	  compliment	  the	  fibril	  forming	  
phenotype	  (Fig.	  1A).	  Taken	  together,	  these	  data	  suggest	  that	  eDNA	  induces	  PSM	  fibril	  formation	  
in	  S.	  aureus	  biofilms.	  	  
	  
We	  next	  sought	  to	  determine	  whether	  or	  not	  PSMs	  and	  eDNA	  physically	  interact	  using	  a	  In	  vitro	  
gel	  shifting	  experiment.	  S.	  aureus	  bacterial	  genomic	  DNA	  (SA	  gDNA)	  was	  isolated	  from	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planktonic	  cultures	  and	  purified.	  This	  gDNA	  was	  mixed	  with	  freshly	  soluble	  PSMα1,	  PSMα1	  that	  
had	  already	  polymerized,	  or	  a	  BSA	  negative	  control,	  and	  was	  incubated	  for	  24	  hours.	  Samples	  
were	  loaded	  into	  an	  agarose	  gel	  and	  separated	  using	  gel	  electrophoresis	  to	  detect	  protein-­‐DNA	  
interactions	  that	  elicit	  a	  "shift"	  in	  band	  migration.	  gDNA	  incubated	  with	  a	  control	  protein	  
(bovine	  serum	  albumen,	  BSA)	  did	  not	  elicit	  a	  shift,	  while	  gDNA	  incubated	  with	  soluble	  PSMα1	  
demonstrated	  shifted	  band	  migration	  relative	  to	  a	  gDNA-­‐only	  sample,	  indicating	  formation	  of	  a	  
protein-­‐DNA	  complex	  (Fig.	  2A).	  gDNA	  incubated	  with	  PSMα1	  fibrils	  produced	  a	  less	  intense	  
band	  shift,	  and	  may	  be	  partially	  due	  to	  physical	  restraint	  from	  molecular	  crowding	  (Fig.	  2A).	  To	  
determine	  PSMα1-­‐DNA	  interaction	  was	  specific	  to	  S.	  aureus	  low	  GC	  content	  DNA,	  we	  also	  
tested	  PSMα1	  samples	  incubated	  with	  E.	  coli	  genomic	  DNA	  (EC	  gDNA).	  Again,	  we	  observed	  that	  
incubation	  in	  the	  presence	  of	  non-­‐polymerized	  PSMα1	  produced	  a	  shifted	  banding	  pattern.	  
PSMa-­‐DNA	  gel	  shifting	  can	  be	  observed	  over	  time,	  and	  by	  4	  hr	  post-­‐inoculation,	  SA	  gDNA	  is	  no	  
longer	  able	  to	  migrate	  through	  the	  gel	  matrix	  (Fig.	  2B).	  Finally,	  we	  found	  that	  gel	  shifting	  was	  
peptide	  concentration	  dependent	  in	  samples	  100	  μg/mL	  DNA,	  indicating	  a	  critical	  peptide	  
concentration	  around	  1000	  μg/mL	  was	  necessary	  for	  DNA	  interaction	  in	  this	  assay.	  (Fig.	  2C).	  
Taken	  together,	  these	  data	  suggest	  that	  soluble,	  non-­‐polymerized	  form	  of	  PSMα1	  is	  capable	  of	  
interacting	  with	  gDNA	  and	  PSM	  fibrils	  display	  reduced	  interaction	  with	  gDNA.	  	  
	  
If	  PSMα1	  and	  DNA	  interact,	  they	  may	  form	  large	  complexes	  where	  DNA	  acts	  as	  a	  kind	  of	  
scaffold.	  PSMs	  are	  cationic	  peptides	  that	  should	  interact	  with	  negatively	  charged	  anions.	  To	  
help	  us	  determine	  the	  relative	  size	  of	  the	  PSMα1-­‐DNA	  complexes	  In	  vitro,	  we	  employed	  
dynamic	  light	  scattering	  (DLS).	  	  DLS	  is	  a	  sensitive	  technique	  used	  to	  measure	  the	  size	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distribution	  of	  heterogeneous	  particles	  in	  solution.	  PSMα1	  associates	  with	  bacterial	  DNA	  
isolated	  from	  Gram-­‐positive	  and	  Gram-­‐negative	  organisms,	  and	  is	  likely	  to	  be	  caused	  by	  
nonspecific	  intermolecular	  force	  interactions	  (Fig.	  2a).	  Thus,	  in	  order	  to	  eliminate	  the	  concern	  
of	  contamination	  from	  cellular	  debris	  in	  gDNA	  samples,	  we	  utilized	  molecular	  biology-­‐grade	  
salmon	  sperm	  DNA	  (sDNA).	  sDNA	  has	  been	  extensively	  studied	  using	  DLS,	  and	  our	  average	  size	  
distribution	  of	  sDNA-­‐only	  samples	  agreed	  with	  previously	  published	  results	  (data	  not	  shown).	  
Samples	  containing	  soluble	  PSMα1	  with	  or	  without	  DNA	  were	  incubated	  overnight,	  to	  allow	  
ample	  time	  for	  complete	  protein-­‐DNA	  interaction.	  As	  expected,	  freshly	  soluble	  “aging”	  PSMα1	  
formed	  aggregates	  spontaneously	  in	  a	  heterogeneous	  distribution	  of	  sizes	  that	  increased	  over	  
time	  (Fig.	  3A).	  PSMs,	  like	  many	  amphipathic	  toxic	  peptides,	  are	  known	  to	  aggregate	  and	  
oligomerize,	  sometimes	  forming	  amyloid	  structures	  [10,	  28].	  When	  sDNA	  was	  incubated	  with	  
freshly	  soluble	  “aging”	  PSMα1,	  we	  detected	  a	  uniform	  distribution	  of	  complexes	  in	  solution	  that	  
were	  larger	  than	  those	  produced	  by	  PSMα1	  alone	  (Fig.	  3B).	  A	  comparison	  between	  samples	  
containing	  DNA	  only,	  PSMα1	  fibrils	  with	  or	  without	  DNA,	  and	  freshly	  soluble	  “aging”	  PSMα1	  
showed	  that	  after	  24	  hours	  of	  incubation,	  soluble	  PSMα1	  incubated	  with	  DNA	  formed	  a	  
distinctive	  and	  large	  complex	  as	  compared	  to	  PSMα1	  fibrils	  or	  DNA	  only	  (Fig.	  3C).	  PSMα1	  fibrils	  
incubated	  with	  DNA	  showed	  size	  distribution	  very	  different	  from	  soluble	  PSMα1	  incubated	  with	  
DNA.	  This	  suggested	  that	  soluble	  species	  were	  forming	  complexes	  with	  DNA.	  Size	  distribution	  of	  
pre-­‐aggregated	  PSMα1	  fibrils	  and	  DNA	  correlated	  to	  those	  observed	  when	  each	  component	  
was	  assayed	  separately	  (Fig.	  3C).	  This	  suggested	  to	  us	  that	  the	  fibrils	  were	  not	  interacting	  with	  
the	  DNA	  and	  each	  component	  stayed	  separate	  in	  solution,	  whereas	  soluble	  PSMα1	  seemed	  to	  
interact	  with	  DNA	  to	  form	  a	  distribution	  of	  complexes	  that	  was	  larger	  than	  each	  individual	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component.	  To	  verify	  that	  soluble	  PSMα1	  was	  interacting	  with	  DNA	  in	  solution,	  we	  ran	  a	  time	  
course	  assaying	  samples	  that	  contained	  soluble	  PSMα1	  only	  or	  soluble	  PSMα1	  with	  sDNA.	  As	  
expected,	  PSMα1	  “aging”	  in	  the	  presence	  of	  DNA	  formed	  larger	  complexes	  than	  PSMα1	  alone	  
over	  time	  (Fig.	  3D).	  From	  the	  results	  of	  our	  gel-­‐shift	  and	  DLS	  experiments,	  we	  concluded	  that	  
not	  only	  can	  PSMα1	  interact	  with	  DNA,	  but	  also	  creates	  complexes	  that	  are	  larger	  than	  fibrils	  or	  
DNA	  by	  itself.	  	  
	  
PSMα1	  and	  other	  S.	  aureus	  PSM	  peptides	  autoaggregate	  to	  form	  amyloid	  fibril	  structures	  	  
[10,13].	  To	  determine	  whether	  the	  large	  structures	  formed	  by	  PSMα1	  and	  DNA	  are	  amyloid	  like	  
in	  nature,	  we	  assayed	  synthetic	  PSMα1	  and	  SA	  gDNA	  ‘s	  interactions	  in	  a	  Thioflavin	  T	  binding	  
assay.	  Thioflavin	  T	  (ThT)	  is	  an	  amyloid	  specific	  dye	  that	  fluoresces	  when	  bound	  to	  amyloid	  
aggregates,	  eliciting	  an	  increase	  in	  intensity	  as	  amyloid	  structures	  form	  in	  solution.	  We	  
observed	  that	  ThT	  fluorescence	  increased	  over	  time	  in	  samples	  containing	  both	  PSMα1	  and	  
DNA	  as	  compared	  to	  PSMα1	  only,	  while	  S.	  aureus	  genomic	  DNA	  alone	  did	  not	  show	  increased	  
fluorescence	  above	  baseline	  (Fig.	  4A).	  Addition	  of	  DNA	  stimulated	  amyloid	  formation	  at	  a	  low	  
concentration	  of	  PSMα1,	  indicating	  that	  DNA	  lowers	  the	  critical	  peptide	  concentration	  
necessary	  for	  spontaneous	  aggregation	  (Fig.	  4B).	  Interestingly,	  we	  determined	  that	  ThT	  binding	  
increases	  logarithmically	  at	  200	  minutes,	  around	  the	  same	  time	  frame	  that	  we	  observed	  DNA	  
gel	  shifts	  and	  an	  increase	  in	  the	  aggregate	  dynamic	  radius	  via	  DLS	  	  (Figs	  2-­‐4).	  To	  confirm	  that	  
the	  amyloid-­‐formation	  effects	  we	  were	  observing	  were	  not	  specific	  to	  PSMα1,	  we	  assayed	  a	  
synthetic	  prep	  of	  the	  newly	  discovered	  PSM-­‐like	  peptide	  N-­‐AgrD	  for	  its	  ability	  to	  interact	  with	  
DNA.	  Again,	  the	  addition	  of	  DNA	  promoted	  amyloid	  formation	  (Fig.	  4C).	  Finally,	  we	  observed	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that	  over	  time,	  PSMα1	  formed	  fibril	  structures	  that	  were	  morphologically	  distinct	  from	  PSMα1	  
that	  was	  incubated	  with	  DNA	  (Fig.	  4D).	  DNA	  alone	  did	  not	  produce	  these	  structures	  (Fig.	  4D).	  
Taken	  together,	  these	  data	  suggest	  that	  PSMα1	  is	  forming	  ordered	  amyloid	  structures	  in	  the	  
presence	  of	  DNA.	  
	  
Finding	  that	  PSMα1	  forms	  amyloid	  aggregates	  in	  the	  presence	  of	  DNA	  lead	  us	  to	  consider	  the	  
role	  that	  DNA	  might	  play	  in	  virulence.	  PSMs	  are	  potent	  toxins,	  contributing	  to	  infection	  by	  
facilitating	  lysis	  of	  multiple	  host	  cell	  types	  [4].	  However,	  our	  lab	  recently	  discovered	  that	  
formation	  of	  amyloid	  fibers	  by	  PSMs	  can	  significantly	  reduce	  their	  toxicity	  in	  a	  red	  blood	  cell	  
hemolysis	  assay	  [13].	  Similarly,	  we	  speculated	  that	  the	  addition	  of	  DNA	  could	  push	  free	  PSMα1	  
into	  the	  fibril	  form,	  thus	  abrogating	  its	  toxic	  activity.	  A	  ΔPSM	  mutant	  shows	  a	  reduced	  zone	  of	  
hemolysis	  as	  compared	  to	  WT	  on	  rabbit	  blood	  plates,	  indicating	  that	  PSMs	  readily	  lyse	  rabbit	  
blood	  cells	  and	  that	  loss	  of	  PSM	  activity	  correlates	  to	  reduced	  toxicity	  (Fig.	  5A).	  We	  then	  sought	  
to	  determine	  whether	  the	  addition	  of	  sterile	  salmon	  sperm	  DNA	  could	  abrogate	  the	  toxicity	  of	  
synthetic	  PSMα1.	  Samples	  were	  prepared	  1	  hour	  prior	  to	  hemolysis	  assay	  and	  were	  inoculated	  
simultaneously	  to	  ensure	  aggregation	  timeframes	  were	  synchronized.	  We	  observed	  that	  
samples	  that	  containing	  only	  PSMα1	  were	  not	  aggregated	  at	  the	  time	  of	  assay,	  but	  PSMα1	  in	  
the	  presence	  of	  DNA	  showed	  considerable	  aggregation	  via	  TEM	  (Fig.	  5B).	  As	  predicted,	  
significant	  lysis	  occurred	  when	  we	  exposed	  red	  blood	  cells	  to	  non-­‐aggregated	  PSMα1,	  while	  this	  
effect	  was	  mitigated	  by	  the	  addition	  of	  DNA	  (Fig.	  5C).	  Similarly,	  pre-­‐formed	  PSMα1	  fibrils	  
incubated	  with	  DNA	  did	  not	  display	  the	  toxicity	  attributed	  to	  soluble	  PSMα1	  (Fig.	  5C).	  These	  
results	  indicate	  that	  PSMα1	  interacts	  with	  DNA	  rapidly	  to	  form	  amyloid	  complexes	  that	  are	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therefore	  observed	  to	  be	  less	  toxic	  than	  the	  same	  concentration	  of	  non-­‐aggregated	  PSMα1	  
under	  the	  same	  conditions.	  	  
Discussion	  
The	  extracellular	  matrix	  produced	  during	  biofilm	  development	  plays	  a	  critical	  role	  in	  the	  
formation	  and	  persistence	  of	  biofilm	  communities.	  However,	  there	  is	  little	  understanding	  of	  
potential	  interactions	  between	  matrix	  components.	  This	  work	  demonstrates	  eDNA’s	  role	  in	  
functional	  bacterial	  amyloid	  formation	  within	  the	  biofilm	  environment.	  DNA	  is	  important	  for	  
phosphate	  cycling,	  sequestration	  of	  divalent	  cations,	  and	  subversion	  of	  host	  antimicrobial	  
responses	  [14,29].	  In	  biofilms,	  DNA	  promotes	  intracellular	  and	  surface	  adhesion,	  modulation	  of	  
visoelastic	  relaxation	  by	  interacting	  with	  matrix	  components	  in	  response	  to	  mechanical	  stress	  
[29-­‐31].	  The	  production	  of	  extracellular	  DNA	  helps	  to	  stabilize	  the	  biofilm	  structure	  against	  
dispersal	  [14].	  Expression	  of	  extracellular	  nucleases	  or	  endogenous	  addition	  of	  DNase	  can	  
disrupt	  bacterial	  biofilms,	  especially	  early	  in	  development	  (20).	  The	  production	  of	  nuclease	  is	  
known	  to	  have	  a	  profound	  effect	  on	  biofilm	  structuring	  and	  dispersal	  in	  S.	  aureus,	  which	  
produces	  two	  thermostable	  nuclease	  enzymes	  that	  are	  active	  under	  variable	  conditions	  (32-­‐34).	  
In	  this	  report,	  we	  describe	  a	  new	  contribution	  of	  eDNA	  to	  biofilm	  physiology	  and	  virulence.	  
	  
AtlA	  is	  a	  bifunctional	  peptidoglycan	  hydrolase	  that	  plays	  a	  role	  in	  S.	  aureus	  cellular	  division,	  
daughter	  cell	  separation,	  and	  autolysis	  (35-­‐34).	  Coordinated	  autolysis	  of	  discreet	  
subpopulations	  within	  S.	  aureus	  biofilms	  lyse	  is	  considered	  to	  a	  form	  of	  programmed	  cell	  death,	  
contributing	  DNA	  to	  bifilm	  environments	  [34,	  38].	  Previous	  research	  demonstrated	  that	  S.	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aureus	  strains	  lacking	  AtlA	  showed	  reduced	  autolytic	  activity	  and	  impaired	  biofilm	  formation	  
[22,27].	  An	  ΔatlA	  mutant	  does	  not	  produce	  extracellular	  fibrils	  under	  fiber-­‐inducing	  growth	  
conditions	  (Fig	  1A,B).	  We	  verified	  that	  an	  ΔatlA	  mutant	  biofilms	  produce	  PSMα1,	  but	  lacks	  
extracellular	  DNA	  (Fig	  1B-­‐D).	  Fibril	  production	  can	  be	  complimented	  by	  co-­‐culture	  with	  a	  ΔPSM	  
isogenic	  mutant,	  which	  lacks	  fibrils	  but	  produces	  eDNA	  in	  biofilms	  (Fig.	  1).	  We	  conclude	  that	  the	  
presence	  of	  eDNA	  is	  required	  for	  PSM	  fibril	  assembly	  in	  the	  biofilm	  environment.	  
	  
Staphylococcal	  PSMs	  form	  amyloid	  structures	  in	  biofilms	  under	  certain	  growth	  conditions	  [10].	  
Amyloid	  aggregation	  has	  been	  shown	  to	  promote	  biofilm	  stability	  and	  reduce	  PSM	  toxicity,	  
implicating	  that	  amyloid	  formation	  serves	  to	  modulate	  PSM	  activity	  [10,13].	  We	  demonstrate	  in	  
this	  report	  that	  DNA	  helps	  to	  push	  PSMα1	  down	  the	  amyloid	  formation	  pathway	  by	  promoting	  
aggregation	  In	  vitro	  (Fig.	  2-­‐4).	  We	  confirm	  that	  PSMα1	  directly	  interacts	  with	  DNA	  to	  form	  large	  
complexes	  with	  relatively	  consistent	  size	  distributions	  (Fig.	  3).	  These	  complexes	  appear	  to	  be	  
amyloid-­‐like	  in	  nature,	  as	  the	  presence	  of	  DNA	  stimulates	  ThT	  binding	  to	  amyloid	  fibers	  (Fig.	  4).	  	  
	  
In	  addition	  to	  electrostatic	  interactions	  between	  positively	  charged	  cationic	  peptides	  and	  
negatively	  charged	  polyanionic	  DNA,	  is	  possible	  that	  DNA	  could	  acting	  as	  a	  molecular	  
“crowding”	  source,	  increasing	  the	  effective	  molarity	  of	  the	  sample.	  DNA	  is	  a	  polyanionic	  
compound,	  and	  many	  other	  polyanions	  are	  present	  in	  the	  environmental	  conditions	  outside	  of	  
and	  throughout	  the	  host	  environment.	  Heparin	  and	  closely	  related	  proteoglycans	  (like	  heparan	  
and	  chondroitin)	  are	  found	  ubiquitously	  throughout	  the	  extracellular	  matrix	  environment	  in	  the	  
human	  body.	  Heparin	  has	  been	  previously	  shown	  to	  promote	  biofilms	  in	  vitro	  and	  in	  catheter	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lock	  solutions	  [39].	  	  It	  is	  possible	  that	  biofilms	  forming	  in	  these	  environments	  are	  at	  least	  
partially	  influenced	  by	  PSM	  amyloid	  formation,	  which	  may	  further	  modulate	  immunogenicity	  of	  
these	  kinds	  of	  infections.	  eDNA	  plays	  a	  role	  in	  several	  biofilm	  diseases	  including	  Candida	  
pneumonia,	  otitis,	  pertussis,	  and	  endocarditis	  [24,	  40-­‐41].	  It	  is	  tempting	  to	  speculate	  that	  other	  
bacterial	  toxins	  or	  amyloids	  form	  macrostructures	  in	  the	  presence	  of	  DNA.	  Similarly,	  the	  
interactions	  between	  PSMs	  and	  DNA	  could	  likely	  reflect	  other	  interactions	  between	  host	  
cationic	  antimicrobial	  peptides	  (CAMPS)	  and	  DNA	  in	  the	  biofilm.	  
	  
Once	  aggregated	  into	  amyloid	  fibrils	  PSMs	  lose	  the	  cytotoxicity	  associated	  with	  the	  soluble	  
forms	  (Fig.	  5B-­‐C).	  Although	  staphylococcal	  α-­‐toxin	  is	  known	  to	  be	  the	  dominant	  hemolysin,	  the	  
PSMs	  also	  display	  an	  observable	  hemolytic	  phenotype	  that	  is	  inhibited	  by	  interaction	  in	  the	  
presence	  of.	  (Fig.	  5A)[6].	  Another	  toxin	  in	  the	  biofilm	  matrix	  that	  was	  characterized	  to	  interact	  
directly	  with	  DNA	  is	  staphylococcal	  neutral	  sphingomyelinase,	  β-­‐toxin,	  which	  can	  also	  bind	  
single	  and	  double	  stranded	  DNA	  to	  create	  matrix	  interactions	  that	  are	  shown	  to	  be	  important	  
for	  endocarditis	  [42].	  	  
	  
Taken	  together,	  these	  data	  support	  the	  claim	  that	  virulence	  can	  be	  modified	  in	  the	  biofilm	  
environment,	  and	  that	  sequestration	  of	  toxins	  in	  an	  aggregation	  dependent	  manner	  can	  occur	  
through	  many	  different	  methods.	  DNA,	  and	  perhaps	  other	  polyanionic	  compounds,	  may	  act	  as	  
an	  environmental	  “switch”	  to	  sequester	  PSM	  toxins	  out	  of	  the	  environment.	  It	  is	  unknown	  why	  
DNA	  would	  induce	  this	  switch,	  or	  what	  benefit	  it	  gives	  to	  the	  bacterial	  community.	  Perhaps	  the	  
DNA	  serves	  as	  an	  extracellular	  signal	  that	  promotes	  bacterial	  adhesion	  to	  protect	  the	  colony	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from	  environmental	  stressors	  and	  cell	  death.	  Further	  research	  is	  needed	  to	  understand	  how	  
this	  finding	  fits	  into	  the	  larger	  picture	  of	  Staphylococcal	  biofilm	  development.	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Figure	  4.1,	  An	  autolysin	  mutant	  lacking	  eDNA	  does	  not	  form	  PSM	  amyloids	  in	  biofilms,	  	  
(A)	  ΔatlA	  mutant	  biofilms	  do	  not	  produce	  extracellular	  fibrils	  like	  the	  wlldtype	  parent.	  Coculture	  
of	  a	  ΔPSM	  and	  an	  ΔatlA	  strain	  compliments	  fibril	  production,	  presumably	  through	  interaction	  of	  
eDNA	  produced	  by	  the	  ΔPSM	  mutant	  and	  PSMs	  produced	  by	  the	  ΔaltA	  mutant.	  Scale	  bar	  
indicates	  500	  nm.	  (B)	  PSMα1	  is	  detected	  in	  fiber	  isolates	  from	  wild	  type,	  but	  not	  ΔPSM	  or	  ΔatlA	  
biofilms.	  (C)	  PSMα1	  is	  detected	  in	  whole	  cell	  lysates	  of	  wild	  type	  and	  ΔatlA	  mutant	  biofilm	  cells,	  
showing	  that	  PSMα1	  is	  produced,	  but	  not	  forming	  fibril	  structures	  in	  the	  biofilm.	  (D)	  
Quantitation	  of	  eDNA	  in	  biofilms.	  Wild	  type	  and	  ΔPSM	  mutant,	  but	  not	  an	  ΔatlA	  mutant,	  
showed	  detectable	  amounts	  of	  eDNA	  when	  extracted	  and	  assayed	  using	  TE	  or	  high	  salt	  TE	  from	  
biofilm	  supernatants.	  Results	  are	  representative	  of	  at	  least	  three	  independent	  trials.	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Figure	  4.2,	  PSMα1	  interacts	  with	  bacterial	  genomic	  DNA	  in	  a	  time	  and	  concentration-­‐
dependent	  manner,	  	  
(A)	  Staphylococcus	  aureus	  (SA)	  genomic	  DNA	  samples	  were	  incubated	  with	  a	  BSA	  control,	  
soluble	  PSMα1	  (1000	  μg/mL),	  or	  PSMα1	  pre-­‐aggregated	  fibrils	  (1000	  μg/mL)	  for	  24	  hours	  
before	  DNA	  separation	  on	  an	  agarose	  gel.	  Incubation	  with	  PSMα1	  prohibited	  DNA	  from	  
migrating	  through	  the	  gel	  matrix.	  PSMα1	  fibrils	  showed	  a	  weaker	  shift,	  while	  BSA	  showed	  no	  
difference	  from	  DNA	  only.	  The	  effect	  was	  not	  specific	  to	  S.	  aureus	  DNA	  as	  Escherichia	  coli	  (EC)	  
genomic	  DNA	  also	  elicited	  a	  shift	  when	  incubated	  overnight	  with	  PSMα1.	  (B)	  The	  interaction	  
between	  PSMα1	  and	  SA	  DNA	  can	  be	  observed	  over	  time.	  Initial	  association	  is	  observed	  as	  a	  
smear	  at	  1	  hr	  and	  by	  4	  hrs	  DNA	  is	  no	  longer	  able	  to	  run	  through	  the	  gel	  matrix.	  (C)	  PSMα1	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Figure	  4.3	  PSMα1	  peptides	  interact	  in	  the	  presence	  and	  absence	  of	  DNA	  using	  DLS,	  	  
(A)	  The	  evolution	  of	  the	  probability	  distribution	  of	  DLS	  relaxation	  times,	  P(τ),	  with	  reaction	  time,	  
T	  (h)	  for	  a	  dilute	  solution	  (200	  ug/mL)	  of	  PSMα1	  monomers.	  After	  24	  h,	  a	  weak	  bi-­‐modal	  
distribution	  is	  seen,	  interpreted	  as	  un-­‐polymerized	  and	  polymerized	  peptides.	  The	  fast-­‐mode	  
peaks,	  seen	  at	  τ	  ≤	  0.4	  ms	  are	  probably	  due	  to	  dust	  or	  artifacts	  arising	  from	  the	  CONTIN	  analysis	  
of	  DLS	  correlation	  data	  13.	  These	  modes	  were	  not	  re-­‐producible.	  (B)	  We	  observed	  the	  growth	  
of	  DLS	  relaxation	  time	  distribution	  with	  reaction	  time	  for	  a	  solution	  containing	  soluble	  PSMα1	  
and	  SDNA.	  At	  all	  reaction	  times	  observed,	  the	  fast	  mode	  peak	  coincides	  with	  that	  of	  bare	  SS	  
DNA,	  indicating	  the	  presence	  of	  un-­‐reacted	  DNA	  in	  the	  solution.	  In	  the	  presence	  of	  DNA,	  the	  
self-­‐polymerization	  of	  PSMα1	  is	  prevented	  in	  the	  favor	  of	  a	  PSMα1	  –	  DNA	  complex	  formation.	  
(C	  )	  Comparison	  of	  the	  P(τ)	  of	  PSMα1	  fibrils	  with	  and	  without	  DNA	  is	  compared	  with	  that	  of	  
naked	  DNA	  and	  PSMα1	  –	  DNA	  complex	  in	  Fig	  3C.	  When	  SS	  DNA	  is	  added	  to	  PSMα1	  in	  its	  
monomeric	  state,	  we	  obtain	  a	  complex	  of	  larger	  RH,	  and	  when	  the	  former	  is	  added	  to	  a	  
polymerized	  PSMα1,	  no	  increase	  in	  the	  sample	  size	  is	  observed.(D)	  the	  growth	  in	  effective	  
hydrodynamic	  radius,	  RH	  (nm),	  of	  PSMα1	  monomer	  with	  and	  without	  SS	  DNA	  as	  a	  function	  of	  
polymerization	  time.	  It	  is	  seen	  that	  in	  the	  presence	  of	  DNA,	  PSMα1	  monomers	  bind	  with	  the	  
DNA	  molecules	  to	  form	  complexes	  that	  are	  about	  3	  times	  larger	  in	  RH	  than	  the	  polymerized	  
PSMα1	  molecules.	  This	  also	  indicates	  that	  the	  polymerization	  process	  in	  both	  the	  solutions	  




Figure	  4.4,	  PSMα1	  forms	  amyloid	  fibrils	  in	  the	  presence	  of	  DNA,	  	  
(A)	  Incubation	  of	  1000	  μg/mL	  PSMα1	  with	  0.1	  μg/mL	  DNA	  shows	  increased	  ThT	  relative	  to	  
PSMα1	  alone,	  indicating	  increased	  amyloid	  formation.	  DNA	  alone	  did	  not	  appreciably	  increase	  
ThT	  fluorescence	  relative	  to	  a	  buffer	  control.	  	  (B)	  DNA	  stimulates	  PSMα1	  amyloid	  formation	  in	  
sub-­‐critical	  peptide	  concentrations	  (100	  μg/mL)	  under	  assay	  conditions,	  indicating	  that	  DNA	  can	  
induce	  rapid	  amyloid	  formation	  when	  peptide	  concentration	  is	  too	  low	  to	  favor	  aggregation.	  (C)	  
DNA	  also	  enhances	  amyloid	  formation	  of	  PSM	  relative	  N-­‐AgrD,	  indicating	  DNA-­‐PSM	  interactions	  
are	  not	  specific	  to	  PSMα1.	  (D)	  Amyloid	  fibrils	  can	  be	  visualized	  via	  TEM	  from	  samples	  of	  PSMα1	  
incubated	  with	  DNA	  after	  24	  hours.	  Data	  is	  representative	  of	  ≥	  3	  independent	  experiments.	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Figure	  4.5,	  Interaction	  with	  DNA	  inhibits	  PSM	  toxicity,	  	  
(A)	  Cultures	  that	  are	  unable	  to	  produce	  PSMs	  show	  reduced	  zone	  of	  clearing	  on	  rabbit	  blood	  
agar	  plates,	  indicating	  PSMs	  are	  import	  for	  hemolysis.	  (B)	  After	  1	  hr	  incubation,	  samples	  
containing	  both	  DNA	  and	  PSMα1	  had	  started	  to	  form	  large	  fibril	  aggregations	  relative	  to	  PSMα1	  
only	  and	  a	  DNA	  control.	  (C)	  PSMα1	  hemolysis	  is	  greatly	  reduced	  in	  the	  presence	  of	  DNA	  or	  in	  
pre-­‐aggregated	  fibrils.	  Co-­‐incubation	  of	  pre-­‐aggregated	  fibrils	  and	  DNA	  did	  not	  reduce	  
hemolysis	  relative	  to	  a	  fibrils	  only	  control.	  %	  hemolysis	  was	  calculated	  from	  the	  average	  of	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My	  work	  stems	  from	  the	  characterization	  of	  small	  S.	  aureus	  peptides	  that	  are	  capable	  of	  
forming	  polymeric	  amyloid	  fibrils	  during	  biofilm	  growth.	  These	  fibrils	  prevent	  biofilm	  dispersal	  
that	  would	  otherwise	  occur	  from	  peptide	  surfactant	  activity.	  The	  persistence	  of	  these	  biofilms	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ultimately	  leads	  to	  altered	  colony	  behavior	  and	  reduction	  of	  virulence	  associated	  with	  soluble	  
peptides.	  	  
1.	  Are	  there	  novel	  conditions	  that	  promote	  biofilm	  resistance	  to	  
dispersal?	  
Biofilm	  communities	  form	  highly	  variable	  structures.	  For	  a	  long	  time,	  biofilm	  research	  has	  
focused	  on	  the	  polysaccharide	  and	  glycocalyx	  slime	  layers	  as	  the	  defining	  characteristic	  of	  the	  
biofilm	  matrix.	  [1,2].	  In	  recent	  years,	  additional	  components	  have	  been	  defined	  as	  crucial	  for	  
biofilm	  formation	  under	  a	  variety	  of	  environmental	  conditions	  promoting	  polysaccharide-­‐
independent	  growth	  [1-­‐5].	  In	  Staphylococcal	  biofilms,	  these	  factors	  include	  extracellular	  DNA	  
and	  proteinaceous	  matrix	  material,	  like	  amyloid	  fibrils	  [6,7].	  Depending	  on	  the	  specific	  biofilm	  
model	  system	  or	  the	  growth	  conditions	  being	  investigated,	  biofilm	  communities	  can	  display	  a	  
wide	  range	  of	  phenotypes.	  As	  a	  result	  of	  their	  variable	  matrix	  composition,	  biofilms	  show	  
adaptable	  adherence,	  structural	  heterogeneity,	  resistance	  to	  dispersal,	  and	  protection	  from	  
antimicrobial	  killing	  [2-­‐4,7-­‐8].	  The	  importance	  of	  matrix	  constituents	  in	  biofilm	  formation	  can	  
be	  examined	  by	  enzymatic	  degradation	  of	  key	  matrix	  compounds	  to	  induce	  dispersal	  [4].	  By	  
investigating	  the	  changeability	  of	  the	  S.	  aureus	  matrix,	  we	  found	  that	  biofilms	  can	  resist	  
conventional	  dispersal	  under	  conditions	  promoting	  amyloid	  fibril	  formation.	  
	  
Amyloids	  often	  form	  as	  an	  alternative	  to	  ordered	  protein-­‐folding	  conformations,	  following	  a	  
folding	  pathway	  driven	  by	  self-­‐templating	  assembly	  from	  small	  nucleators	  to	  large	  fibril	  
structures	  [5].	  The	  polypeptide	  sequences	  of	  amyloid	  proteins	  often	  bear	  no	  direct	  homology	  in	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in	  primary	  sequence,	  but	  all	  amyloid	  fibrils	  share	  the	  characteristic	  cross-­‐β	  structure	  where	  β-­‐
sheet	  strands	  stack	  perpendicular	  to	  the	  fibril	  axis.	  [5].	  Assembly	  is	  driven	  by	  peptide	  backbone	  
interactions	  and	  coordinated	  side	  chain	  interactions	  of	  alternating	  hydrophobic	  burying	  and	  
hydrophilic	  residues.	  The	  biophysical	  characteristics	  that	  define	  the	  amyloid	  fold	  have	  been	  
extensively	  studied,	  and	  methodology	  to	  test	  for	  them	  is	  well	  defined	  [5].	  
	  
Amyloid	  formation	  can	  be	  studied	  using	  a	  variety	  of	  In	  vitro	  and	  In	  vivo	  techniques.	  Assays	  like	  
circular	  dichroism	  (CD)	  can	  be	  used	  to	  assess	  structural	  variation	  as	  amyloids	  transition	  from	  
their	  monomeric	  form	  to	  large	  β-­‐rich	  aggregates.	  Amyloid	  specific	  dyes	  like	  Congo	  Red	  and	  
Thioflavin	  T	  (ThT)	  can	  be	  used	  to	  quantitate	  amyloid	  aggregation	  in	  vitro	  or	  to	  stain	  amyloid	  
plaques	  from	  In	  vivo	  biological	  samples.	  Amyloid	  fibrils	  can	  resist	  degradation	  from	  detergents,	  
urea,	  salt,	  and	  enzymatic	  digestion	  due	  to	  the	  strong	  protein	  interactions.	  In	  S.	  aureus	  biofilm	  
systems,	  we	  	  have	  shown	  that	  amyloid	  structures	  stabilize	  the	  matrix	  and	  promote	  resistance	  to	  
dispersal	  [7].	  Using	  assays	  previously	  defined	  for	  determining	  bacterial	  amyloids,	  my	  work	  has	  
shows	  that	  S.	  aureus	  produces	  amyloids	  in	  its	  biofilm	  matrix	  [6-­‐8].	  
	  
In	  Chapter	  2	  of	  this	  work,	  I	  have	  demonstrated	  that	  Staphylococcus	  aureus	  biofilms	  form	  
amyloid	  fibrils	  composed	  of	  phenol	  soluble	  modulins	  (PSMs)	  when	  grown	  under	  non-­‐standard	  
laboratory	  conditions.	  Under	  these	  conditions,	  S.	  aureus	  biofilms	  are	  resistant	  to	  enzymatic	  and	  
mechanical	  dispersal.	  Loss	  of	  PSM	  production	  restores	  the	  dispersal-­‐sensitive	  phenotype	  
correlating	  with	  loss	  of	  extracellular	  fibril	  production	  [7].	  The	  correlation	  of	  fibrils	  with	  
dispersal-­‐resistant	  phenotype	  echoes	  the	  resilient	  biofilm	  phenotype	  that	  has	  been	  previously	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observed	  in	  other	  biofilm	  systems	  producing	  functional	  amyloids	  [9].	  PSMs	  have	  been	  
previously	  associated	  with	  biofilm	  dispersal,	  and	  I	  present	  evidence	  that	  aggregation	  inhibits	  
this	  dispersal	  activity	  [7,10].	  This	  work	  suggests	  that	  the	  biofilm	  matrix	  displays	  variable	  
phenotypes	  differently	  depending	  on	  growth	  conditions.	  Although	  the	  exact	  mechanism	  
causing	  increased	  fibril	  formation	  in	  PNG	  media	  is	  unknown,	  this	  work	  reinforces	  the	  
understanding	  that	  researchers	  should	  pay	  careful	  attention	  to	  growth	  and	  media	  conditions	  to	  
avoid	  relying	  on	  confined	  laboratory	  conditions	  when	  studying	  bacterial	  behavior.	  
2.	  How	  does	  amyloid	  formation	  contribute	  to	  S.	  aureus	  virulence?	  
My	  work	  demonstrates	  that	  PSMs,	  which	  are	  known	  virulence	  factors,	  exhibit	  a	  fascinating	  
propensity	  for	  amyloid	  fibril	  formation.	  Our	  discovery	  contributes	  to	  a	  growing	  body	  of	  
knowledge	  showing	  amyloid	  formation	  is	  a	  ubiquitous	  and	  useful	  process	  .	  Many	  functional	  
bacterial	  amyloids	  have	  been	  characterized,	  some	  of	  which	  contribute	  to	  disease	  in	  host	  
systems	  [9].	  Our	  findings	  add	  functional	  amyloids	  to	  a	  growing	  list	  of	  PSM	  functions	  that	  
includes	  virulence,	  immunomodulation,	  and	  biofilm	  structuring	  [7-­‐8,	  10-­‐13].	  
	  
The	  agr	  quorum	  sensing	  system	  has	  a	  multitiered	  role	  in	  S.	  aureus	  virulence.	  Activation	  of	  
quorum-­‐sensing	  negatively	  regulates	  biofilm	  formation,	  impeding	  attachment	  and	  development	  	  
[4,15-­‐16].	  Supporting	  this	  is	  work	  by	  Yarwood	  et	  al.	  who	  demonstrated	  that	  S.	  aureus	  biofilm	  
detachment	  correlates	  with	  increased	  agr	  activity	  and	  virulence	  [17,18].	  Agr	  quorum	  sensing	  
coordinates	  RNA	  III	  regulated	  virulence	  mechanisms,	  including	  superantigen,	  toxin,	  and	  tissue	  
degrading	  enzyme	  production	  while	  downregulating	  production	  of	  cellular	  adhesions	  [18-­‐24].	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We	  have	  found	  that	  agr	  may	  promote	  biofilm	  stabilization	  under	  fibril	  inducing	  conditions	  
through	  PSM	  aggregation	  [7,8].	  In	  addition	  to	  agr’s	  contribution	  to	  PSM	  production,	  I	  have	  also	  
discovered	  that	  S.	  aureus	  strains	  with	  highly	  upregulated	  agr	  expression	  produce	  fibrils	  that	  are	  
composed	  of	  the	  AgrD	  signaling	  molecule	  cleavage	  fragment,	  N-­‐AgrD	  in	  addition	  to	  the	  
canonical	  PSM	  peptides	  [8].	  	  
	  
In	  Chapter	  3	  of	  this	  work,	  I	  provide	  evidence	  that	  N-­‐AgrD	  is	  an	  amyloidogenic	  PSM-­‐like	  
cytotoxin	  [8].	  The	  discovery	  of	  N-­‐AgrD	  in	  biofilm	  fibrils	  demonstrates	  a	  novel	  function	  for	  what	  
was	  previously	  considered	  to	  be	  a	  byproduct	  of	  AIP	  propeptide	  processing.	  N-­‐AgrD	  is	  N-­‐
terminal	  leader	  peptide	  and	  a	  cleavage	  fragment	  from	  the	  agr	  quorum	  sensing	  autoinducer	  
propeptide.	  The	  AgrD	  propeptide	  is	  processed	  at	  the	  cell	  surface	  by	  AgrB	  and	  SpsB,	  which	  
catalyze	  the	  thiolactone	  ring	  formation	  and	  peptide	  cleavage	  that	  releases	  the	  N-­‐terminal	  
leader	  peptide	  as	  an	  amphipathic	  helix	  outside	  of	  the	  cell	  [25-­‐28].	  We	  first	  discovered	  that	  N-­‐
AgrD	  was	  incorporated	  into	  S.	  aureus	  fibrils	  in	  a	  highly	  virulent	  strain,	  USA300.	  N-­‐AgrD	  was	  also	  
detected	  in	  earlier	  fibril	  preps	  from	  lab	  strain	  SH1000,	  albeit	  at	  lower	  levels	  than	  USA300	  [7,8].	  
Others	  have	  shown	  a	  unique	  biochemistry	  of	  other	  small	  leader	  fragments	  that	  can	  contribute	  
to	  cellular	  processes	  like	  DNA	  transport,	  cell	  signaling,	  and	  even	  virus	  maturation	  [29-­‐38].	  I	  
speculate	  that	  there	  is	  likely	  an	  undiscovered	  realm	  of	  cellular	  activity	  and	  regulation	  associated	  
with	  these	  kinds	  of	  leader	  peptides	  that	  has	  been	  overlooked.	  N-­‐AgrD’s	  incorporation	  into	  
fibrils	  and	  ability	  to	  form	  and	  seed	  amyloid	  fibrils	  led	  us	  to	  investigate	  whether	  it	  showed	  the	  
characteristic	  PSM	  virulence	  activity.	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The	  host	  immune	  response	  relies	  on	  the	  efficient	  sensing	  and	  clearing	  of	  microorganisms,	  both	  
of	  which	  are	  subverted	  by	  the	  expression	  of	  S.	  aureus	  PSMs	  [11-­‐14].	  Staphylococci	  evade	  innate	  
immunity	  by	  secreting	  an	  array	  of	  immunomodulatory	  peptides,	  like	  PSMs,	  to	  hinder	  molecular	  
recognition.	  While	  freely	  soluble	  PSMs	  recruit	  and	  lyse	  neutrophils,	  and	  this	  activity	  is	  inhibited	  
when	  PSMs	  are	  aggregated	  into	  fibrils	  [8].	  We	  show	  that	  N-­‐AgrD	  displays	  cytolytic	  and	  
immunomodulatory	  activity	  similar	  to	  the	  well	  characterized	  PSM	  toxin,	  PSMα1.	  PSMs’	  toxicity	  
is	  attributed	  to	  its	  amphipathic	  helix	  structure	  and	  capacity	  to	  interact	  with	  cell	  membranes,	  
causing	  cell	  lysis	  [39-­‐45].	  We	  have	  demonstrated	  that	  N-­‐AgrD,	  like	  PSMα1,	  causes	  significant	  
lysis	  of	  red	  and	  white	  blood	  cells.	  Furthermore,	  it	  is	  able	  to	  recruit	  neutrophils	  in	  a	  chemotaxis	  
assay	  and	  induces	  IL-­‐8	  expression,	  correlated	  with	  TLR2	  sensing	  of	  PSM	  peptides	  [11-­‐13].	  
Finally,	  we	  demonstrate	  for	  the	  first	  time	  that	  amyloid	  aggregation	  of	  these	  toxic	  peptides	  
inhibits	  both	  cell	  lysis	  and	  neutrophil	  recruitment.	  This	  suggests	  that	  PSMs	  may	  act	  as	  a	  kind	  of	  
toxin	  repository	  when	  aggregated	  into	  amyloids.	  This	  is	  a	  first	  hint	  that	  amyloid	  fibril	  formation	  
can	  modulate	  S.	  aureus’	  interactions	  with	  host	  cells,	  constituting	  a	  genuine	  switch	  from	  
pathogen	  to	  non-­‐invasive	  lifestyles.	  
	  
S.	  aureus	  is	  sensed	  by	  	  macrophages,	  triggering	  an	  inflammatory	  immune	  response	  which	  
recruits	  neutrophils	  [11-­‐13].	  PSMs	  are	  described	  to	  be	  the	  major	  neutrophils	  chemoattractants	  
in	  S.	  aureus	  supernatants,	  and	  our	  work	  with	  PSMs	  and	  N-­‐AgrD	  supports	  this	  [82,	  102-­‐103].	  
PSMs	  and	  their	  proteolytic	  derivatives	  are	  strong	  activators	  of	  neutrophil	  formyl-­‐peptide	  
receptor	  2	  (FPR2),	  and	  FPR1	  to	  a	  lesser	  extent	  [46,47].	  Interestingly,	  FPR2	  binds	  a	  wide	  variety	  
of	  amyloid-­‐like	  ligands	  [47],	  including	  LL-­‐37,	  serum	  amyloid	  A	  [47],	  brain	  amyloid	  precursor	  [48],	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and	  annexin	  1	  [49],	  indicating	  a	  link	  between	  immune	  response	  to	  PSMs	  and	  other	  amyloids.	  
Remarkably,	  amyloid	  aggregation	  of	  PSMs	  impairs	  neutrophil	  chemotaxis	  and	  cytokine	  
production	  [46]	  and	  efficiently	  reduces	  the	  PSMs’	  impact	  on	  the	  immune	  system	  and	  
fundamentally	  changes	  the	  way	  S.	  aureus	  interacts	  with	  its	  host.	  	  
	  
PSMs	  are	  detergent	  like	  peptides	  that	  aggregate	  into	  multimeric	  complexes	  at	  lipid	  membranes	  
[50].	  Many	  small	  peptide	  toxins	  interact	  with	  host	  cell	  membranes	  to	  cause	  pores	  ultimately	  
induce	  cell	  lysis	  in	  what	  is	  likely	  to	  be	  a	  receptor	  independent	  process	  with	  no	  specificity	  for	  cell	  
type	  [40-­‐45].	  Indeed,	  PSMs	  were	  found	  to	  associate	  with	  phophatidylcholine	  vesicles.	  In	  vitro,	  
demonstrating	  their	  ability	  to	  associate	  with	  membranes	  [42,44].	  PSMα	  peptides	  are	  much	  
more	  toxic	  to	  neutrophils	  than	  PSMβs,	  but	  all	  PSMs	  show	  synergistic	  lysis	  with	  other	  
staphylococcal	  hemolysins	  both	  from	  native	  expression	  and	  exogenous	  addition	  of	  synthetic	  
peptide	  [44].	  PSM-­‐mediated	  lysis	  is	  abrogated	  in	  the	  presence	  of	  lipoproteins	  found	  in	  human	  
serum,	  suggesting	  that	  their	  toxicity	  is	  largely	  mediated	  by	  the	  extracellular	  environment	  in	  
which	  they	  are	  produced	  [51,52].	  It	  is	  possible	  that	  the	  presence	  of	  these	  lipoproteins	  is	  
somehow	  enhancing	  amyloid	  fibril	  sequestration	  of	  toxins,	  although	  this	  theory	  is	  yet	  to	  be	  
tested.	  When	  PSMs	  form	  fibrils,	  they	  are	  less	  cytotoxic,	  presumably	  due	  to	  interference	  of	  
membrane-­‐interaction	  as	  large	  aggregates	  [7,8].	  	  
	  
Taken	  together,	  Chapter	  3	  of	  this	  work	  provides	  evidence	  that	  N-­‐AgrD,	  like	  PSMα1,	  can	  
modulate	  its	  activity	  through	  amyloid	  fibril	  formation.	  By	  forming	  amyloid	  aggregates,	  these	  
peptides	  show	  a	  drastic	  decline	  in	  virulence	  capacity.	  S.	  aureus	  colonies	  may	  use	  amyloid	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formation	  to	  modulate	  their	  interactions	  with	  the	  host	  using	  this	  unusual	  post-­‐translational	  
regulatory	  mechanism.	  The	  signals	  or	  accessories	  that	  facilitate	  the	  switch	  from	  soluble	  peptide	  
to	  inert	  aggregate	  are	  unknown,	  but	  a	  potentially	  noteworthy	  mechanism	  is	  described	  in	  
Chapter	  4.	  
3.	  Are	  there	  external	  factors	  that	  promote	  PSM	  aggregation?	  
To	  further	  investigate	  how	  S.	  aureus	  uses	  PSMs	  to	  control	  its	  pathogenicity,	  I	  looked	  to	  other	  
biofilm	  matrix	  components.	  The	  mechanism	  driving	  PSM	  aggregation	  in	  situ	  is	  not	  known,	  but	  
some	  initial	  hints	  suggest	  that	  the	  presence	  of	  extracellular	  DNA	  could	  stimulate	  fibril	  
formation.	  Amyloid-­‐DNA	  interactions	  have	  been	  characterized	  elsewhere	  [53-­‐60].	  Using	  
prototypic	  prion	  fragment	  and	  amyloid-­‐beta	  as	  model	  for	  aggregation,	  Domizio	  et	  al.	  
complexed	  amyloid	  proteins	  with	  the	  oligonucleotide	  CpGB	  fixed	  to	  a	  surface.	  They	  found	  that	  
not	  only	  did	  nucleic	  acids	  promote	  amyloid	  formation,	  but	  produced	  species	  that	  were	  more	  
immunologically	  active	  than	  with	  protein	  alone,	  suggesting	  that	  the	  immune	  system	  can	  
recognize	  nucleic	  acids	  as	  part	  of	  the	  amyloid	  complex	  [53,54].	  Other	  studies	  show	  that	  poly	  (A)	  
RNA	  is	  critical	  for	  infectious	  prion	  protein	  conversion	  [61,62].	  DNA	  has	  been	  described	  as	  an	  
osmotic	  chaperone	  that	  can	  either	  promote	  or	  discourage	  amyloid	  aggregation	  of	  Parkinson’s	  
disease	  agent	  α-­‐synuclein	  and	  Alzheimer-­‐associated	  amyloid-­‐beta	  and	  τ	  peptides,	  by	  stabilizing	  
intermediate	  protein	  conformations	  [55].	  Amyloid	  peptide	  and	  nucleic	  acid	  interactions	  may	  
even	  have	  implications	  for	  early	  Darwinian	  evolution	  by	  promoting	  nucleic	  acid	  hybridization	  to	  
create	  a	  “scaffold”	  for	  sequestration	  of	  nucleic	  acids	  for	  replication	  and	  division	  [63,64].	  Based	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on	  previous	  observations,	  there	  is	  substantial	  support	  for	  the	  hypothesis	  that	  extracellular	  DNA	  
induces	  amyloid	  fibril	  formation.	  
	  
Extracellular	  DNA	  is	  produced	  by	  autolysis	  in	  Staphylococcal	  biofilms.	  Autolysins	  are	  required	  
cell	  wall	  metabolism	  by	  making	  specific	  cuts	  in	  the	  peptidoglycan	  cell	  wall	  to	  enable	  insertion	  of	  
new	  muropepide	  strands	  during	  cellular	  growth	  and	  daughter	  cell	  separation.	  This	  cutting	  
activity	  is	  believed	  to	  also	  cause	  breaches	  in	  the	  cell	  wall	  under	  carefully	  regulated	  conditions	  to	  
induce	  cellular	  lysis	  of	  small	  subpopulations	  of	  bacteria	  in	  biofilms.	  Atl	  is	  a	  bifunctional	  
peptidoglycan	  hydrolase	  composed	  of	  an	  amidase	  domain	  and	  a	  glucosaminidase	  domain	  and	  
the	  predominant	  peptidoglycan	  hydrolase	  in	  staphylococci	  [65-­‐67].	  The	  importance	  for	  Atl-­‐
mediated	  autolytic	  release	  of	  eDNA	  in	  early	  biofilm	  development	  was	  demonstrated	  in	  closely	  
related	  species	  Staphylococcus	  epidermidis	  [65].	  Qin	  et	  al.	  demonstrate	  that	  the	  major	  autolysin	  
Atl	  is	  the	  primary	  mediator	  of	  eDNA	  release	  assisting	  in	  initial	  attachment	  to	  glass	  or	  plastic	  
surfaces	  and	  that	  DNase	  I	  treatment	  prevents	  attachment	  and	  biofilm	  formation	  S.	  aureus	  cells	  
lacking	  AtlA	  form	  large	  clusters	  consistent	  with	  impaired	  cell-­‐separation.	  Planktonic	  growth	  in	  
complex	  media	  is	  largely	  unaffected	  by	  loss	  of	  AtlA	  function,	  but	  adhesion	  and	  biofilm	  
formation	  was	  impaired	  [66].	  	  
	  
In	  S.	  aureus,	  eDNA	  release	  is	  mediated	  by	  additional	  autolysins	  controlled	  by	  the	  cid/lrg	  
operons,	  which	  function	  through	  a	  toxin/antitoxin	  “programmed	  cell	  death”	  process	  that	  
respond	  to	  changes	  in	  carbohydrate	  metabolism	  and	  acetate	  accumulation	  [67].	  AtlA	  is	  also	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known	  to	  contribute	  to	  cell	  lysis	  in	  biofilms,	  so	  to	  remove	  any	  ambiguity	  associated	  with	  cid/lrg	  
regulation,	  we	  chose	  to	  investigate	  the	  major	  autolysin	  AtlA’s	  role	  in	  fibril	  formation.	  
	  
Under	  fibril	  inducing	  conditions,	  an	  ΔatlA	  mutant	  biofilm	  did	  not	  produce	  PSM	  fibrils	  (Fig.	  4.1).	  
This	  was	  determined	  both	  by	  TEM	  microscopy	  and	  via	  Western	  blot	  of	  PSMα1	  in	  fibril	  isolation	  
preps	  (Fig.	  4.1A-­‐D).	  The	  ΔatlA	  mutant	  still	  produced	  PSMs,	  but	  they	  did	  not	  form	  fibrils	  outside	  
of	  the	  cell	  (Fig.	  4.1C).	  I	  confirmed	  that	  DNA	  was	  not	  present	  in	  ΔatlA	  biofilms,	  but	  was	  present	  
in	  both	  wildtype	  and	  ΔPSM	  mutants	  (Fig.	  4.1D).	  Co-­‐culturing	  of	  a	  ΔPSM	  mutant,	  which	  produces	  
eDNA,	  and	  an	  ΔatlA	  mutant,	  which	  produces	  PSMs,	  complemented	  for	  fibril	  formation,	  
suggesting	  that	  both	  PSMs	  and	  DNA	  are	  necessary	  for	  PSM	  aggregation	  in	  S.	  aureus	  biofilms	  
(Fig.	  4.1A).	  	  
	  
My	  recent	  work	  presented	  in	  Chapter	  4	  suggests	  that	  PSM-­‐DNA	  interactions	  contribute	  to	  fibril	  
formation	  and	  can	  inhibit	  virulence.	  DNA	  gel	  shift	  and	  dynamic	  light	  scattering	  assays	  
demonstrate	  that	  non-­‐aggregated	  PSMα1	  interacts	  with	  DNA	  to	  form	  large	  aggregates.	  
Aggregation	  in	  the	  presence	  of	  S.	  aureus	  genomic	  DNA	  promotes	  amyloid	  formation,	  again	  
supporting	  DNA’s	  role	  in	  promoting	  biofilm	  amyloid	  assembly.	  Furthermore,	  DNA-­‐promoted	  
aggregation	  inhibits	  PSM	  cytolytic	  activity,	  suggesting	  that	  DNA	  can	  detoxify	  PSMs	  by	  
promoting	  amyloid	  assembly.	  Taken	  together,	  these	  data	  provide	  basic	  evidence	  that	  biofilm	  
matrix	  components,	  like	  DNA,	  can	  modulate	  PSM	  activity	  to	  promote	  biofilm	  formation,	  or	  
reduce	  interactions	  with	  the	  host	  immune	  system.	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My	  graduate	  work	  has	  shown	  that	  bacterial	  amyloid	  formation	  is	  a	  complex,	  and	  oftentimes	  
incidental,	  occurrence	  of	  bacterial	  physiology.	  The	  discovery	  that	  PSM	  peptides	  can	  form	  
amyloid	  structures	  changes	  the	  way	  we	  should	  view	  their	  pathology	  and	  bacterial	  infection	  
models.	  The	  elucidation	  of	  a	  novel	  function	  for	  the	  N-­‐AgrD	  peptide	  demonstrates	  the	  
complexity	  of	  S.	  aureus	  virulence	  and	  its	  reliance	  on	  small	  peptide	  toxins	  as	  a	  form	  of	  that	  is	  
both	  recycling	  for	  economical	  and	  efficacious	  in	  its	  effects.	  The	  discovery	  that	  eDNA	  promotes	  
PSM	  amyloid	  assembly	  adds	  further	  detail	  to	  our	  understanding	  of	  how	  extracellular	  factors	  
modulate	  virulence.	  The	  fact	  that	  PSMs	  interact	  with	  DNA,	  similar	  to	  other	  known	  amyloid	  
proteins	  also	  ties	  together	  disparate	  concepts	  and	  techniques,	  bridging	  between	  pathology,	  
biochemistry,	  and	  microbiology.	  Taken	  together,	  I	  have	  defined	  how	  this	  recently	  discovered	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The	  work	  presented	  in	  my	  thesis	  is	  just	  the	  beginning	  of	  a	  new	  and	  exciting	  field	  of	  S.	  aureus	  
research.	  Among	  the	  many	  remaining	  questions,	  I	  find	  the	  following	  to	  be	  most	  critical:	  
1.	  How	  do	  PSMs	  aggregate/disaggregate	  In	  vivo?	  
2.	  How	  does	  PSM	  aggregation	  affect	  the	  biofilm	  lifecycle?	  
3.	  What	  is	  the	  functional	  role	  of	  PSM	  aggregation	  in	  situ?	  
How	  do	  PSMs	  aggregate/disaggregate	  In	  vivo?	  
	  
We	  hypothesize	  that	  PSMs	  form	  “toxin	  repositories”	  that	  sequester	  toxins	  from	  the	  
environment	  under	  a	  certain	  set	  of	  conditions	  (See	  Fig.	  1.5).	  To	  define	  this	  as	  a	  biologically	  
relevant	  impact,	  our	  next	  step	  will	  be	  to	  find	  specific	  conditions	  under	  which	  PSMs	  aggregate	  
and	  conversely,	  disaggregate.	  Bacterial	  amyloids	  that	  aggregate	  to	  inhibit	  toxic	  activity	  have	  
been	  described	  in	  other	  systems	  [1].	  These	  include	  MccE492	  in	  Klebsiella	  pneumoniae	  [2]	  and	  
listerioloysin	  O	  (LLO)	  in	  Listeria	  monocytogenes	  [3].	  LLO	  has	  been	  shown	  to	  aggregate	  under	  
alkaline	  conditions	  to	  form	  inert	  fibrous	  structures	  that	  bind	  amyloid	  specific	  dyes	  while	  
forming	  cytolytic	  dimers	  in	  acidic	  conditions	  (similar	  to	  that	  of	  the	  phagolysosome).	  As	  PSMs	  
are	  known	  to	  be	  expressed	  after	  neutrophil	  engulfment,	  it	  would	  be	  useful	  to	  determine	  
whether	  PSMs	  can	  aggregate/disaggregate	  in	  a	  similar	  manner	  [4].	  Other	  factors	  that	  should	  be	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explored	  include	  salts,	  trace	  metals,	  and	  osmolytes,	  all	  of	  which	  are	  known	  to	  affect	  the	  
polymerization	  kinetics	  of	  amyloid	  formation	  [5].	  Understanding	  how	  PSMs	  behave	  in	  solution	  
will	  be	  especially	  important	  to	  guide	  our	  research	  into	  understanding	  how	  PNG	  media	  
promotes	  fibril	  formation.	  
	  
Little	  is	  known	  about	  how	  individual	  PSM	  peptides	  interact	  to	  form	  amyloid	  fibrils.	  The	  In	  vitro	  
assay	  conditions	  I	  have	  used	  in	  my	  work	  test	  only	  a	  very	  limited	  set	  of	  environmental	  conditions	  
to	  answer	  basic	  questions	  about	  amyloid	  formation.	  Multiple	  PSM	  species,	  including	  PSMβs	  and	  
δ-­‐toxin,	  were	  detected	  in	  our	  initial	  MS	  screen,	  and	  many	  of	  these	  have	  not	  been	  assayed	  for	  
virulence	  or	  function	  in	  our	  lab.	  Some	  of	  my	  early	  assays	  using	  synthetic	  peptides	  suggested	  
that	  some	  PSMs	  form	  amyloids	  while	  others	  do	  not,	  despite	  their	  structural	  similarity	  (Figs.	  1.4,	  
6.1).	  A	  fundamental	  understanding	  of	  how	  each	  PSM	  interacts	  and	  folds	  to	  adopt	  amyloid	  
structure	  is	  critical.	  We	  also	  know	  little	  about	  the	  basic	  stoichiometry	  of	  each	  component	  in	  
fibril	  development.	  A	  more	  specific	  understanding	  of	  PSM	  interactions	  in	  amyloid	  formation	  will	  
be	  critical	  to	  understanding	  how	  amyloid	  aggregation	  happens	  In	  vivo.	  
	  
A	  confounding	  factor	  in	  my	  work	  has	  been	  reliance	  on	  synthetic	  peptides	  to	  assay	  fibril	  
formation.	  While	  synthetic	  peptides	  have	  the	  advantage	  of	  being	  pure	  and	  free	  of	  cellular	  
contaminants,	  lot-­‐to-­‐lot	  variation	  yields	  a	  product	  that	  can	  alter	  assay	  results,	  making	  
comparison	  difficult	  over	  time.	  To	  correct	  this,	  it	  would	  be	  helpful	  to	  design	  a	  method	  to	  purify	  
or	  extract	  PSMs	  in-­‐house.	  Purification	  or	  isolation	  of	  aggregative	  proteins,	  like	  amyloids,	  is	  
problematic	  and	  requires	  troubleshooting	  to	  optimize	  yield.	  Although	  methods	  have	  been	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published	  to	  isolate	  or	  detect	  PSMs	  in	  culture	  supernatants,	  I	  have	  thus	  far	  been	  unsuccessful	  
to	  do	  so	  [6-­‐8].	  These	  methods	  include	  phase	  separation	  with	  phenol	  or	  butanol.	  Even	  after	  
following	  exact	  protocols	  published	  using	  HPLC	  and	  electrospray	  MS	  to	  detect	  and	  quantitate	  
PSMs	  from	  culture	  supernatants,	  I	  was	  unable	  to	  get	  usable	  results,	  even	  with	  the	  help	  of	  an	  
HPLC	  expert	  consult	  (Ray	  Barbahan,	  UM	  Dept.	  of	  MCDB).	  One	  method	  I	  had	  initially	  attempted	  
to	  set	  up	  to	  purify	  PSMs	  used	  SUMO	  tagging	  to	  express	  and	  purify	  peptides	  from	  an	  E.	  coli	  
expressions	  system.	  The	  plasmids	  were	  created,	  but	  purification	  was	  not	  attempted	  due	  to	  time	  
constraints.	  Future	  researchers	  following	  up	  on	  my	  work	  may	  want	  to	  explore	  this	  as	  a	  possible	  
avenue	  for	  generating	  PSMs	  in-­‐house.	  
	  
Another	  potentially	  interesting	  aspect	  of	  PSM	  fibril	  formation	  is	  the	  effect	  of	  methionine	  
oxidation	  on	  peptide	  behavior.	  All	  PSMs	  have	  N-­‐terminal	  methionines,	  and	  in	  the	  cellular	  
environment	  pools	  of	  formylated	  and	  non-­‐formylated	  PSMs	  exist	  (7,9-­‐10).	  Our	  analysis	  of	  S.	  
aureus	  fibril	  composition	  did	  not	  detect	  formylation,	  but	  the	  oxidative	  state	  of	  this	  methionine	  
residue	  may	  have	  implications	  for	  protein	  folding.	  For	  example	  –	  amyloid-­‐	  beta	  contains	  a	  
methionine	  residue	  (M35)	  that	  can	  inhibit	  amyloid	  formation	  when	  oxidized	  [11,12].	  The	  
oxidation	  state	  of	  methionine	  can	  be	  affected	  by	  many	  factors,	  including:	  atmospheric	  oxygen,	  
oxygen	  radicals	  (like	  H2O2),	  buffers	  that	  are	  not	  de-­‐gassed,	  metal	  ions,	  desiccation,	  freeze/thaw	  
cycles,	  photo	  reactions,	  and	  even	  DMSO.	  Any	  one	  of	  these	  factors	  can	  create	  variable	  amounts	  
of	  oxidized/reduced	  peptide	  if	  not	  carefully	  controlled.	  If	  methionine	  oxidation	  does	  affect	  PSM	  
amyloid	  formation,	  the	  environmental	  factors	  may	  provide	  biologically	  relevant	  triggers	  to	  
initiate	  aggregation.	  One	  example	  of	  a	  biologically	  relevant	  oxidation	  event	  may	  occur	  during	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ROS	  exposure	  inside	  neutrophils.	  By	  utilizing	  the	  ThT	  assay,	  peptides	  oxidation	  states	  should	  be	  
tested	  for	  inhibition	  or	  promotion	  of	  amyloid	  formation.	  
How	  does	  PSM	  aggregation	  affect	  the	  biofilm	  lifecycle?	  
PSMs	  may	  contribute	  to	  biofilm	  organization	  by	  affecting	  cellular	  movement.	  It	  is	  well-­‐
established	  that	  the	  agr	  quorum	  sensing	  system	  promotes	  biofilm	  dispersal	  through	  several	  
mechanisms.	  Dispersal	  occurs	  largely	  from	  the	  expression	  of	  proteases	  that	  degrade	  
proteinaceous	  adhesins	  of	  the	  biofilm	  [13].	  Agr	  also	  promotes	  dispersal	  by	  upregulating	  
production	  of	  PSMs	  that	  function	  as	  “detergent-­‐like”	  molecules	  to	  stimulate	  spreading	  and	  
separation	  of	  the	  biofilm	  matrix	  [13-­‐18].	  Staphylococci	  do	  not	  produce	  specialized	  motility	  
structures	  like	  flagella,	  and	  are	  described	  as	  being	  non-­‐motile.	  Indeed,	  it	  has	  been	  shown	  that	  
PSMs	  display	  a	  unique	  form	  of	  “colony	  spreading”	  motility	  when	  bacterial	  cultures	  are	  spotted	  
on	  low	  agar	  plates	  [14].	  This	  colony	  spreading	  is	  agr	  and	  PSM	  dependent	  [17,18]	  and	  the	  effect	  
of	  each	  individual	  PSM’s	  contribution	  to	  spreading	  on	  low	  agar	  TSB	  has	  already	  been	  well	  
characterized	  and	  it	  was	  seen	  that	  smaller	  PSMs	  including	  PSMα3	  and	  delta	  toxin	  promoted	  
spreading	  [17,18].	  Initial	  evidence	  suggests	  that	  PSMs	  influence	  spreading	  on	  low	  agar	  plates	  
under	  fibril	  inducing	  media.	  I	  have	  observed	  that	  a	  form	  of	  agar	  “cracking”	  occurs	  only	  in	  the	  
presence	  of	  PSMs	  (Fig.	  6.2).	  It	  is	  unknown	  whether	  this	  is	  related	  to	  spreading	  motility	  or	  an	  
artifact	  observation	  of	  the	  technique.	  Exogenous	  addition	  of	  PSMα1	  promotes	  colony	  
expansion	  in	  S.	  aureus	  culture	  spots	  (Fig.	  6.2a).	  Virulent	  strains	  that	  are	  known	  to	  have	  highly	  
up-­‐regulated	  agr	  activity	  display	  distinct	  spreading	  and	  cracking	  on	  low	  agar	  PNG	  media	  relative	  
to	  a	  PSM	  mutant	  (Fig.	  6.2b).	  The	  effects	  of	  fibril	  formation	  should	  be	  studied	  to	  determine	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whether	  it	  can	  also	  inhibit	  spreading,	  as	  it	  appears	  to	  inhibit	  biofilm	  dispersal	  activity	  also	  
associated	  with	  surfactant-­‐like	  behavior	  (Figs.	  2.7-­‐2.8).	  Another	  factor	  that	  influences	  spreading	  
is	  eDNA.	  Kaito	  et	  al.	  found	  that	  extracellular	  nuclease	  activity	  is	  necessary	  to	  degrade	  eDNA	  for	  
colony	  spreading	  [19].	  The	  mechanism	  by	  which	  eDNA	  interacts	  with	  PSMs	  is	  unknown.	  I	  have	  
also	  observed	  that	  loss	  of	  nuclease	  activity	  correlates	  to	  reduced	  movement,	  likely	  due	  to	  the	  
presence	  of	  DNA	  interfering	  with	  movement	  (Fig.	  6.2b).	  My	  current	  research	  implies	  that	  the	  
presence	  of	  DNA	  can	  trigger	  PSM	  amyloid	  formation,	  inherently	  changing	  the	  biochemistry	  the	  
amphipathic	  peptides,	  and	  inhibiting	  their	  surfactant-­‐like	  activity.	  If	  so,	  DNA	  and	  PSMs	  may	  be	  
interacting	  in	  such	  a	  way	  that	  movement	  is	  inhibited.	  On	  the	  other	  hand,	  DNA	  may	  guide	  
bacterial	  motility	  similar	  to	  that	  described	  by	  Gloag	  et	  al.	  wherein	  DNA	  provides	  a	  sort	  of	  “rail	  
system”	  for	  bacterial	  motility	  [20].	  Endogenous	  addition	  of	  PSMs	  to	  ΔPSM	  bacterial	  cultures	  
spotted	  onto	  low-­‐agar	  plates	  with	  DNA	  may	  inform	  us	  whether	  DNA	  inhibits	  spreading	  in	  our	  
strains	  under	  these	  conditions.	  	  
	  
Finally,	  one	  big	  question	  that	  is	  unanswered	  for	  me	  is	  simply:	  are	  biofilms	  that	  produce	  PSM	  
fibrils	  less	  toxic	  to	  cells	  than	  biofilms	  not	  producing	  PSM	  fibrils?	  I	  had	  attempted	  to	  test	  this	  in	  
my	  last	  manuscript	  using	  DNA	  as	  a	  sort	  of	  “chelater”	  for	  toxic	  peptides.	  I	  found	  that	  the	  
hemolysis	  assay	  protocol	  I	  was	  using	  did	  not	  show	  different	  toxicity	  between	  supernatants	  of	  
biofilms	  grown	  in	  conventional	  media	  (TSBg)	  or	  fiber	  inducing	  media	  (PNG).	  One	  reason	  for	  this	  
may	  be	  the	  presence	  of	  α-­‐hemolysin,	  another	  agr-­‐regulated	  toxin	  known	  for	  its	  robust	  
hemolytic	  activity.	  Creation	  of	  α-­‐hemolysin	  null	  mutants	  with	  inducible	  PSM	  expression	  could	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be	  used	  to	  generate	  PSM-­‐rich	  supernatants	  in	  an	  assay	  similar	  to	  that	  described	  in	  Chapter	  3	  
(Fig.	  3.4c),	  which	  could	  then	  be	  mixed	  with	  DNA	  to	  test	  the	  “chelater”	  hypothesis.	  
What	  is	  the	  functional	  role	  of	  PSM	  aggregation	  in	  situ?	  
If	  PSM	  aggregation	  has	  a	  role	  in	  modulating	  virulence,	  what	  other	  conditions	  favor	  amyloid	  
formation?	  One	  way	  to	  address	  this	  question	  would	  be	  to	  determine	  whether	  other	  polyanions,	  
like	  heparin	  or	  polyphosphate,	  can	  induce	  amyloid	  formation.	  DNA	  is	  a	  polyanionic	  compound,	  
and	  many	  other	  polyanions	  are	  present	  in	  the	  environmental	  conditions	  outside	  of	  and	  
throughout	  the	  host	  environment.	  Heparin,	  and	  closely	  related	  proteoglycans	  like	  heparan	  and	  
chondroitin,	  can	  be	  found	  throughout	  the	  Animalia	  kingdom.	  Heparin	  is	  commonly	  used	  as	  an	  
anticoagulant	  to	  keep	  blood	  from	  clotting	  in	  catheter	  lock	  solutions.	  Hospital	  patients	  are	  at	  
great	  risk	  from	  hospital	  acquired	  S.	  aureus	  infections,	  and	  it	  is	  known	  that	  S.	  aureus	  can	  persist	  
in	  catheters.	  Heparin	  has	  been	  previously	  shown	  to	  promote	  biofilms	  In	  vitro	  and	  in	  catheter	  
lock	  solutions	  [21].	  S.	  aureus	  is	  also	  known	  to	  attach	  to	  prosthetic	  joints	  and	  fixtures	  coated	  in	  
proteoglycans	  used	  to	  stimulate	  growth	  and	  reassimilation	  into	  the	  body	  [22].	  It	  is	  possible	  that	  
biofilms	  forming	  in	  these	  environments	  are	  at	  least	  partially	  influenced	  by	  PSM	  amyloid	  
formation,	  which	  may	  further	  modulate	  immunogenicity	  of	  these	  kinds	  of	  infections.	  My	  initial	  
work	  suggests	  that	  PSMα1	  aggregation	  is	  enhanced	  by	  heparin	  salts	  (Fig.	  6.3).	  Previous	  efforts	  
to	  detect	  amyloid	  fibrils	  in	  S.	  aureus	  –	  positive	  patient	  catheters	  were	  unsuccessful,	  mostly	  
because	  TEM	  is	  not	  sensitive	  enough	  on	  its	  own	  to	  detect	  amyloid	  fibrils.	  Staining	  fixed	  biofilms	  
with	  ThT,	  or	  using	  immunocytochemistry	  to	  detect	  PSMα1	  in	  fibril	  structures,	  may	  prove	  to	  be	  
more	  useful	  techniques.	  Beyond	  the	  body	  environment,	  there	  is	  evidence	  that	  polyphosphate,	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polymers	  of	  charged	  phosphate	  monomers	  that	  are	  important	  phosphate	  sink	  for	  aquatic	  and	  
soil	  dwelling	  organisms,	  may	  function	  as	  a	  type	  of	  molecular	  chaperone	  during	  amyloid	  
aggregation	  [23].	  It	  would	  be	  interesting	  to	  see	  if	  polyphosphate	  plays	  a	  role	  in	  PSM	  amyloid	  
aggregation,	  similar	  to	  heparin.	  
	  
Finally,	  an	  unexplored	  but	  potentially	  fruitful	  field	  of	  study	  involves	  PSM	  interaction	  with	  
neutrophil	  DNA.	  It	  has	  been	  shown	  that	  neutrophils	  rapidly	  eject	  extracellular	  DNA	  nets	  in	  a	  
process	  called	  NETosis	  (Neutrophil	  Extracellular	  Traps)	  to	  sequester	  and	  kill	  invasive	  bacteria.	  
NETosis	  is	  signaled	  by	  sensing	  of	  PSMs,	  suggesting	  they	  may	  interact	  [24].	  If	  PSMs	  form	  
amyloids	  in	  the	  presence	  of	  neutrophil	  DNA,	  it	  may	  serve	  to	  detoxify	  the	  bacterial	  presence,	  
and	  reduce	  inflammatory	  response	  by	  containing	  the	  infection.	  Immunostaining	  in	  abscess	  
models	  may	  show	  the	  presence	  of	  PSM	  fibrils	  in	  chronic	  infections.	  Looking	  to	  interactions	  
between	  PSMs	  and	  host	  cells,	  like	  neutrophils,	  will	  help	  us	  to	  understand	  what	  role	  they	  play	  in	  
the	  body	  environment	  of	  humans	  suffering	  from	  chronic	  and	  acute	  S.	  aureus	  infections.	  
	  
The	  future	  directions	  outlined	  here	  are	  just	  a	  small	  sample	  of	  the	  many	  directions	  my	  research	  
could	  take.	  As	  previously	  stated,	  the	  fundamental	  discovery	  of	  functional	  bacterial	  amyloids	  in	  
S.	  aureus	  biofilms	  	  opens	  doors	  to	  fields	  including	  medicine,	  biophysics,	  bacterial	  genetics	  and	  
physiology,	  environmental	  ecology,	  and	  so	  on.	  The	  annotated	  aims	  stated	  here	  will	  help	  to	  
fulfill	  our	  basic	  understanding	  of	  how	  PSMs	  aggregate	  In	  vitro	  (for	  assay	  optimization)	  and	  In	  







Fig.	  6.1,	  Polymerization	  of	  synthetic	  PSMs	  In	  vitro,	  	  
In	  our	  original	  MS	  analysis	  of	  Staphylococcus	  aureus	  extracellular	  fibrils	  (summarized	  in	  Chapter	  
2,	  Fig.	  2.3D),	  we	  detected	  the	  presence	  of	  several	  PSM	  species	  (PSMα1,2,4,	  PSMΒ1,2,	  and	  δ-­‐
hemolysin).	  Of	  these,	  I	  found	  that	  some	  polymerize	  readily	  in	  a	  concentration-­‐dependent	  
manner	  under	  standard	  assay	  conditions	  (Described	  in	  detail	  in	  Chapter	  2).	  These	  include	  


















Fig.	  6.2,	  	  S.	  aureus	  colony	  spreading	  depends	  on	  PSM	  and	  nuclease	  activity,	  
	  A)	  Exogenous	  addition	  of	  1mg/mL	  PSMα1	  to	  S.	  aureus	  culture	  prior	  to	  spotting	  induces	  
spreading	  and	  cracking	  on	  low	  agar	  PNG	  plates	  in	  lab	  strain	  SH1000.	  B)	  S.	  aureus	  USA300	  strain	  
with	  up-­‐regulated	  agr	  shows	  distinct	  spreading	  and	  cracking	  while	  a	  PSM	  mutant	  does	  not.	  Loss	  












	   	  
	  
	  
Fig.	  6.3,	  PSMα1	  interacts	  with	  heparin	  to	  induce	  amyloid	  formation,	  	  
PSMα1	  (1	  mg/mL)	  was	  incubated	  with	  heparin	  sulfate	  salt	  (Sigma)	  under	  conditions	  described	  
in	  Chapter	  4.	  Heparin	  increased	  ThT	  levels	  in	  a	  concentration-­‐dependent	  manner.	  From	  this	  
data,	  it	  may	  be	  understood	  that	  heparin,	  like	  DNA,	  can	  promote	  amyloid	  formation,	  and	  may	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